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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) employs multiple 
functions to modulate host’s innate immune response, and several viral nonstructural proteins 
(nsps) are major players. In this dissertation, the research was mainly focused on identification 
and functional dissection of ORF1a-encoded nsps. 
PRRSV replicase polyproteins encoded by ORF1a region are predicted to be processed 
into at least ten nonstructural proteins. In chapter 2, these predictions were verified by using a 
panel of newly established antibodies specific to ORF1a-encoded nsps. Most predicted nsps 
(nsp1β, nsp2, nsp4, nsp7α, nsp7β and nsp8) were identified, and observed to be co-localized with 
de novo-synthesized viral RNA in the perinuclear region of the cell.  
Among all PRRSV proteins screened, nsp1β is the strongest type I interferon antagonist. 
In chapter 3, mutagenesis analysis of nsp1β was performed to knock down nsp1β’s IFN 
antagonist function. A highly conserved motif, GKYLQRRLQ, was determined to be critical for 
nsp1β’s ability to suppress IFN-β and reporter gene expression. Double mutations introduced in 
this motif, K130A/R134A (type 1 PRRSV) or K124A/R128A (type 2 PRRSV), improved 
PRRSV’s ability to stimulate the expression of IFN-α, IFN-β and ISG15. In addition to its 
critical roles involving in modulating host innate immune response, in the studies of Chapter 4, 
we demonstrated that PRRSV nsp1β functions as a transactivator to induce the -2/-1 ribosomal 
frameshifting in nsp2, which results in expression of two novel PRRSV proteins, nsp2TF and 
nsp2N. The conserved motif GKYLQRRLQ is also determined to be critical for the 
transactivation function of nsp1β.  
In chapter 5, the interferon antagonist, de-Ub and de-ISGylation activity of newly 
identified nsp2TF and nsp2N were evaluated. In vitro and in vivo characterization of three 
nsp2TF-deficient recombinant viruses indicated that all mutant viruses have improved ability to 
stimulate the innate immune response and provide improved protection in mutant virus-
vaccinated animals. 
In summary, this study verified the previously predicted PRRSV pp1a processing 
products, further evaluated the function of nsp1β and nsp2-related proteins. These data obtained 
here will provide basic knowledge for future development of vaccines and control measurements. 
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Abstract 
Porcine reproductive and respiratory syndrome virus (PRRSV) employs multiple 
functions to modulate host’s innate immune response, and several viral nonstructural proteins 
(nsps) are major players. In this dissertation, the research was mainly focused on identification 
and functional dissection of ORF1a-encoded nsps. 
PRRSV replicase polyproteins encoded by ORF1a region are predicted to be processed 
into at least ten nonstructural proteins. In chapter 2, these predictions were verified by using a 
panel of newly established antibodies specific to ORF1a-encoded nsps. Most predicted nsps 
(nsp1β, nsp2, nsp4, nsp7α, nsp7β and nsp8) were identified, and observed to be co-localized with 
de novo-synthesized viral RNA in the perinuclear region of the cell.  
Among all PRRSV proteins screened, nsp1β is the strongest type I interferon antagonist. 
In chapter 3, mutagenesis analysis of nsp1β was performed to knock down nsp1β’s IFN 
antagonist function. A highly conserved motif, GKYLQRRLQ, was determined to be critical for 
nsp1β’s ability to suppress IFN-β and reporter gene expression. Double mutations introduced in 
this motif, K130A/R134A (type 1 PRRSV) or K124A/R128A (type 2 PRRSV), improved 
PRRSV’s ability to stimulate the expression of IFN-α, IFN-β and ISG15. In addition to its 
critical roles involving in modulating host innate immune response, in the studies of Chapter 4, 
we demonstrated that PRRSV nsp1β functions as a transactivator to induce the -2/-1 ribosomal 
frameshifting in nsp2, which results in expression of two novel PRRSV proteins, nsp2TF and 
nsp2N. The conserved motif GKYLQRRLQ is also determined to be critical for the 
transactivation function of nsp1β.  
In chapter 5, the interferon antagonist, de-Ub and de-ISGylation activity of newly 
identified nsp2TF and nsp2N were evaluated. In vitro and in vivo characterization of three 
nsp2TF-deficient recombinant viruses indicated that all mutant viruses have improved ability to 
stimulate the innate immune response and provide improved protection in mutant virus-
vaccinated animals. 
In summary, this study verified the previously predicted PRRSV pp1a processing 
products, further evaluated the function of nsp1β and nsp2-related proteins. These data obtained 
here will provide basic knowledge for future development of vaccines and control measurements. 
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Chapter 1 - Literature review 
1.1 Porcine Reproductive and Respiratory Syndrome and the etiological agent 
Porcine reproductive and respiratory syndrome (PRRS) is one of the most 
economically significant viral diseases to swine industry worldwide for over two decades. It 
causes an estimated loss of 664 million to the United States annually alone (Miller, 2011). 
This disease was first reported in North America in 1987 (Keffaber, 1989) and almost 
simultaneously in Central Europe (Wensvoort et al., 1991). Initially, PRRS was referred to as 
"mystery swine disease" and "mystery reproductive syndrome", and characterized as blue-ear 
pig disease. Reproductive failure in sows and respiratory distress in young pigs are typical 
clinical signs of this disease. Since its emergence, several highly pathogenic PRRSV strains, 
which have caused PRRS disease outbreaks, were reported in different countries. In 2006, 
highly pathogenic (HP) PRRSV strains were isolated in China and South East Asia (Feng et 
al., 2008; Tian et al., 2007). Another highly pathogenic East European subtype 3 PRRSV, 
Lena, was reported in Eastern Europe (Karniychuk et al., 2010). Infection with HP-PRRSV 
strains is associated with severe clinical signs, pulmonary lesions and aberrant host immune 
responses (Hu et al., 2013; Lv et al., 2008; Xiao et al., 2010). 
The etiological agent, porcine reproductive and respiratory syndrome virus (PRRSV), 
is a small, enveloped virus with positive sense RNA genome. It belongs to the order 
Nidovirales, family Arteriviridae, which also includes equine arteritis virus (EAV), lactate 
dehydrogenase-elevating virus (LDV) and simian hemorrhagic fever virus (SHFV) (Snijder et 
al., 2013; Snijder & Meulenberg, 1998). PRRSV can be further divided into two distinct 
genotypes, type 1 (European genotype) and type 2 (North American genotype), which share 
about 63% nucleotide identity (Allende et al., 1999; Nelsen et al., 1999; Ropp et al., 2004). 
Lelystad virus (Wensvoort et al., 1991) and VR-2332 (Benfield et al., 1992; Collins et al., 
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1992), first isolated in Europe and Northern America, represent prototypic strains of 
European and North American genotypes.  
To date, PRRSV virion structure has been analyzed by employing several techniques, 
including negative stain electron microscopy (EM), cryo-EM and Cryo-electron tomography 
(Dea et al., 1995; Mardassi et al., 1994; Spilman et al., 2009). By cryo-EM, PRRSV virions 
appear as round or egg-shaped particles with a diameter from 50 nm to 74 nm (Spilman et al., 
2009). Unlike the structure of club-shaped protrusions on coronaviruses, PRRSV particles 
display a smooth and mostly featureless surface with few protruding features (Dea et al., 
1995; Mardassi et al., 1994). The virions contain an internal core with an average diameter of 
39 nm, and a lipid bilayer envelope about 4.5 nm in thickness, which are separated from each 
other by a 2-3 nm gap. In addition to the two-dimensional structure revealed by electron 
micrographs, cryo-electron tomography shows the pleiomorphic morphology of the PRRSV 
virions in greater detail and in three dimensions (Spilman et al., 2009).  
Swine are the only known natural host of PRRSV. PRRSV also has a very restricted 
cell tropism for cells of the monocytic lineage. The fully differentiated porcine alveolar 
macrophage (PAM) serves as a primary cell target for PRRSV infection (Duan et al., 1997a; 
b). Among many different cell lines tested, only the African green monkey kidney cell line 
MA-104 and derivatives such as MARC-145 are fully permissive to PRRSV replication (Kim 
et al., 1993). PRRSV enters PAM through standard clathrin-mediated endocytosis. The viral 
nucleocapsid is released into the cytosol following endosome acidification and membrane 
fusion (Nauwynck et al., 1999). The host factors mediating viral entry have been extensively 
studied for PRRSV (Van Breedam et al., 2010a; Welch & Calvert, 2010). To date, CD163 is 
believed to be major receptor which mediates viral internalization and disassembly. Van 
Breedam et al. (2010b) suggested that sialoadhesin (CD169) mediates viral internalization by 
the interaction with the ectodomains of GP5/M heterodimer (Van Breedam et al., 2010b). 
However, Prather et al. (2013) demonstrated that an intact sialoadhesin (CD169) is not 
required for attachment/internalization of the porcine reproductive and respiratory syndrome 
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virus using a CD169 gene knockout pig (Prather et al., 2013). By screening a PAM cDNA 
library for receptor function, CD163, a member of the scavenger receptor cysteine-rich 
family, was identified as a key factor in the initiation of PRRSV infection (Calvert et al., 
2007). Overexpression of CD163 renders a variety of non-permissive cell lines susceptible to 
PRRSV infection. Two minor structural proteins, GP2a and GP4, were determined as viral 
attachment proteins which mediate virus entry into susceptible host cell by interacting with 
CD163 (Das et al., 2010). In addition, EAV minor structural proteins (GP2a, GP3, GP4 and E) 
swapped into a chimeric PRRSV extended PRRSV cell tropism (Tian et al., 2012), which 
further provides genetic evidence to support that the minor GPs are the prime determinants of 
host cell binding and possibly also fusion and entry. 
After release of viral genomic RNA, PRRSV encodes replicase subunits through 
polyprotein processing in cytoplasm. Like all + RNA viruses, PRRSV replicase subunits 
appear to co-localize in the perinuclear region and assemble into replication and transcription 
complexes (RTC) for viral RNA synthesis. However, it is noteworthy that the majority of 
PRRSV nsp1β localizes to nuclear region at the late stage of virus infection, and nsp2TF 
seems to co-localize with Golgi (Chen et al., 2010; Fang et al., 2012). In EAV, large numbers 
of “double membrane vesicles” (DMV) are formed during virus infection, and the viral RTC 
is likely anchored on these DMVs (Pedersen et al., 1999; van Hemert et al., 2008). ORF1a-
encoded putative membrane-spanning proteins nsp2, nsp3 and nsp5 are major proteins 
involved in the formation of this membranous structure for the RTC (Snijder et al., 2001). 
Based on the evolutionary relationship, PRRSV infection is also supposed to induce DMV for 
viral RNA synthesis. Clearly, additional research is needed to further address the questions 
about PRRSV replicative cycle. 
During PRRSV replication, viral structural proteins are translated from 3’-co-
terminal nested set of subgenomic (sg) mRNAs, which serves as a hallmark of arteriviruses 
and other nidoviruses. All sg mRNAs share a common 5’ “leader sequence” which is 
identical to the 5’-proximal part of viral genome (Yu et al., 2009). The synthesis of sg mRNA 
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is considered to rely on discontinuous negative-strand RNA synthesis – a mechanism that 
similar to copy – choice RNA recombination (Pasternak et al., 2001; Sola et al., 2011). In 
brief, discontinuous negative strand RNA synthesis is considered to generate a nested set of 
negative-stranded sg RNAs, which subsequently serve as templates for sg mRNA synthesis. 
In this model, base pairing between leader transcriptional regulatory sequence (TRS) and 
body TRSs plays a key role in regulating viral transcription (Zheng et al., 2014). In addition, 
Sg mRNAs are supposed to be functionally monocistronic, with the exception of sg mRNA2 
and sg mRNA5, which encode two partial overlapped genes, E/GP2 and ORF5a/GP5, 
respectively. 
 
 1.2 PRRSV genome organization and gene expression 
PRRSV contains a ~15-kb plus-strand genomic RNA. The viral genome consists of a 
5’ - untranslated region (UTR) with 5’ cap structure, at least ten open reading frames (ORF1a, 
ORF1b, ORF2a, ORF2b, ORF3, ORF4, ORF5a, ORF5, ORF6 and ORF7), followed by a 3’ - 
untranslated region and a poly-A tail. The viral nonstructural proteins (nsp), major 
components of viral replication-transcription complex, are encoded in ORF1a and ORF1b 
which are located in 5’ proximal end of the genome and occupy about 75% of genome. Once 
the genome is released into the cytoplasm, two polyproteins, pp1a and pp1ab, are translated 
with the expression of the latter depending on a -1 ribosomal frameshift signal in the 
ORF1a/ORF1b overlap region. These polyproteins are processed by four viral proteases 
(PLP1α (nsp1α), PLP1β (nsp1β), PLP2 (nsp2) and SP (nsp4)) to yield at least 14 functional 
nonstructural proteins. The 3’-terminal quarter of viral genome encodes structural proteins, 
including four envelope glycoproteins (GP2a, GP3, GP4 and GP5), three non-glycosylated 
membrane proteins [2b, ORF5a and matrix (M)] and the nucleocapsid protein (N) (Bautista et 
al., 1996; Firth et al., 2011; Johnson et al., 2011; Mardassi et al., 1996; Meng et al., 1996; 
Meulenberg & Petersen-den Besten, 1996; Meulenberg et al., 1995; Mounir et al., 1995; 
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Snijder et al., 1999; Wu et al., 2001) (Table 1.1). All these structural proteins are translated 
from a nested set of 3’-coterminal subgenomic RNA, which is a unique replication strategy to 
viruses in the order Nidovirales. In addition, a TF ORF overlapping with the nsp2 coding 
region was discovered recently, which generated two novel viral proteins, nsp2TF and nsp2N. 
nsp2TF, which is translated through a programmed -2 ribosomal frame shifting (PRF) 
mechanism, is a tranframe protein sharing the N-terminal region with nsp2. At the same 
position of -2 PRF, a programmed -1 ribosomal frameshifting seems also occur to express 
nsp2N, a C-terminal truncated form of nsp2, named as nsp2N (Fang et al., 2012).  
The translation of pp1a and pp1ab replicase polyproteins initiates viral replication in 
PRRSV-infected host cells. Through serial proteolytic cleavages of pp1a and pp1ab 
polyproteins, individual PRRSV nonstructural proteins (nsps) are generated. Instead of 
polyprotein precursor, the functional nonstructural proteins play a key role in both viral 
genomic RNA synthesis and subgenomic RNA transcription. Currently, the proteolytic 
cleavages of PRRSV polyproteins are still not much known.  
In EAV, the prototypic virus of Arterivirus family, the processing of pp1a and pp1ab 
is well-understood by using bioinformatics, nsp-specific antisera, and various experimental 
systems (Snijder & Meulenberg, 1998; van Aken et al., 2006; Ziebuhr et al., 2000). Thus, 
most of our current knowledge about PRRSV nsps and their function are predicted by 
comparative sequence alignment between PRRSV and EAV. According to the processing 
scheme of pp1a and pp1ab developed in EAV, nsp1 and nsp2 are rapidly released from pp1a 
and pp1ab by co and posttranslational proteolytic cleavages of viral autoproteases, which 
contain papain-like cysteine proteases (PLP1 and PLP2) respectively. The remaining 
polyproteins from nsp3 to nsp12 are further processed into individual nonstructural proteins 
by a serine protease (SP) located in nsp4. Nsp7 is further processed into nsp7α and nsp7β by 
an internal cleavage. In addition, many intermediate cleavage products of unknown functions 
have been detected (Snijder et al., 1994; van Dinten et al., 1996). Wassenaar et al. (1997) 
proposed a processing model for EAV nsp3-8 region, including alternative major and minor 
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processing pathways. In the major processing pathway, cleaved nsp2 interacts with nsp3 and 
acts as a co-factor of SP, for cleavage of the nsp4/5 site in the nsp3–8 processing intermediate. 
Alternatively, when nsp2 does not associate with nsp3–8, a minor pathway can be followed in 
which the nsp5/6 and nsp6/7 sites are processed instead of the cleavage of nsp4/5 site 
(Wassenaar et al., 1997) (Fig. 1.1).  
Based on comparative sequence analysis (Ziebuhr et al., 2000), many features of 
replicase polyproteins appear to be conserved in other arteriviruses, there are still a number of 
striking differences. Firstly, PRRSV and EAV are only distantly related. For instance, the 
overall sequence identity in the pp1ab replicase polyproteins of EAV and PRRSV is about 
30–45 %, depending on the genome region and specific strains used for alignment (Nelsen et 
al., 1999). Secondly, there are considerable size differences, in particular in nsp2 of ORF1a. 
EAV nsp2 is about 571 aa, whereas the PRRSV counterpart can be up to ~1196 aa. Finally, 
an additional protease domain (papain-like protease α, PLPα) residing in nsp1 region was 
determined to be functional in PRRSV, which has lost its enzymatic activity in EAV (den 
Boon et al., 1995). Thus, the PRRSV polyproteins are assumed to be cleaved by three papain-
like proteases (PLPα, PLPβ and PLP2) located in the nsp1–nsp2 region, and the viral main 
protease, SP, residing in nsp4. According to the polyprotein processing scheme in EAV, 
PRRSV replicase polyproteins are being cleaved into at least 14 nsps, specifically nsp1 to 
nsp12, with nsp1 and nsp7 being subject to an internal cleavage. The nsp1 is auto-cleaved by 
PLPα yielding two subunits, nsp1α and nsp1β (Chen et al., 2010), and the nsp7 is processed 
by main protease (nsp4) into nsp7α and nsp7β.  
Recently, the authentic cleavage sites of nsp1α/nsp1β and nsp1β/2 were determined 
by crystal structure analysis and N-terminal protein sequencing (Chen et al., 2010; Sun et al., 
2009). In type 2 PRRSV, M180 and A181, 14 amino acids downstream of a previously 
proposed candidate site (166Q↓R167), was identified as the nsp1α/nsp1β cleavage site. Based 
on sequence alignment of nsp1 from type 1 and type 2 PRRSV, 180H↓S181 is predicted to 
be nsp1α/nsp1β site in type 1 PRRSV. Also, consistent with a previous prediction (Ziebuhr et 
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al., 2000), 383G↓A384 was confirmed as nsp1β/2 cleavage site in Type II PRRSV (Fang & 
Snijder, 2010).  
PRRSV nsp2 contains a papain-like cysteine protease domain (PLP) in its N-
terminal domain, which rapidly releases nsp2 from pp1a/pp1ab by cleaving nsp2/3 and has 
cis- and trans-cleavage activities (Han et al., 2009; Snijder et al., 1995). Through sequence 
alignment analysis, two possible nsp2/3 cleavage sites were predicted (Ziebuhr et al., 2000). 
Also, the candidate of nsp2/nsp3 cleavage site (1445GG↓A1447 in type 2 PRRSV), one 
amino acid downstream from the previously predication, close to the highly conserved nsp3 
subunit was believed to be authentic site most likely (Fang & Snijder, 2010).  
PRRSV nsp4, the main protease involved in polyprotein processing, is a 3C-like 
serine protease belonging to a subgroup of chymotrypsin-like enzymes named after the 
picornavirus 3C proteases. The crystal structure of PRRSV nsp4 has been resolved, which 
reveals that the protein is composed of three domains, with the C-terminal domain III 
dispensable for proteolytic activity (Tian et al., 2009). Based on a comparison with EAV, the 
PRRSV nsp4 mediates nine cleavages in nsp3-nsp12 region. In addition, the previously 
predicted cleavage sites of nsp3/4, nsp4/5, and nsp11/12 (Ziebuhr et al., 2000) were 
confirmed as cleavable peptides (Tian et al., 2009). 
 
 1.3 Non-canonical translation and PRRSV replicase expression 
Whilst a majority of cellular mRNAs are monocistronic, many viruses have evolved 
a profusion of non-canonical mechanisms which allow them to translate multiple viral 
proteins from a single RNA transcript. Non-canonical translational strategies comprise 
internal ribosome entry, leaky scanning, non-AUG initiation, ribosome shunting, reinitiation, 
ribosomal frameshifting and stop-codon readthrough. Particularly in RNA viruses, some 
individual viruses employ several different strategies to translate viral proteins. As a positive-
stranded RNA virus, PRRSV has a relatviely compact genome which is ~15.0 kb in length. 
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To optimize the usage of the availability of sequence space, PRRSV uses multiple strategies 
to translate non-structural or structural proteins. Meulenberg et al. (1993) identified a 
heptanucleotide slippery sequence (UUUAAAC) and a putative pseudoknot structure in the 
overlapping region of ORF1a and ORF1b of type 1 PRRSV, which are required for efficient -
1 ribosomal frameshifting. Recently, an efficient -2 programmed ribosomal frameshifting 
(PRF) was reported in PRRSV to be utilized for the expression of nsp2N and nsp2TF, 
although the detailed mechanism is still elusive (Fang et al., 2012). Here, it is the first -2 PRF 
reported in eukaryotic systems including the potential shift sites and stimulatory elements. 
PRRSV GP2 and E (2b) protein appear to be encoded by a single subgenomic mRNA2, with 
the translation of E protein dependent on a leaking ribosomal scanning (Wu et al., 2001). 
They identified a 10-kDa structural protein of PRRSV encoded by ORF2b, whose start codon 
is only 6 nucleotides downstream of the adenine of the ORF2a start codon. Another case of 
leaking ribosomal scanning in PRRSV was studies by Johnson et al. (2011). In this study, 
they screened highly purified virions of strain VR2332 for additional structural proteins. 
Based on the analysis of proteins incorporated into virions by mass spectrometry, ORF5a 
protein (a 51 amino acids polypeptide) was discovered that is encoded by an alternative ORF 
of the subgenomic mRNA5 encoding the major envelope glycoprotein, GP5. These results 
suggested that GP5 and ORF5a protein are encoded by the same subgenomic mRNA via a 
translation initiation mechanism involving leaky ribosomal scanning. The study of Sun et al. 
(2013) further confirmed that ORF5a protein is essential for virus viability by inactivating its 
expression in both type 1 and type 2 PRRSV.  
-1 programmed ribosomal frameshifting and the expression of PRRSV pp1ab 
Programmed -1 ribosomal frameshifting was first reported as a mechanism utilized 
by Rous sarcoma alpharetrovirus to express the Gag-Pol polyprotein from overlapping gag 
and pol ORFs (Jacks & Varmus, 1985; Jacks et al., 1988). -1 frameshifting has since been 
documented in many other viruses, including HIV, coronaviruses and arteriviruses. -1 
frameshifting has also been identified in conventional cellular genes of both prokaryotes and 
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eukaryotes, as well as in other replicating elements (reviewed by Giedroc & Cornish, 2009; 
Brierley et al., 2010). In eukaryotic systems, the -1 frameshifting signal consists of two 
elements: a slippery sequence with consensus X_XXY_YYZ (underlines separate zero-frame 
codons; XXX represents anythree identical nucleotides, YYY represents AAA or UUU, and 
Z represents A, C or U) where the ribosome changes frame, and a downstream stimulatory 
RNA structure (Firth and Brierley, 2012). A requirement of appropriate spacing (typically 5-9 
nt) between these two elements for efficient frameshifting is important. Although extensive 
investigations have been conducted to dissect the mechanism using different systems, it is 
still uncertain how the stimulatory RNAs function to promote frameshifting. As reviewed in 
(Ahlquist, 2006), the utilization of frameshifting as an expression strategy has numerous 
potential advantages. For instance, in retroviruses, frameshifting allows the virus to express 
Gag:Gag-Pol at a defined ratio that is likely to be optimized for virion assembly, as down-
regulation of this ratio inhibits retrovirus assembly, release and infectivity (Karacostas et al., 
1993; Shehu-Xhilaga et al., 2001). Similarly, in many other positive-sense RNA viruses, 
frameshifting is used to downregulate polymerase expression. By this strategy, like 
coronaviruses, they may produce the polymerase at a fixed ratio relative to other components 
of the replication complex. In addition, manipulating the frameshifting efficiency is able to 
attenuate RNA viruses, like HIV and severe acute respiratory syndrome (SARS) 
coronaviruses (Dulude et al., 2006; Plant et al., 2010), although a modest stimulation of 
frameshifting can actually increase HIV infectivity (Miyauchi et al., 2006). Recently, the 
possibility of ribosomal frameshifting targeted for antiviral therapy was tested in SARS 
coronavirus (Ahn et al., 2011). Their data showed that SARS replication was suppressed by 
antisense peptide nucleic acids through interference of ribosomal frameshifting. 
In PRRSV, programmed -1 frameshifting is utilized to express pp1ab dependent on 
the frameshifting elements within the overlapping region between ORF1a and ORF1b, 
including a heptanucleotide slippery sequence (U_UUA_AAC) and a putative pseudoknot 
RNA structure (Meulenberg et al., 1993). The estimated frameshifting efficiency is about 15-
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20% in a reporter system (den Boon et al., 1991; Firth & Brierley, 2012). There is almost a 
knowledge gap of -1 ribosomal frameshifting in PRRSV, although it has been extensively 
characterized in many RNA viruses. Based on the biological significance of -1 ribosomal 
frameshifting in other RNA viruses, -1 PRF may play critical roles in viral replication and the 
host-virus interaction. On one hand, through low efficiency of -1 PRF, PRRSV may produce 
replicase proteins in ORF1a and ORF1b at a preferred ratio to assemble viral replication and 
transcription complexes. On the other hand, PRRSV may produce more ORF1a-encoded 
nonstructural proteins to arrest host systems for its own benefits, since several ORF1a-
encoded nonstructural proteins were identified as antagonist to the host innate system.  
-2 programmed ribosomal frameshifting and the expression of PRRSV nsp2N and nsp2TF 
Recently, additional -2/-1 PRF was described to express two nsp2 variants 
(nsp2TF/nsp2N) in all arteriviruses except EAV (Fang et al., 2012). It is the first case of -2 
PRF described for eukaryotes. On the basis of bioinformatics prediction, this -2/-1 PRF was 
identified by identifying specific peptide covering the frameshifting site by mass 
spectrometry analysis. The estimated efficiencies of -2 and -1 PRF in PRRSV-infected cells 
are 16-20% and 7%, respectively. By using reverse genetics, two critical elements of -2 PRF 
were demonstrated, including a slippery sequence (G_GUU_UUU) and a conserved 
downstream RNA sequence (CCCANCUCC). However, unlike -1 PRF in RNA viruses 
reported previously, no particular RNA structure was predicted to function as frameshifting 
stimulatory element. It is also noteworthy that PRRSV nsp2TF and nsp2N share the N-
terminus of nsp2 containing an OTU domain (Ovarian Tumor domain) which inhibits Ub- 
and ISG15-dependent antiviral pathways (Frias-Staheli et al., 2007; Sun et al., 2010a; Sun et 
al., 2012). In addition, viable recombinant viruses with -2/-1 PRF inactivated were recovered 
in both PRRSV genotypes, and showed attenuated viral growth in vitro, which implied a 
possible application of -2/-1 PRF in PRRSV vaccine development.  
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 1.4 PRRSV Reverse genetics and their application 
For RNA viruses, reverse genetics is an approach utilizing recombinant DNA 
technology to reverse transcribe virus genome into cDNA and generate viruses from the 
cloned DNA. Since establishing the first reverse genetics system of polio virus, a positive-
strand RNA virus (Racaniello & Baltimore, 1981), reverse genetics systems have been 
constructed for many groups of RNA viruses, which has accelerated investigation in many 
aspects of virologic research, including characterization of viral replication and viral 
pathogenesis determinants, virus-host interactions, and vaccine development. The first 
PRRSV infectious cDNA clone was constructed for Lelystad virus strain, the prototype of 
European type PRRSV (Meulenberg et al., 1998). In this system, a copy of viral genome 
length cDNA was assembled and cloned into a low copy number plasmid under the 
bacteriophage T7 RNA polymerase promoter. The linearized plasmid created by digestion 
immediately downstream of the viral polyA tail was used as a template for in vitro 
transcription utilizing T7 RNA polymerase in the presence of a cap analog. The RNA 
transcripts were transfected into baby hamster kidney (BHK-21) cells which provided high 
transfection efficiency. At 24 h after transfection, the culture supernatant from transfected 
BHK-21 cells was harvested and transferred to porcine alveolar lung macrophages or CL2621 
cells to rescue infectious virus. In addition, a genetic marker was introduced into the cDNA 
clone to differentiate the recombinant virus from parental virus by creating a new restriction 
enzyme site immediately downstream of ORF7. A few years later, an infectious clone of VR-
2332, the prototype North American PRRSV, was generated (Nielsen et al., 2003). Based on 
the P129 infectious clone containing a highly virulent PRRSV isolated in 1995 under the T7 
promoter, Lee et al. (2005) established a DNA-launched reverse genetics system for PRRSV 
(Lee et al., 2005). The T7 promoter in the infectious clone was switched with the human 
cytomegalovirus (hCMV) immediate early promoter. PRRSV was rescued by direct 
transfection of DNA plasmid into Marc-145 cells, and cytopathic effects were observed at 3 
days post-transfection. To date, several reverse genetics systems have been developed for 
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various PRRSV isolates, including classic PRRSV (Choi et al., 2006; Fang et al., 2006; Li et 
al., 2013; Ran et al., 2008) and highly pathogenic PRRSV (Lv et al., 2008; Truong et al., 
2004; Zhang et al., 2011; Zhou et al., 2009), and they are widely employed in many aspects 
of PRRSV investigation. Among numerous applications of PRRSV infectious clone, in this 
section, we will mainly summarize the investigations employing infectious clone in 
identification of virulence determinant and vaccine development. 
Reverse genetics in identification of virulence determinants 
To date, multiple research groups have employed infectious clone to search for 
genetic markers for virulence. The results from (Wang et al., 2008) suggested that the 
replicase gene is a critical player in viral virulence and attenuation. Herein, they established 
infectious clones for two genetically distinct PRRSV stains, Ingelvac® PRRS MLV (vaccine) 
and MN184 (virulent strain). Through exchanging the genomic regions between two PRRSV 
strains, two reciprocal chimeric clones (pMLVORF1/MN184 and pMN184ORF1/MLV) were 
created. The pathogenesis of parental and chimeric viruses was evaluated in a nursery pig 
model, which showed that introduction of the 5’ four-fifths of the vaccine virus into virulent 
virus disrupted the acute pathogenicity of MN184. At the same, another study of (Kwon et al., 
2008) provided a more detailed analysis of virulence factors embedded in the PRRSV 
replicase gene. In this study, a highly virulent PRRSV infectious clone (pFL12) was used as 
backbone to construct a series of chimeric viruses with specific genomic regions swapped 
from an attenuated vaccine strain (Prime Pac). The in vivo pathogenicity of parental and 
chimeric viruses was evaluated in a sow reproductive failure model. Nsp3-8-coding region in 
the replicase gene appeared to be key player in PRRSV virulence, since the sows inoculated 
with the chimeric virus carrying nsp3-8 region from the vaccine strain exhibited a 
significantly improved piglet survival rate in comparison to that of parental virus group. In 
addition, the nsp1-3 and nsp10-12 regions may also contain potential virulence determinants. 
Although above results suggest that the genomic region of nsp3-8 from the vaccine strain 
attenuates highly virulent PRRSV, it is still unknown whether the same region from the 
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highly virulent PRRSV could elevate the virulence of PRRSV vaccine. Recently, Li et al. 
(2014) further dissected PRRSV virulence determinant using infectious clones constructed 
from two genetically distinct PRRSV strains isolated in China, HB-1/3.9 (low pathogenic 
strain) and JXwn (highly pathogenic strain) (Li et al., 2014). A series of recombinant viruses 
with swapped coding regions between the highly pathogenic and low pathogenic PRRSV 
were generated, and were characterized both in vitro and in vivo. Their data showed that both 
HP-PRRSV nsp9- and nsp10-coding regions increased the replication efficiency of low 
pathogenic PRRSV in vitro and in vivo and were related to the increased pathogenicity and 
fatal virulence for piglets. Consistently, the corresponding regions of low pathogenic PRRSV 
swapped into highly pathogenic PRRSV backbone attenuated HP-PRRSV in vitro and in vivo.  
PRRSV infectious clones in vaccine development 
To date, modified-live attenuated vaccines (MLV) against PRRSV are most efficient 
in in combating clinical disease. However, the animals vaccinated with current commercial 
MLV can’t be differentiated from naturally infected animals. Reverse genetics system opens 
the possibility for designing and generating the vaccine candidates with genetic markers 
which allow the differentiation of naturally infected and vaccinated animals (DIVA). There 
are two types of genetic markers utilized in designing marker vaccines for various animal 
RNA and DNA viruses, positive markers created by insertion of foreign antigens and 
negative markers created by deletion of epitopes or nonessential genomic sequences. Thus, 
the complementary assays can be performed to differentiate vaccinated animals from 
naturally infected animals by detecting the antibody response to genetic markers or modified 
genomic sequences (Castillo-Olivares et al., 2003; van Oirschot et al., 1996; Walsh et al., 
2000a; Walsh et al., 2000b). 
Several research groups have designed and generated marker vaccine candidates for 
PRRSV. Taking advantage of type I PRRSV infectious clone (pSD 01-08), Fang, et al. (2006) 
generated a recombinant PRRSV with eGFP gene expressed in the central region of the nsp2-
coding sequence (Fang et al., 2006). In a following study (Fang et al., 2008), using this GFP-
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tagged PRRSV as a backbone, a recombinant virus with both positive and negative marker 
virus were constructed by deletion of the B-cell epitope ES4 of nsp2, located downstream of 
the GFP insertion. The recovered virus (GFP/∆ES4 marker virus) was characterized in a 
nursery piglet disease model. Additionally, GFP- and ES4 epitope-based ELISA assays were 
developed as accompanying tests. The results showed that marker virus-vaccinated pigs could 
be recognized by GFP-positive and ES4-negative ELISA results, whereas wild type virus-
infected pigs could be identified by GFP-negative and ES4-positive ELISA results. Similarly, 
several type 2 PRRSV infectious clones were used as a backbone to construct marker vaccine 
candidates by manipulating the PRRSV nsp2 region. A VR2332 infectious clone was used as 
a backbone to express GFP gene as a nsp2 fusion protein by insertion of GFP into a nsp2 
deletion (V7-nsp2∆324-434) (Han et al., 2007). Although the recombinant virus was viable, 
the GFP insertion was unstable after being passaged on permissive cells. Also, a similar 
strategy was used to express GFP gene in the pCMV-129 infectious clone by replacing 131-
aa in the C-terminal region of nsp2. To date, many other foreign sequences were inserted into 
the nsp2 high-variable region to create marker viruses (de Lima et al., 2008; Lin et al., 2012; 
Sang et al., 2012; Xu et al., 2013; Xu et al., 2012). Nevertheless, the stability of the marker 
viruses is still a problem for its application in field. Pei, et al. (2009) described an additional 
strategy to express GFP and porcine circovirus type 2 capsid protein from a dedicated 
subgenomic RNA (Pei et al., 2009). In this strategy, using an infectious clone of type 2 
PRRSV strain P129 as backbone, the foreign genes were inserted between ORF1b and 
ORF2a followed by a copy of TRS6 to drive ORF2a/b transcription. The data of serial in 
vitro passage showed that the marker viruses are phenotypically stable for at least 37 
passages. To evaluate the immunogenicity of the recombinant viruses, piglets were 
immunized with wild type virus and marker viruses. Specific antibody response to GFP or 
PCV2 capsid were elicited in the animals inoculated with marker viruses, but not in the wild 
type virus-infected animals.  
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During the past decade, multiple PRRSV proteins were identified to be responsible 
for the delayed host innate immune response and neutralizing antibody response. By using 
available PRRSV infectious clones, several recombinant PRRSV with improved ability to 
elicit host immune response were generated by introducing specific mutations into the viral 
genome. By using reverse genetics, the effect of three putative N-linked glycosylation sites 
located on PRRSV GP5 ectodomain on the neutralizing antibody response was evaluated 
(Ansari et al., 2006). By incorporating targeted mutations into a full-length cDNA clone, 
three recombinant viruses with glycosylation sites disrupted were rescued and characterized 
in vitro and in vivo. Neutralizing antibody profiles in pig serum showed that the mutant 
viruses induced significantly higher levels of neutralizing antibodies against the mutant and 
wild type PRRSV. By using a type 1 PRRSV infectious cDNA clone (pCMV-SD 01-08), Sun 
and coworkers knocked down the inhibitory effect of PRRSV on the host innate immune 
response by introducing mutations/deletions to impair the deubiquitination activity of OTU 
domain embedded in nsp2 (Sun et al., 2012; Sun et al., 2010b). In their investigations, the 
cysteine protease domain embedded in PRRSV nsp2 was identified as an innate immune 
antagonist, which was facilitated by two major mechanisms, deubiquitination and 
deISGylation. The recombinant viruses with reduced deubiquitination and deISGylation 
activity were generated by modifying nsp2 PLP2 domain with mutations or deletions. Thus, 
all the investigations summarized above demonstrate that improved vaccine candidates with 
increased ability to elicit the host immune response may be designed and generated by 
utilizing reverse genetics. 
 
1.5 Host innate immunity and immune evasion by PRRSV nonstructural 
proteins 
Host antiviral innate immunity 
Host innate immune response function as the first line of defense against viral 
infection, which also provide a time interval for establishing specific adaptive immunity. 
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Interferons (IFNs) are a group of multifunctional cytokines which play significant roles in 
initial innate immune defense and modulating adaptive immunity. IFNs comprise two types, 
type I and type II IFNs. Recently, three novel IFNs, IFN-λ1 to λ3 have been classified into 
type III IFNs whose role in antiviral immunity remains to be evaluated (Randall & 
Goodbourn, 2008). Type I IFNs are believed to be the main players for innate immunity 
against viral infections and consist of various subtypes depending on the mammal species. In 
pigs, type I IFNs comprise multiple porcine IFN-α, IFN-ω, and IFN-δ like molecules, such as 
porcine IFN-α which are encoded by up to fifteen functional genes (Cheng et al., 2006; Sang 
et al., 2011). Additionally, porcine IFN-β, IFN-ε and IFN-κ are encoded by single gene loci 
in pigs (Artursson et al., 1992; Sang et al., 2011). Up on viral infection, pathogen associated 
molecular patterns (PAMP) stimulate IFNα/β expression through Toll-like receptors (TLR) 
and Retinoic acid inducible gene I-like receptors (RLR) in infected cells (Fig. 1.2A). After 
being recognized by host PAMP receptors, viral PAMPs activate serial protein signaling 
cascades, which results in the activation of transcription factors, including interferon 
regulatory factor 3 (IRF3), NF-κB, and ATF-2/c JUN. The coordinated activation of these 
transcription factors leads to the formation of transcriptionally competent enhanceosomes in 
the cell nucleus to induce the expression of type I interferons. Local production of type I 
IFNs establishes a major antiviral defense to inactivate and restrict virus spreading to 
adjacent cells. Many viruses, including Hepatitis C virus, HIV and severe acute respiratory 
syndrome (SARS) coronavirus, are very sensitive to type I IFNs, which has led to the 
development of several IFN-based antiviral therapies (Deutsch et al., 2007; Haagmans & 
Osterhaus, 2006; Loomba & Liang, 2007; Sulkowski & Benhamou, 2007; Yu et al., 2007). 
Besides direct antiviral activity, type I IFNs induce antiviral response through a receptor 
containing two subunits, IFNAR-1 and IFNAR-2. After being secreted, the interaction 
between type I IFNs and their receptors on adjacent cell surfaces activates the so-called JAK-
STAT signaling pathway (Fig. 1.2B). Briefly, the receptor binding activates JAKs (Janus 
activated kinases) and Tyk2, which phosphorylate signal transducers and activators of 
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transcription (STATs). The phosphorylated STAT1 and STAT2, in association with IRF9, 
form the heterotrimeric complex ISGF3 (interferon-stimulated gene factor 3), which is 
imported into the nucleus where it binds to IFN stimulated response elements (ISRE) in the 
promoter and induces the transcription of IFN-stimulated genes (ISGs). Activation of these 
genes enables the cell to establish an antiviral state to fight the infection and inhibit virus 
replication. 
Multiple studies have described that PRRSV infection elicits poor innate immune 
response, which may in turn result in a weak adaptive immune response. Miller et al. (2014) 
showed that PRRSV infection significantly suppressed the activation of type I interferon in 
Marc-145 cells, while stimulation by exogenous double-stranded RNA induced a significant 
production of type I interferon mRNA (Miller et al., 2004). Consistent with that, results from 
(Luo et al., 2008) indicated that the induction of IFN-β production is significantly inhibited 
by PRRSV infection. Recently, the luciferase gene based reporter assays have been employed 
to investigate the function of PRRSV nonstructural proteins in modulating host innate 
immune response. By using these tools, several PRRSV nonstructural proteins appear to 
possess the ability to modulate type I IFN synthesis and / or signaling in in vitro expression 
systems. The results from previous investigations (Beura et al., 2010; Chen et al., 2010; Kim 
et al., 2010; Sun et al., 2010a) suggested that PRRSV nsp1α/β and nsp2 strongly antagonize 
IFN-β promoter activation, although the detailed mechanisms are still not well-understood. 
The antagonism function of PRRSV nsp4 on IFN-β promoter activation has also been 
documented (Huang et al., 2014), although it induces apoptosis dependent on its serine 
protease activity (Ma et al., 2013). In addition, nsp11 was reported to have an inhibitory 
effect on IFN-β promoter activation (Beura et al., 2010). However, this observation may need 
detailed follow-up studies to rule out the possibility that the inhibitory effect may be due to 
toxicity to host cells when these potentially toxic viral enzymes are expressed in vitro. The 
inhibitory effect of PRRSV nsp2 PLP2 domain on IFN-β production and signaling was 
evaluated in HEK-293T cells. The results also confirmed that PRRSV nsp2 PLP2 domain is 
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able to de-conjugate both ubiquitin and interferon stimulated gene 15 (ISG15) from cellular 
proteins, which exerts inhibitory effect on ubiquitin- and ISG15- dependent innate immune 
response(Sun et al., 2010a; Sun et al., 2012).  
Suppression of Type I interferon synthesis and signaling by PRRSV nsp1α and nsp1β 
PRRSV nsp1α and nsp1β are the first two viral proteins synthesized after viral 
infection, and show predominantly nucleus localization at the later stages of infection (Chen 
et al., 2010). They appear to exert inhibitory effects on type I IFN production and signaling 
through different mechanisms. Expressed individually in cell culture systems, nsp1α shows 
stronge suppression on IFN synthesis, while nsp1β has the ability to inhibit both IFN 
synthesis and signaling (Beura et al., 2010; Chen et al., 2010; Kim et al., 2010). When testing 
the IFN antagonist mechanism in vitro using luciferase gene based immune assays, the 
regulatory factor 3 (IRF3)- dependent gene induction pathway for IFN-β synthesis appeared 
to be significantly arrested by nsp1β expression (Beura et al., 2010; Chen et al., 2010). The 
results from (Beura et al., 2010) showed that nsp1β inhibited Sendai virus-mediated 
activation of porcine IFN-β promoter activity in a porcine myelomonocytic cell line. At the 
same time, Chen et al. (2010) screened each molecule that could be targeted by nsp1α/β in 
the IRF3 induction pathway. However, none of the cytoplasmic components were identified, 
indicating PRRSV nsp1α/β may act downstream of IRF3 activation, which may have a direct 
effect on the formation of the transcription enhanceosome on the IFN-β promoter in the 
nucleus. The study of (Kim et al., 2010) suggested that nsp1α/β may interfere with IFN-β 
production through degradation of transcription factor CREB-binding protein (CBP300) in 
the cell nucleus. Their data indicated that nsp1α/β did not block IRF3 phosphorylation or its 
nuclear translocation, but inhibited IRF3 association with CBP300 to form the transcription 
enhanceosome in the nucleus, when expressed in HeLa or MARC-145 cells. Han et al. (2013) 
showed that the N-terminal zinc finger motif (ZF1) is the essential element of nsp1α for IFN 
suppression. In their study, the IFN antagonism of nsp1α was impaired by inactivating the 
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ZF1 motif by site-directed mutations, which indicated that the CBP degradation is likely the 
key mechanism for IFN suppression mediated by the nsp1α (Han et al., 2013).  
Besides its role in suppression of IFN production, PRRSV nsp1β showed strong 
ability to suppress the IFN-dependent signaling pathway leading to ISG expression (Beura et 
al., 2010). In another study, reporter gene expression from an IFN-stimulated response 
element (ISRE) promoter was significantly inhibited after IFN-β stimulation (Chen et al., 
2010). The results indicated that the phosphorylation and nuclear translocation of the 
transcription factor STAT1 was blocked by nsp1β expression. Song et al. (2009) identified a 
protein inhibitor of activated STAT1 (PIAS1) as a specific cellular interaction partner for 
nsp1α and nsp1β. In addition(Song et al., 2009), Wang et al. (2013) suggested that nsp1β 
inhibited interferon-activated JAK/STAT signal transduction by inducing karyopherin-α1 
degradation. Nsp1β induced the degradation of karyopherin-α1 (KPNA1, also called 
importin-α5), which is known to mediate the nuclear import of ISGF3, heterodimers 
comprising phosphorylated STAT1, STAT2 and IRF9 (Wang et al., 2013).  
PRRSV nsp2 antagonisms the host innate immunity through multiple mechanisms 
In PRRSV, nsp2 is the largest (mature) viral protein and contains at least four 
distinct domains: the N-terminal PLP2/OTU domain, a central hypervariable region, a 
putative transmembrane domain, and a C-terminal region of unknown function that is rich in 
conserved Cys residues (Snijder et al., 1995). Based on comparative sequence analysis, the 
PRRSV nsp2 PLP2 domain appears to be a member of the OTU family of deubiquitinating 
enzymes (Makarova et al., 2000). The deubiquitinating activity of nsp2 PLP2 domain for 
arteriviruses was further confirmed both in vitro and cell-based assays, and the protease 
activity of PLP2 is considered to be essential for its deubiquitinase function (Frias-Staheli et 
al., 2007; Sun et al., 2010a; van Kasteren et al., 2012). Frias-Staheli et al. (2007) also 
reported the deISGylation function of the nsp2 PLP2 domain, which deconjugates ISG15, an 
interferon-induced ubiquitin-like molecule, from host cellular proteins to exhibit antiviral 
activity (Frias-Staheli et al., 2007). The biological significance of this activity was supported 
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by its capacity to inhibit NF-κB dependent signaling and antagonize the antiviral effects of 
ISG15 when expressed in combination with a Sindbis virus infection in vivo. The 
investigation of (Sun et al., 2010a) showed that PRRSV nsp2 inhibited the IFN-β promoter 
dependent luciferase reporter expression in response to Sendai virus-medicated stimulation, 
when expressed in human HEK-293T cells. The results indicated that PRRSV nsp2 PLP2 
domain antagonizes the type I IFN induction by interfering with the NF-κB signaling 
pathway. This domain interfered with the polyubiquitination process of IκBα, which 
subsequently prevents IκBα degradation to inhibit NF-κB activation. ISG15 overexpression 
inhibited PRRSV replication in cell culture, while PRRSV replication antagonized ISG15 
production and conjugation (Sun et al., 2012). When overexpressed in human HEK-293T 
cells, nsp2, especially PLP2 domain, showed a strong inhibitory effect on ISG15 production 
and ISG15 conjugation of cellular proteins. By engineering a panel of mutants with deletions 
and/or mutations at the N-terminal border of the nsp2 PLP2 domain of type 1 PRRSV, a 19-
amino-acid deletion, in combination with a single mutation of S465A, partially relieved the 
ISG15 antagonist function.  
Inhibition of type I interferon production by PRRSV nsp4 
PRRSV nsp4, the main protease responsible for replicase polyprotein processing, 
has been identified as a type I IFN antagonist. Beura et al. (2010) showed that nsp4, together 
with nsp1α/β, nsp2 and nsp11, suppressed IFN-β promoter activation. Recently, two more 
studies have been performed to dissect the antagonist function of nsp4 on type I IFN 
production (Chen et al., 2014; Huang et al., 2014). The results (Chen et al., 2014) suggests 
that nsp4 inhibited IFN synthesis mainly through suppressing NF-κB-dependent signaling 
pathway without interfering with NF-κB phosphorylation and nuclear translocation. The 
nuclear localization property of nsp4 was found to be responsible for inhibiting IFN-β 
activation. In addition, the IFN antagonism ability of nsp4 from different PRRSV strains with 
different pathogenesis was compared, which indicated that the nsp4 from Asian highly 
pathogenic (HP)-PRRSV exhibited a stronger inhibitory effect. Huang et al. (2014) also 
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studied the mechanism of nsp4’s immune antagonism function on IFN-β promoter, and 
suggested that nsp4 targeted the NF-κB essential modulator (NEMO) at the E349-S350 site to 
mediate its cleavage. The serine protease (SP) of nsp4 appears to mediate the cleavage of 
NEMO, since mutated nsp4 with inactivated SP domain lost its ability to cleave NEMO and 
inhibit IFN-β production. Interestingly, these two studies contradict with each other, because 
different steps of NF-κB signaling pathway were considered to be targeted by PRRSV nsp4. 
Also, PRRSV nsp4 was found to induce apoptosis dependent on its 3C-Like serine protease 
activity (Ma et al., 2013). Thus, more detailed investigations are needed to further dissect the 
mechanism of nsp4’s inhibitory effect on IFN-promoter activation, ruling out whether the 
observed effects may be (partially) due to its ability to induce apoptosis.  
 
 1.6 Purpose of this research 
Since its emergence, PRRSV became the most devastating and economically 
important pathogen to challenge the global swine industry. During the past two decades, a 
great amount of information has been obtained on PRRSV structural proteins. However, the 
structure and function of PRRSV nsps is largely undetermined. Therefore, the overall goal of 
this research is to identify PRRSV nonstructural proteins in infected cells and determine their 
functions in host innate immunity. Based on the current knowledge on PRRSV nsps, four 
specific aims will be fulfilled in this investigation, including: a) to identify PRRSV ORF1a-
encoded non-structural proteins in virus-infected cells; b) to determine the role of PRRSV 
nsp1β protein in host innate immune response; c) to elucidate the function of nsp1β in trans-
activating the expression of nsp2-related products; d) to attenuate PRRSV by inactivating 
expression of -2/-1 ribosomal frameshifting products: implication for the rational design of 
vaccines.  
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Figure 1. 1 Model for alternative processing of the EAV nsp3–8 region in pp1a.  The 
interaction between cleaved nsp2 and nsp3-8 directs cleavage of the nsp4/5 site by the nsp4 
SP (major pathway). Alternatively, instead of processing the nsp4/5 site, the nsp5/6 and 6/7 
sites are cleaved in the absence of nsp2. Figure adapted from Fang & Snijder (2010). 
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Figure 1. 2 Type I interferon production and signaling pathways. (A) mda-5- and RIG-I-
dependent signalling. (B) Signalling pathway activated by IFN-α/β. Figures adapted from 
Randall & Goodbourn (2008). 
A 
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Table 1. 1 PRRSV proteins and their (potential) functions. 
name 
Coding region 
Known or predicted functions
2
 
Type 1 PRRSV Type 2 PRRSV 
Nonstructural proteins encoded by ORF1a and ORF1b
1
 
nsp1α 1-? 1-180 zinc finger-protein; accessory protease PCPα; 
regulator of sg mRNA synthesis; potential IFN 
antagonist 
nsp1β ?-385 181-383 accessory protease PCPβ; potential IFN 
antagonist 
nsp2 386-1446 384-1579 accessory protease CP; deubiquitinating (DUB) 
enzyme (OTU class); potential IFN antagonist; 
transmembrane protein, involved in membrane 
modification 
nsp3 1447-1677 1580-1809 transmembrane protein, involved in membrane 
modification 
nsp4 1678-1879 1810-2013 main protease SP; induce apoptosis; potential 
IFN antagonist 
nsp5 1880-2049 2014-2183 transmembrane protein, possibly involved in 
membrane modification 
nsp6 2050-2065 2184-2199 Unknown  
nsp7α 2066-2214 2200-2348 Unknown 
nsp7β 2215-2334 2349-2458 Unknown 
nsp8 2335-2379 2459-2503 Unknown 
nsp9 2335-3019 2459-3143 RNA-dependent RNA polymerase 
nsp10 3020-3461 3144-3584 NTPase; RNA helicase; contains putative zinc-
binding domain 
nsp11 3462-3685 3585-3807 endoribonuclease (NendoU); arrest cell cycle 
nsp12 3686-3837 3808-3960 Unknown 
Newly identified viral proteins
3
 
nsp2TF 1371-3518, 
3517-4023 
1340-3889, 
3888-4394 
Potential deubiquitinating (DUB) enzyme (OTU 
class); potential IFN antagonist 
nsp2N 1371-3518 1340-3889 Potential deubiquitinating (DUB) enzyme (OTU 
class); potential IFN antagonist 
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Structural proteins
3
 
GP2 11745-12494 12074-12844 Form GP2/GP3/GP4 complex; virus entry 
E 11750-11962 12079-12300 Ion channel; play a role in processing of GP2/3/4 
GP3 12353-13150 12697-13461 Form GP2/GP3/GP4 complex; virus entry 
GP4 12895-13446 13242-13778 Form GP2/GP3/GP4 complex; induce 
neutralizing antibody; virus entry 
GP5 13443-14048 13789-14391 Major structural protein; form GP5/M dimer; 
induce neutralizing antibody; reduce the capacity 
of antibodies to neutralize PRRSV by “glycan 
shielding”; drive force for virus assembly and 
budding 
ORF5a 13448-13579 13779-13934 unknown 
M 14036-14557 14376-14900 Major structural protein; form GP5/M dimer; 
drive force for virus assembly and budding 
N 14547-14933 14890-15261 Genome package; potential IFN antagonist 
1 
Amino acid numbers refer to the pp1ab sequence of Type I PRRSV strain SD01-08 
(GenBank accession # DQ489311) or Type II PRRSV strain SD95-21 (GenBank accession # 
KC469618). 
2
 PCP: Papain-like cysteine proteine protease; CP: cysteine protease; SP: serine protease. 
3 
Nucleotide numbers refer to the genomic sequence of Type I PRRSV strain SD01-08 
(GenBank accession # DQ489311) or Type II PRRSV strain SD95-21 (GenBank accession # 
KC469618). 
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Chapter 2 - Identification of Porcine Reproductive and 
Respiratory Syndrome Virus ORF1a-Encoded Nonstructural 
Proteins in Virus-Infected Cells 
Abstract: The porcine reproductive and respiratory syndrome virus (PRRSV) replicase gene 
consists of two large open reading frames, ORF1a and ORF1b, of which the latter is 
expressed by ribosomal frameshifting. The ORF1a-encoded part of the resulting replicase 
polyproteins (pp1a and pp1ab) is predicted to be proteolytically processed into ten 
nonstructural proteins (nsps), known as nsp1 to nsp8, with both the nsp1 and nsp7 regions 
being cleaved internally (yielding nsp1α plus nsp1β, and nsp7α plus nsp7β). The 
experimental verification of these predictions strongly depends on the ability to identify 
individual cleavage products with specific antibodies. In this study, a panel of monoclonal 
and polyclonal antibodies was generated, which together can recognize eight ORF1a-encoded 
PRRSV nsps. Using these reagents, replicase cleavage products were detected in PRRSV- 
infected MARC-145 cells using a variety of immunoassays. By immunofluorescence 
microscopy, most nsps could be detected as early as 7 hours post-infection. During the early 
stages of infection, nsp1β, nsp2, nsp4, nsp7α, nsp7β and nsp8 co-localized in distinct 
punctate foci in the perinuclear region of the cell, which were determined to be the site of 
viral RNA synthesis by in situ labeling. Western blot and immunoprecipitation analysis 
identified most individual nsps and several long-lived processing intermediates (nsp3-4, 
nsp5-7, nsp5-8, nsp3-8). The identification and subcellular localization of PRRSV nsps in 
virus-infected cells documented here provides a basis for the further structure-function 
studies. Thus, our PRRSV antibody panel will be an important tool for future studies on the 
replication and pathogenesis of this major swine pathogen. 
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 2.1 Introduction 
PRRS, a disease first described in the US in 1987 (Keffaber, 1989) and in Europe in 
1991 (Wensvoort et al., 1991), has caused tremendous economic losses to the swine industry 
since its appearance, with recent annual costs estimated to be at least $600 million in the US 
alone (Neumann et al., 2005). Hallmark symptoms of PRRS are mild to severe respiratory 
disease in infected newborn and growing pigs, and reproductive failure in pregnant sows. The 
etiological agent, PRRSV, was first identified in the Netherlands in 1991, and is represented 
by the European prototypic strain, Lelystad virus (LV) (Wensvoort et al., 1991). In the US, 
PRRSV was first isolated in 1992, and the North American prototypic strain was designated 
as VR-2332 (Benfield et al., 1992; Collins et al., 1992). At the genome level, these two 
genotypes, European (Type I) and North American (Type II), share about 60% sequence 
identity (Allende et al., 1999; Nelsen et al., 1999). PRRSV is classified in the family 
Arteriviridae, which also includes equine arteritis virus (EAV), lactate dehydrogenase-
elevating virus (LDV), and simian hemorrhagic fever virus (SHFV) (Snijder & Meulenberg, 
1998).   
PRRSV is a small, enveloped virus containing a single positive-stranded RNA 
genome. The genome is about 15 kb in length and contains at least ten open reading frames. 
The 3’– terminal quarter of the genome encodes structural proteins, including four envelope 
glycoproteins (GP2a, GP3, GP4, and GP5), three nonglycosylated membrane proteins (2b, 
ORF5a and M) and the nucleocapsid protein (N) (Meulenberg et al., 1995a; Meulenberg et 
al., 1995b; Mounir et al., 1995; Bautista et al., 1996; Mardassi et al., 1996; Meng et al., 1996; 
Meulenberg & Petersen-den Besten, 1996; Snijder et al., 1999; Wu et al., 2001; Firth et al., 
2011; Johnson et al., 2011). The PRRSV replicase gene consists of open reading frames 
(ORFs) 1a and 1b, which occupy the 5’-proximal three quarters of the genome. Both these 
ORFs are expressed from the viral genome, with expression of ORF1b depending on a 
conserved ribosomal frameshifting mechanism. Subsequently, extensive proteolytic 
processing of the resulting pp1a and pp1ab polyproteins yields the functional nonstructural 
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proteins (nsps), most of which assemble into a membrane-associated replication and 
transcription complex. This enzyme complex not only mediates genome replication but also 
controls the synthesis of a nested set of subgenomic (sg) mRNAs for expression of the 
structural protein genes (Snijder et al., 1994; van Dinten et al., 1996; van der Meer et al., 
1998; Ziebuhr et al., 2000; Fang & Snijder, 2011).   
The proteolytic maturation of the arterivirus pp1a and pp1ab replicase polyproteins 
has been studied in detail only for EAV, the family prototype. A complex proteolytic cascade 
was uncovered, involving three of ORF1a-encoded proteases, at least 11 cleavage events 
(Snijder et al., 1992; Snijder et al., 1995; Ziebuhr et al., 2000), and alternative processing 
pathways (Wassenaar et al., 1997). Although, based on sequence comparison, many of these 
features appear to be conserved in other arteriviruses, a number of striking differences 
complicate a straightforward comparison (Fig. 2.1). First of all, the currently known 
arteriviruses are only distantly related. For example, the overall sequence identity in the 
pp1ab replicase polyproteins of EAV and PRRSV is about 30-45% amino acids (aa) identity, 
depending on the genome region and specific strains analyzed (Nelsen et al., 1999). Secondly, 
there are considerable size differences, in particular in the N-terminal region of ORF1a, 
leading to a pp1a of only 1727 aa in EAV, whereas the PRRSV counterpart can be up to 
~2500 aa long. Finally, an additional protease domain is known to be functional in the case of 
PRRSV, and likely all other arteriviruses, which has lost its proteolytic activity in the case of 
EAV (den Boon et al., 1995). Thus, the PRRSV polyproteins are assumed to be cleaved by 
three papain-like proteases (PLPα, PLPβ, and PLP2) located in the nsp1-nsp2 region, and the 
viral main protease, a serine protease (SP) residing in the nsp4. A comparison with the EAV 
sequence and data would suggest that the PRRSV replicase polyproteins are being cleaved 
into at least 14 nsps, specifically nsp1 to nsp12, with both the nsp1 and nsp7 parts being 
subject to an internal cleavage (yielding nsp1α plus nsp1β, and nsp7α plus nsp7β). Although 
nsp1α and nsp1β were previously detected in PRRSV-infected cells (Chen et al., 2010), a 
comprehensive analysis of the processing steps and products in PRRSV replicase maturation 
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clearly depends on the availability of specific antibodies that can recognize individual 
cleavage products in a variety of immunoassays. Since the identification of PRRSV more 
than 20 years ago, and despite the importance of the virus as a veterinary pathogen, such a 
panel of reagents has not been described so far. Therefore, as a first and essential step toward 
understanding the structure and function of PRRSV nsps, we have now generated a panel of 
antibodies against the PRRSV ORF1a-encoded nsps, and have used it to detect the expression 
of these proteins and analyze their subcellular localization in virus-infected cells.   
 
 2.2 Materials and methods 
Cells and Viruses: Embryonic monkey kidney cells (MARC-145) were maintained in 
appropriate medium and incubation conditions as previously described (Kim et al., 1993).  
The Type 1 PRRSV strain SD01-08 (GenBank Accession #DQ489311; Fang et al., 2006a) 
was propagated in MARC-145 cells.   
Antigen expression: Recombinant proteins, including nsp1 (α plus β together), nsp2, nsp4, 
nsp7 and nsp8, were generated based on the sequence of the PRRSV SD01-08 strain. For 
nsp2 antigen expression, the conserved PLP2 domain region was expressed as a recombinant 
protein. The antigens for production of antibodies to nsp1, nsp4, nsp7, and nsp8 were 
expressed as recombinant proteins based on the predicted cleavage sites (Table 1). These nsp-
coding regions were amplified by RT-PCR, and the PCR products were cloned into the pET-
28a (+) vector (Novagen). Recombinant proteins were expressed and purified as described 
previously (Johnson et al., 2007; Brown et al., 2009). Sequence analysis (Hopp-Wood 
hydrophilicity) showed that nsp3 and nsp5 contain mostly hydrophobic regions, but include 
several predicted B-cell linear epitopes. Therefore, instead of expressing the entire nsp3 and 
nsp5 regions as recombinant proteins, predicted B-cell linear epitope regions were 
synthesized as synthetic peptides for mouse immunization. The predicted nsp6 subunit, 
consisting of only 11 amino acids, was also synthesized. A rabbit antiserum recognizing both 
nsp2 and nsp3 was raised previously (Kroeze et al., 2008) using synthetic peptides. These 
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were based on the sequences of the PRRSV type-I Lelystad isolate, with the N-terminal nsp2 
peptide containing four point mutations compared to SD01-08 and the nsp3 C-terminal 
peptide being identical for both isolates. 
Antibody production: Monoclonal antibodies (mAb) were produced by immunizing 
BALB/c mice with 50 ug of antigen mixed with Freund’s incomplete adjuvant at two-week 
intervals for eight weeks. Mouse splenocytes were fused with NS-1 myeloma cells. Specific 
anti-PRRSV mAbs were screened by enzyme-linked immunosorbent assay (ELISA) and 
indirect immunofluorescent assays (IFA) as described previously (Fang et al., 2006a).  
Hybridomas secreting PRRSV-specific mAbs were sub-cloned. The mAbs were produced by 
intraperitoneal injection of pristine-primed mice with hybridoma cells (5x10
4
 cells), and the 
mAb-containing mouse ascites fluids were collected about 2 weeks after injection. MAbs 
were isotyped using an IsoStrip Kit (Serotech, Inc.) following the manufacture’s instruction.     
Polyclonal antibodies (pAb) were raised in New Zealand white rabbits. For primary 
immunizations, 100 ug of antigen was mixed with an equal volume of Freund’s incomplete 
adjuvant, and injected subcutaneously at six different locations. Rabbits were boosted twice 
at two-week intervals. The immune response was monitored using IFA and ELISA.  
Expression plasmids and transfection: The nsp4-, nsp7-, nsp7α-, and nsp7β-coding regions 
of the SD01-08 virus were RT-PCR amplified from genomic RNA, and PCR products were 
cloned into eukaryotic expression vector, pCAGGS (a generous gift from Dr. AdolfoGarcia-
Sastre), designated as pCAGGS-nsp4, pCAGGS-nsp7, pCAGGS-nsp7α, and pCAGGS-nsp7β.  
HEK293T cells were seeded in 24-well plates and were co-transfected with pCAGGS-nsp4 
and pCAGGS-nsp7 DNA, or transfected with individual pCAGGS-nsp4, pCAGGS-nsp7, 
pCAGGS-nsp7α, or pCAGGS-nsp7β expression plasmids. Transfection was performed using 
HD-FuGENE 6 transfection reagent following the manufacturer's instruction (Roche 
Molecular Biochemicals). At 24 hours post-transfection, cells were fixed with 80% acetone 
for immunofluorescence microscopy. For Western blot detection of nsp expression, 
transfected cells were harvested and lysed in Laemmli sample buffer (Laemmli, 1970).     
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Immunofluorescence microscopy: For detection of nsp expression, MARC-145 cells were 
infected with 0.1 MOI of PRRSV, and cells were fixed with 3.7% formaldehyde in PBS (pH 
7.4) at 6, 7, 8, 10, and 12 h post-infection. Following permeabilization with 0.1% - 0.2% 
Triton X-100 in PBS for 15 min at room temperature, cells were incubated with nsp-specific 
mAbs or polyclonal rabbit antisera at dilutions of 1:1000 or 1:200, respectively for 1h. 
Subsequently, FITC-conjugated goat anti-mouse IgG (ICN Biomedicals) or FITC-conjugated 
goat anti-rabbit IgG (Invitrogen) were used as secondary antibody. For nsp co-localization 
studies, polyclonal rabbit antiserum pAb Eu-nsp2 was used to stain nsp2, and DyLight 549-
labeled goat anti-rabbit IgG (H+L) (KPL, red fluorescent) was used as the secondary 
antibody. The same infected cell was dual stained with mAbs against nsp1β, nsp4, nsp7α, 
nsp7β, or nsp8 as indicated in Figure 2.2, and FITC-conjugated goat anti-mouse antibody 
(ICN Biomedicals) was added as the secondary antibody. Nuclear staining with DAPI (4’, 6’-
diamino-2-phenylindole 2HCl) was performed as recommended by the manufacturer 
(Molecular Probes). Specimens were imaged using a Zeiss LSM510 confocal microscope 
with a 63x objective, and images were processed with NIH Image/J and Adobe Photoshop 6.0 
software.  
BrUTP labeling of viral RNA synthesis: Metabolic labeling of viral RNA synthesis with 5-
bromouridine 5’-triphosphate (BrUTP, Sigma) was performed as described previously (van 
der Meer et al., 1998). Briefly, the newly synthesized viral RNA in PRRSV-infected MARC-
145 cell was labeled at 9 h post-infection and 30 min before labeling cells were given 10 
ug/ml of actinomycin D (Sigma) to block host cell transcription. BrUTP was introduced into 
the cells by liposome-mediated transfection using X-tremeGENE 9 (Roche) following the 
manufacturer’s instructions. Viral RNA synthesis was labeled for 1 h, after which cells were 
fixed with 3.7% formaldehyde for 15 min at room temperature and blocked with 0.1% - 0.2% 
Triton X-100 and 3% BSA in PBS for 15 min at room temperature. BrUTP-labeled viral 
RNA was visualized using anti-BrdU mAb clone BU-33 (Sigma) and DyLight 549 labeled 
goat anti-rabbit IgG (H+L) (KPL) as secondary antibody. Cells were also stained for nsp2 
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using the polyclonal rabbit antiserum and a goat anti-rabbit FITC-conjugate (ICN 
Biomedicals, Inc). 
Western Blotting: PRRSV-infected MARC-145 cell lysates were heated in Laemmli sample 
buffer for 10 min and proteins were separated by SDS-PAGE. Protein bands were blotted 
onto a nitrocellulose membrane as described previously (Wu et al., 2001). After blotting, 
membranes were blocked with PBST and 5% nonfat dry milk. The membranes were then 
incubated with nsp-specific antibodies (1:500 dilution of mAbs and 1:50 dilution of rabbit 
antisera) for 1h at RT. After washing with PBST, HRP-conjugated goat anti-mouse or HRP-
conjugated goat anti-rabbit antibodies were added and samples were incubated for 45 minutes. 
Protein bands were visualized using a chemiluminescence detection kit (Pierce) following the 
manufacturer’s instructions.   
Radioimmunoprecipitation and SDS-PAGE: MARC-145 cells were infected with MOI 5 
of PRRSV SD01-08 for 24 hours in DMEM containing 2% fetal calf serum. Cells were 
washed with PBS, followed by starvation for 30 minutes in methione- and cysteine-free 
medium. Subsequently, protein synthesis in the infected cells was metabolically labeled for 6 
hours in methionine- and cysteine-free medium containing 200 µCi/ml of a [
35
S] 
methionine/cysteine mixture. After labeling, cells were harvested in lysis buffer (20mM Tris-
HCl pH 7.6, 150 mM NaCl, 1% NP-40, 0.1% DOC, 0.1%SDS) and nuclei were removed by 
centrifugation. Routinely, 5 µl of mouse ascites or rabbit antiserum was used for the 
immunoprecipitation analysis of a 200-µl aliquot of cell lysate, the equivalent of 4x10
5
 cells.  
Binding was carried out overnight at 4°C in lysis buffer containing 0.1-0.5 % SDS, 
depending on the antibody used. Subsequently, immune complexes were pulled down using a 
1:1 mixture of protein A- and protein G-sepharose beads (GE Healthcare). Beads were 
washed three times in NET buffer (50 mM Tris-HCL, 150 mM NaCl, 5mM EDTA, 0.5% NP-
40) before complexes were dissolved in Laemmli sample buffer. Prior to loading onto 12% 
polyacrylamide gels, samples were heated at 96°C for 6 min. Gels were exposed to phosphor 
imager screens,
 
which were subsequently scanned using a Typhoon Variable Mode
 
Imager 
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(GE Healthcare). Image analysis and quantification of band intensities were performed with 
the ImageQuant TL software (GE
 
Healthcare). 
 
 2.3 Results 
Generation of antibodies to ORF1a-encoded replicase subunits 
Based on comparative sequence analysis and the established EAV replicase cleavage 
sites, the predicted cleavage sites for PRRSV replicase polyprotein processing had been 
inferred previously (Ziebuhr et al., 2000; Fang & Snijder, 2011). In this study, these putative 
cleavage sites were used as borders for cloning and expression in E. coli of sequences 
representing individual PRRSV replicase subunits (nsp1, nsp2, nsp4, nsp7, and nsp8) or 
synthesis of peptide antigens (nsp2, nsp3, nsp5, and nsp6) for production of nsp-specific 
antibodies (Table 1). Previous studies had identified the nsp1α/1β and nsp1β/2 cleavage sites 
of type II PRRSV (Chen et al., 2010; Sun et al., 2010). Based on sequence comparison, 
amino acids 1-180 of pp1a of type 1 PRRSV SD01-08 was expressed as recombinant protein 
for production of an nsp1α-specific antibody. Mice were immunized with individual 
recombinant proteins or synthetic peptides. After mouse splenocytes had been fused with NS-
1 myeloma cells, the supernatants of the resulting hybridoma cell lines were initially screened 
by Enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA), and 
further analyzed by Western blot as described in the following paragraph.   
Mice immunized with nsp1 produced a strong antibody response to nsp1β. All of the 
mAbs obtained from the mice immunized with nsp1 recognized nsp1β. Additionally, we 
obtained mAbs against nsp2, nsp4, nsp7, and nsp8, but not for nsp1α, nsp3, nsp5, and nsp6.  
The isotypes of the various mAbs are listed in Table 1. To facilitate dual labeling experiments, 
we immunized rabbits with recombinant proteins representing nsp1α or nsp2, or a 
combination of synthetic peptides derived from the nsp2 N-terminus and the nsp3 C-terminus 
(Table 1), and obtained a set of rabbit polyclonal antisera (pAb).   
 45 
 
Immunofluorescence microscopy was performed on cells infected with either strain 
SD01-08 (genotype I virus) or strain VR2332 (genotype II virus), which revealed that this 
panel of mAbs is highly genotype-specific since cross-reactivity between our type I-specific 
mAbs and type II virus-infected cells was not observed. The pAb against nsp1α was also 
genotype specific, but the Eu-nsp2 and nsp2+3 pAbs generated with type I-specific antigens 
also reacted with type II virus (data not shown). 
Monoclonal antibody reactivity to nsp7α and nsp7β  
In EAV, the nsp7 subunit was previously found to contain an internal cleavage site 
(van Aken et al., 2006), which is used with a relatively low efficiency by the nsp4 SP to 
generate nsp7α and nsp7β subunits. Sequence alignment showed that this cleavage site is 
conserved in PRRSV nsp7 (E2214/N2215). To determine which part of nsp7 was recognized by 
the anti-nsp7 mAbs that we obtained (Table1: mAb Eu9-31/Eu24-40), nsp7, nsp7α, and 
nsp7β were expressed from CMV promoter constructs (vector pCAGGS) and a similar 
construct was used to co-express nsp4. Initially, HEK 293T cells were transfected with 
pCAGGS-nsp7α or pCAGGS-nsp7β, and IFA was performed using mAb Eu9-31 or Eu24-40. 
The result showed that mAb Eu9-31 recognized nsp7α, while mAb Eu24-40 recognized 
nsp7β (Figure 2A). To further confirm that PRRSV nsp7 can actually be cleaved into α and β 
subunits, nsp7 and nsp4 were co-expressed in HEK 293T cells and the nsp7 processing was 
analyzed by Western blot. As shown in Figure 2B, nsp7 was detected as a single ~30 kDa 
protein in lysates from cells transfected with pCAGGS-nsp7 only. In contrast, in cells co-
transfected with pCAGGS-nsp7 and pCAGGS-nsp4 the level of nsp7 was much lower than in 
cells transfected with pCAGGS-nsp7 only, and both nsp7 and nsp7α were detected by mAb 
Eu9-31, demonstrating that nsp7 was indeed cleaved by nsp4. In three independent 
experiments, mAb Eu24-40 appeared not to react with nsp7β in the Western blot, but it did 
recognize the full length nsp7 (Fig. 2.2B). In our previous studies (Brown et al., 2009; 
Langenhorst et al., 2012), we noted that recombinant nsp7β was sensitive to degradation after 
purification from E. coli. This observation may relate to the result of the current study, as 
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most of the cleaved nsp7β could be rapidly degraded during sample preparation for Western 
blot analysis, and/or our detection method may not have been sensitive enough to detect the 
remaining part of nsp7β if it were present. 
Identification of ORF1a-encoded replicase proteins in virus-infected cells by Western 
blot and radioimmunoprecipitation 
To investigate the expression and processing of the 2379 amino acids encoded by 
PRRSV SD01-08 ORF1a, we used the panel of antibodies raised against nsps 1-8 of the 
SD01-08 virus in Western blot and radioimmunoprecipitation (RIP) analysis. Rabbit 
preimmunization sera, mouse ascites containing non-PRRSV specific mAb, and uninfected 
cell lysates were used as negative controls.   
In Western blot, the pAb Eu-nsp1α detected a single protein band just below the 22-
kDa molecular marker, which corresponded to the predicted size of nsp1α (18.9 kDa, Fig. 
2.3A), while mAb Eu22-28 detected a strong protein band above the 22 kDa molecular 
marker, corresponding to the predicted size of nsp1β (25.1 kDa, Fig. 2.3B). These two 
proteins, nsp1α and nsp1β were also consistently detected in radioimmunoprecipitation (RIP) 
experiments (Fig. 2.4A and 2.4B).   
The mAb against nsp2 (EU36-19) generated a strong background signal in the 
Western blot analysis (data not shown), but in RIP this mAb brought down a specific protein 
band migrating substantially slower than the 98-kDa molecular weight marker (Fig. 2.4C).  
Several additional weak protein bands were detected in the nsp2 RIP, but it remains to be 
established whether these represent nsp2-related processing or degradation products. 
Rabbit antiserum pAb-nsp2+3 was raised using a combination of nsp2 and nsp3 
epitopes (Table 1) and in Western blot analysis indeed both a specific protein of about 22 
kDa (nsp3) and a large protein in the size range predicted for nsp2 were detected (Fig. 2.3C). 
However, in immunoprecipitation analysis of infected cell lysates pAb-nsp2+3 mainly 
recognized nsp3 (Fig. 2.4D). The apparent size of the presumed nsp2 subunit detected in both 
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Western blot and RIP appeared to be larger than the predicted size (114 kDa), but this may be 
due to aberrant migration of this product, which contains a sizeable hydrophobic domain.  
MAb Eu54-19 against nsp4, the viral main protease, detected a distinct protein band around 
24 kDa in both Western blot (Fig. 2.3D) and RIP (Fig. 2.4E). In the case of EAV, nsp3-4 and 
nsp3-8 were observed as relatively long-lived intermediate cleavage products (Snijder et al., 
1994). The predicted sizes of the PRRSV counterparts of these products are 46 kDa (nsp3-4) 
and 100 kDa (nsp3-8), and in RIP analysis, products nicely matching these sizes were 
specifically recognized by mAb Eu54-19 (Fig. 2.4E). This observation suggests important 
parallels between the two arteriviruses with regard to the sequence and timing of replicase 
processing events. 
In virus-infected cell lysates, the nsp7α-specific mAb Eu9-31 recognized a doublet 
just above the 46-kDa size marker (Fig. 2.3E), which appeared to match the calculated sizes 
of the prominent nsp5-7 (49.7 kDa) and nsp5-8 (54.7 kDa) processing intermediates observed 
in the EAV system (Snijder et al., 1994; Wassenaar et al., 1997). In addition, a ~15-kDa 
product was observed that likely corresponded to nsp7α (see also Fig. 2.2B). The 
identification of nsp5-7 and nsp5-8 was further supported by the fact that only the upper of 
the two bands was recognized by the nsp8-specific antibody Eu12-40 (Figure 3F). Nsp8 is the 
last subunit upstream of the ribosomal frameshift site and is identical to the N-terminal 
domain of the RdRp-containing nsp9 subunit, of which the N-terminus is released by 
cleavage of the nsp7/8 site. On Western blot, we noticed a weak protein band around 85 kDa, 
which is the predicted size of nsp9 (Fig. 2.3F), but further studies are needed to confirm the 
identity of this product.  
The antibody against nsp7β (mAb Eu24-40) did not specifically recognize any 
PRRSV proteins in Western blot (data not shown), which was consistent with the result 
obtained in the eukaryotic expression system (Fig. 2.2B). However, upon its use in RIP, this 
antibody did bring down the presumed nsp5-7 and nsp5-8 bands (Fig. 2.4F). Also the nsp8-
specific mAb Eu24-40 brought down the same doublet (Fig. 2.4G), which must be explained 
 48 
 
by co-immunoprecipitation of the two products under these conditions, since nsp5-7 should 
not be recognized by this antibody and only the nsp5-8 band was recognized in Western blot 
(Fig. 2.3F). The nsp8-specific RIP also revealed a very small product that may correspond to 
fully cleaved nsp8 (predicted size about 5 kDa). Finally, the RIP experiments targeting nsp4, 
nsp7, and nsp8 revealed a number of larger precursors, including nsp3-8 (Fig. 2.4E-G). 
Intracellular localization of PRRSV ORF1a replicase proteins 
Previous immunofluorescence microscopy studies of EAV- infected cells showed that 
replicase processing products assemble in the perinuclear region where they form a 
membrane-associated complex that is thought to direct viral replication and transcription (van 
der Meer et al., 1998). We now employed our newly obtained antibody panel to study 
whether PRRSV nsps behave similarly and to visualize the site of viral RNA synthesis.   
To investigate the intracellular localization of PRRSV ORF1a-encoded replicase subunits, the 
panel of antibodies was used in immunofluorescence microscopy of infected cells. To assess 
the timing of replicase expression, PRRSV-infected MARC-145 cells were fixed at 6, 7, 8, 10, 
and 12 hours post infection (hpi) and stained with various antibodies. No nsp-specific 
labeling was detected at 6 hpi, but by 7 hpi all PRRSV-infected MARC-145 cells could be 
stained with anti-nsp1β, anti-nsp2, anti-nsp4, anti-nsp7α, nsp7β, and anti-nsp8 antibody, 
revealing small but bright fluorescent foci that were mostly concentrated on one side of the 
nucleus. By 12 hpi, a more intense and diffuse labeling pattern was observed. For nsp1β, a 
predominantly nuclear and perinuclear staining pattern was observed in about 80% of the 
cells, both at 10 and 12 hpi (Fig. 2.5). The pAb directed against nsp1α (Eu-nsp1α) could not 
be used in IFA since it produced a high background signal. To verify colocalization of the 
different nsps, PRRSV-infected MARC-145 cells were double stained with anti-nsp mAbs 
and a rabbit antiserum to nsp2. At 7 hpi, the labeling for nsp1β, nsp4, nsp7α, nsp7β and nsp8 
was largely co-localized with nsp2 in punctate and perinuclear spots (Fig. 2.6), although 
some additional nsp2 labeling was commonly found in the periphery of the cell. Furthermore, 
as described previously, part of nsp1β localized to the nucleus. 
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In EAV- infected cells viral RNA synthesis was previously found to be associated 
with the nsp-containing membrane structures in the perinuclear region (van der Meer et al., 
1998; Pedersen et al., 1999). To determine if the perinuclear foci that labeled for PRRSV 
nsps were indeed the site of viral RNA synthesis, we treated infected cells with actinomycin 
D to block host cell mRNA synthesis, and transfected them with BrUTP to label the newly 
synthesized viral RNA for 1 hour. Transfected cells were double stained with antibodies that 
recognize BrU-labeled RNA and PRRSV nsp2. The result showed co-localization of PRRSV 
nsp2 with de novo-synthesized viral RNA (Fig. 2.7). Overall, these data supported the 
findings of previous studies on EAV (van der Meer et al., 1998), and suggested that also 
PRRSV nsps assemble into a membrane-bound replication and transcription complex. 
 
 2.4 Discussion 
Since the first isolation of PRRSV, a wealth of information has been obtained on the 
structural proteins of this pathogen. However, little is known about the structure and function 
of PRRSV nsps, whose coding sequence occupies ~ 75% of the viral genome (Snijder & 
Meulenberg, 1998; Fang & Snijder, 2010). Thus far, the existence of individual PRRSV nsps 
and their involvement in genome replication and expression were mainly deduced from 
studies of EAV. As underlined by these EAV studies, specific antisera are key reagents in 
studies on nsp structure and function. Although previous PRRSV studies yielded a large 
panel of mAbs against structural proteins (Nelson et al., 1993; Drew et al., 1995; Yoon et al., 
1995; Dea et al., 1996; Magar et al., 1997; Yang et al., 1999; Yang et al., 2000), few mAbs 
were raised against nsps. This study is the first to describe the development of a panel of 
antibodies against PRRSV ORF1a-encoded-nsps and its use to detect these proteins in 
PRRSV-infected cells.   
For nsp1, we detected two products, nsp1α and 1β, in PRRSV-infected cells, in 
contrast to one mature nsp1 product from EAV. PRRSV nsp1β showed two different 
intracellular localization patterns, an early punctate perinuclear localization and a 
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predominantly nuclear labeling late in infection. Since our anti-nsp1α antiserum did not 
specifically recognize nsp1α of Type I PRRSV in IFA, its intracellular localization could not 
be determined. However, our previous study using Type II PRRSV demonstrated that nsp1α 
also localizes to the nucleus during the course of infection (Chen et al., 2010), and similar 
observations were made for EAV nsp1. This protein was also found to interact with the host 
protein p100, a transcriptional co-activator, suggesting that nsp1 might modulate transcription 
in the infected cell (Tijms & Snijder, 2003). Recent studies demonstrated that PRRSV nsp1α 
and nsp1β are likely involved in modulating the interferon response; in particular, the nuclear 
localization of PRRSV nsp1 was determined to be associated with the degradation of 
interferon transcription factor CREB-binding protein (Kim et al., 2010). These studies 
suggest that arterivirus nsp1 proteins not only function in viral replication, but also play an 
important role in host metabolism and immune modulation.          
Comparative sequence analysis showed that the PRRSV nsp2 was predicted to be 
cleaved at 385G/A386 of SD01-08 at its N-terminus. The C-terminal cleavage site is most likely 
located at 1446G/A1447, one amino acid downstream from the previously predicted site at 
1445G/G1446 (Ziebuhr et al., 2000), since the nsp2-encoded cysteine protease is now known to 
have a preference to cleave after GG instead of between GG (Frias-Staheli et al., 2007). The 
predicted size for nsp2 (replicase residues 386-1446 of SD01-08) is 114 kDa. However, in 
our analysis, the nsp2-specific antibody recognized a product with a considerably larger 
apparent molecular weight. Whether this is caused by aberrant migration or post-translational 
modifications could not be resolved in this study. In addition, several smaller and less 
abundant products were also detected by nsp2-specific antibodies in terms of RIP 
experiments. A similar phenomenon was also observed in nsp2 immunoprecipitation 
experiments using Type II PRRSV, VR2332 (Han et al., 2010). At this time, we cannot 
exclude the possibility of the existence of other nsp2-related processing or degradation 
products. Furthermore, we also cannot exclude the involvement of host cell proteases that 
could generate smaller nsp2-related products. In EAV, the 61-kDa nsp2 was found to be 
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cleaved internally by a host cell-specific protease, yielding 18 kDa and 44 kDa cleavage 
products in Vero cells, but not in BHK-21 and RK-13 cells (Snijder et al., 2001).  
Identification of other smaller protein products is in progress in our laboratories.     
Protein sequence analysis showed that nsp3 and nsp5 are largely composed of 
hydrophobic domains as in other arteriviruses. The generally hydrophobic nature of these 
proteins is a likely explanation for our failure to generate specific mAbs against these 
replicase subunits. Nsp6 is predicted to consist of only 11 amino acids, but this peptide 
seemed to be poorly immunogenic and we could not generate the antibodies by immunizing 
mice with an nsp6 synthetic peptide.  
Based on the EAV replicase processing model of major versus minor proteolytic 
processing pathways (Wassenaar et al., 1997), nsp5 and nsp5-6 may not be produced at all 
since cleavage of the nsp4/5 site seems to prevent cleavage of the nsp5/6 and nsp6/7 sites and 
vice versa. Consequently, nsp5 and nsp6 were only detected in the form of processing 
intermediates with other nsps. Using the PRRSV nsp7- and nsp8-specific antibodies, we 
specifically detected a protein doublet with a molecular weight around 50 kDa. Based on 
their size estimates, we assume that this protein doublet is formed by the processing 
intermediates nsp5-7 and nsp5-8 (predicted sizes of about 50 and 55 kDa). Further studies, in 
particular mutagenesis of specific cleavage sites, are needed to determine the actual protein 
components of these products. Unlike the N-terminal portion of the pp1a/pp1ab, no 
functional assignments have been made for the C-terminal portion, nsp6 to nsp8 region. We 
believe that antibodies generated from this study will prove to be valuable tools for future 
studies on the structure and function of these proteins. 
In immunofluorescence assays, PRRSV ORF1a-encoded nsps could be detected by 7 
hpi. This implies that nsp-specific mAbs can also be useful tools for the early detection of 
PRRSV infection. Furthermore, since replicase proteins contain both highly variable domains 
and regions that are conserved within/between genotypes, it would be useful to identify a 
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panel of nsp-specific mAbs that is both broadly reactive to various field strains and able to 
differentiate between certain specific strains or (sub) genotypes.     
In conclusion, we developed a panel of antibodies against PRRSV ORF1a-encoded 
nsps, and confirmed the existence of individual mature nsps in virus-infected cells. This study 
provides a basis for both applied and basic research on the role of PRRSV nsps in viral 
replication and pathogenesis. 
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Figure 2. 1 Comparison of EAV and PRRSV replicase polyprotein size, domain 
organization, and (tentative) proteolytic processing schemes. Top: PRRSV genome 
organization, showing the 5’-proximal replicase open reading frames (ORFs) 1a and 1b, as 
well as the downstream ORFs encoding the viral structural proteins envelope (E), membrane 
(M), nucleocapsid (N), ORF5a (5a), glycoproteins (GP) 2 - 5 and the 3’ poly(A) tail (An). 
Bottom: overview of the PRRSV and EAV pp1ab replicase polyproteins that derive from 
genome translation when ORF1a/1b ribosomal frameshifting (RFS) occurs. Arrowheads 
represent the sites cleaved by the three or four virus-encoded proteases [the cysteine 
proteases PLPα (Pα), PLPß (Pß), PLP2 (CP), and the ‘main protease’, the nsp4 serine 
protease (SP)]. The numbering/nomenclature of the resulting nonstructural proteins (nsp) is 
indicated. In addition, to the protease domains, three ORF1b-encoded enzymatic domains are 
depicted: the nsp9 RNA-dependent RNA polymerase (RdRp), the nsp10 helicase (Hel), and 
the nsp11 endoribonuclease (Ne). Domains labeled T are putative transmembrane regions that 
are thought to be involved in membrane anchoring of the viral replicase complex. Note the 
presence of an uncleaved nsp1 in EAV and nsp1α and nsp1ß subunits in PRRSV, and the 
remarkable size difference between the nsp2 subunits of both viruses. Amino acid numbering 
is based on PRRSV strain SD01-08 (Fang et al., 2006a) and EAV strain Bucyrus (den Boon 
et al., 1991) ZF: zinc finger; HVR: hypervariable region; C: cluster of conserved Cys 
residues; Z: predicted zinc-binding domain; RFS: -1 ORF1a/1b ribosomal frameshift site. 
Figures adapted from Nedialkova et al., 2010 and Fang & Snijder, 2010. 
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Figure 2. 2 Reactivity of monoclonal antibodies to PRRSV nsp7α and nsp7β. A). 
HEK293T cells were transfected with plasmids expressing PRRSV nsp7α or nsp7β proteins 
and analyzed by immunofluorescence microscopy following staining with the specific 
antibodies indicated at the left side of the panel. Images were taken by fluorescence 
microscopy; B). HEK293T cells were transfected with a plasmid expressing PRRSV nsp7 or 
co-transfected with plasmids expressing nsp7 and nsp4. At 24 h posttransfection, cells were 
harvested and Western blot analysis was performed using nsp7- or nsp4-specific antibodies as 
indicated at the bottom of each panel. Arrows point to specific PRRSV proteins detected by 
Western blot. 
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Figure 2. 3 Western blot detection of ORF1a-encoded nsps in PRRSV-infected cell 
lysates using a panel of ORF1a protein-specific antibodies. Cell lysates from PRRSV 
SD01-08-infected or mock-infected cells were separated by SDS-PAGE, and transferred to a 
nitrocellulose membrane. Each membrane was probed with an nsp-specific mAb or pAb as 
indicated on the bottom of each panel. M, Mock-infected cell lysate; V, PRRSV-infected cell 
lysate.  
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Figure 2. 4 Radioimmunoprecipitation analysis of PRRSV-infected or mock-infected 
MARC-145 cell lysates with ORF1a protein-specific antibodies. For each antibody 
(indicated at the bottom of each panel), a set of two lanes is shown: M, immunoprecipitation 
with mock-infected cell lysate; V, immunoprecipitation with PRRSV-infected cell lysate. The 
position of the molecular weight marker and various PRRSV nonstructural proteins are 
indicated. Cells were infected with MOI 5 and 
35
S-labeled from 24 to 30 hours post-infection.  
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Figure 2. 5 Detection of PRRSV ORF1a-encoded nsp expression in infected cells by 
immunofluorescence microscopy. MARC-145 cells were infected with PRRSV SD01-08 
and fixed at 7, 8, 10, or 12 hpi. Cells were stained with the nsp-specific antibodies listed in 
Table 2.1. Specimens were imaged on a Zeiss LSM510 confocal microscope. A 0.8-μm slice 
through the nucleus is shown in each image.   
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Figure 2. 6 Colocalization of PRRSV replicase proteins. MARC-145 cells were fixed at 8 
h post infection, and were double stained with an nsp2-specific rabbit antiserum and a panel 
of mAbs recognizing other nsps. Note that each individual nsp localizes to the perinuclear 
region. 
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Figure 2. 7 Colocalization of PRRSV nsp2 with de novo-synthesized viral RNA. PRRSV-
infected MARC-145 cells were transfected with BrUTP in the presence of actinomycin D, 
incubated for 60 min, fixed and double stained with a rabbit antiserum against nsp2 (A) and 
an anti-BrdU mAb to detect newly synthesized RNA (B);  (C). Overlay image of A and B. 
Specimens were imaged on a Zeiss LSM510 confocal microscope.  
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Table 2. 1 Generation of antibodies to PRRSV SD01-08 ORF1a-encoded replicase 
protein
Nonstructural 
protein 
Predicted 
MW (kDa) 
*Antigen 
(replicase pp1a 
residues) 
Antiserum/antibody 
name 
mAb 
isotype 
Detection assays# 
nsp1 
(nsp1α + 
nsp1β) 
44.0 1 - 385 
pAb Eu-nsp1 (nsp1α) 
mAb Eu22-28 
(nsp1β) 
IgG1 
pAb: RIP 
mAb: IFA, WB, RIP 
nsp2 114.1 427 - 505 
pAb Eu-nsp2 
mAb Eu36-19 
IgG1 
pAb: IFA, RIP 
mAb: IFA, RIP 
nsp2+3 24.6 
385-408 (nsp2) 
1658-1676 (nsp3) 
pAb Eu-nsp2+3 N/A IFA, WB, RIP 
nsp4 21.1 1677 - 1879 mAb Eu54-19 IgG1 IFA, WB, RIP 
nsp7α 15.7 2066 - 2214 mAb Eu9-31 IgG1 IFA, WB, RIP 
nsp7β 13.8 2215 - 2334 mAb Eu24-40 IgG1 IFA, RIP 
nsp8 4.8 2335 – 2379 mAb Eu12-40 IgG1 IFA, WB, RIP 
* The nsp2+3 antigen was made from PRRSV Lelystad isolate (GenBank accession number M96262), and the rest 
of the antigens were made from PRRSV SD01-08 isolate (GenBank accession number DQ489311).  
# IFA: immunofluorescence microscopy assay; WB: Western Blot; RIP: radio immunoprecipitation. 
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Chapter 3 - Attenuation of interferon antagonizing function of 
PRRSV by targeted mutations in a highly conserved motif of 
nsp1β protein 
Abstract: Nonstructural protein 1β (nsp1β) of porcine reproductive and respiratory syndrome 
virus (PRRSV) contains a papain-like cysteine protease (PCPβ) domain, and was determined 
to be the main viral protein antagonizing host innate immune response. In this study, nsp1β 
was determined to suppress the expression of reporter genes as well as suppress “self-
expression” in transfected cells, and this activity appeared to associate with its interferon 
(IFN) antagonist function. To knock down the effect of nsp1β on IFN activity, a panel of site-
specific mutations in nsp1β was analyzed. Double mutations K130A/R134A (type 1 PRRSV) 
or K124A/R128A (type 2 PRRSV), targeting on a highly conserved motif of nsp1β, 
GKYLQRRLQ, impaired the nsp1β’s ability to suppress IFN-β and reporter gene expression, 
as well as to suppress “self-expression” in vitro. Subsequently, viable recombinant viruses, 
vSD01-08-K130A/R134A and vSD95-21-K124A/R128A, containing double mutations in 
GKYLQRRLQ motif were generated using reverse genetics. In comparison to wild-type 
viruses, these nsp1β mutants showed impaired growth ability in infected cells, but the PCPβ 
cleavage function was not directly affected. The expression of selected innate immune genes 
was determined in vSD95-21-K124A/R128A mutant-infected cells. The results consistently 
showed that gene expression levels of IFN-α, IFN-β and ISG15 were up-regulated in cells 
that were infected with the vSD95-21-K124A/R128A compared with that of wild-type virus. 
These data suggest that PRRSV nsp1β may selectively suppress cellular gene expression, 
including those involved in host innate immune function. Modifying the key residues on the 
conserved GKYLQRRLQ motif could attenuate the virus growth and improve cellular innate 
immune responses.  
 
 3.1 Introduction 
Porcine reproductive and respiratory syndrome (PRRS) continues to be a major 
problem in the swine industry worldwide. It causes late term reproductive failure in sows and 
severe pneumonia in neonatal pigs. Since its emergence, PRRS has been estimated to cost the 
US swine industry at least $600 million annually (Miller, 2011). The etiological agent is a 
small, enveloped, positive-stranded RNA virus, which belongs to the order Nidovirales, 
family Arteriviridae, including equine arteritis virus (EAV), lactate dehydrogenase-elevating 
67 
 
virus (LDV), and simian hemorrhagic fever virus (SHFV) (Snijder & Meulenberg, 1998). 
PRRSV can be divided into distinct European (type 1) and North American (type 2) 
genotypes, sharing about 63% nucleotide identity (Allende et al., 1999; Nelsen et al., 1999; 
Ropp et al., 2004). 
The PRRSV genome is about 15kb in length and contains at least ten open reading 
frames. The replicase-associated genes, ORF1a and ORF1ab encode two long nonstructural 
polyproteins, pp1a and pp1ab, with expression of the latter depending on a -1 ribosomal 
frame shift signal in the ORF1a/ORF1ab overlap region. Following their synthesis from the 
genomic mRNA template, the pp1a and pp1ab replicase polyproteins are processed into 14 
nonstructural proteins by a complex proteolytic cascade that is directed by four proteinase 
domains encoded in ORF1a, which includes two papain-like cysteine proteases (PLPα and 
PLPβ) located in the nsp1α and nsp1β, a papain-like protease (PLP2) domain located at the 
N-terminal of nsp2, and a serine protease (SP) located in nsp4. The PLPα autocleaves 
between nsp1α/1β, PLPβ autocleaves between nsp1β/2, and PLP2 cleaves between nsp2/3, 
which mediate nsp1α, nsp1β and nsp2 rapid releasing from the polyprotein. The SP of nsp4 
mediates 9 cleavages in the nsp3-12 region to generate the other individual nsps (Fang & 
Snijder, 2010). In addition, a new ORF (TF) was recently discovered in the central region of 
ORF1a, which expresses a transframe protein, nsp2TF, through a novel -2 ribosomal frame 
shifting mechanism (Fang et al., 2012). 
Viruses depend on host cellular machinery for survival and replication. Most viral 
infections are efficiently resolved by the host innate and adaptive immune system. The innate 
immune response provides an important first line of defense against pathogen intruders. It is 
essential for the initial control of infection and allows time for the establishment of an 
adaptive immune response. A key aspect of the antiviral innate immune response is the 
synthesis and secretion of type I interferon (IFN), such as IFN-α and IFN-β. After being 
secreted, type I IFNs bind to their receptors on adjacent cell surfaces to activate the so-called 
JAK–STAT signaling pathway. Activation of this pathway induces the activation of IFN-
stimulated response elements (ISRE) in the promoter, results the transcription of IFN-
stimulated genes (ISGs). Expression of this group of ISGs enables the cell to fight the 
infection and inhibit virus replication (Weber et al., 2004). As a counteraction to host innate 
antiviral responses, viruses have evolved strategies to actively suppress and/or evade the 
innate immune responses. Some viruses encode proteins that selectively interfere with certain 
components of the IFN system, while some others have evolved to target the general host 
gene expression machinery resulting in blocking the innate immune responses (Basler et al., 
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2000; Chen et al., 1999; Foy et al., 2003; Kamitani et al., 2009; Kamitani et al., 2006; 
Komatsu et al., 2004; Le May et al., 2004; Lokugamage et al., 2012; Wang et al., 2000). 
Various PRRSV nonstructural proteins (nsp1α, nsp1β, nsp2, nsp11) appear to be able to 
suppress the host innate antiviral function (Fang & Snijder, 2010; Yoo et al., 2010). Previous 
studies from our laboratory and others demonstrated that individually expressed PRRSV 
nsp1β showed strong inhibitory effects on IFN-β promoter activation (Beura et al., 2010; 
Chen et al., 2010; Kim et al., 2010). The nsp1β was also determined to be able to inhibit the 
IFN-dependent signaling pathway leading to ISGs expression (Beura et al., 2010; Chen et al., 
2010). As an effort to attenuate the IFN antagonist function of PRRSV nsp1β, in this study, 
we analyzed a panel of site-specific mutations in nsp1β region using both expression system 
and reverse genetics. A highly conserved GKYLQRRLQ motif of nsp1β was identified and 
mutations in this motif were further characterized to determine their effect on nsp1β’s 
function in viral replication and cellular immune responses. 
 
 3.2 Materials and methods 
Cells and viruses. HEK-293T cells, BHK-21 cells and MARC-145 cells were maintained in 
Eagle’s minimum essential medium (Invitrogen) supplemented with 10% fetal bovine serum 
and antibiotics at 37
0
C with 5% CO2. Porcine alveolar macrophages were obtained by lung 
lavage of 6-week-old PRRSV-naive piglets using a method described previously (Zeman et 
al., 1993).The Sendai virus (SeV) Cantell strain was grown in embryonated chicken eggs and 
used for Type I IFN stimulation. The US Type 1 PRRSV isolate SD01-08 (Fang et al., 2006), 
type 2 PRRSV isolate SD95-21 (GenBank accession: KC469618), and their nsp1β mutants 
were used to infect macrophages or MARC-145 cells for subsequent experiments.   
Plasmids. The nsp1α or nsp1β expressing plasmids were constructed by RT-PCR 
amplification of the nsp1α or nsp1β region from the genomic RNA of SD01-08 (EU) or 
SD95-21 (NA) virus. The PCR product was cloned into a eukaryotic expression vector, 
p3xFLAG-CMV-24 (sigma), designated as p3xFLAG-EU-nsp1α (222 nt to 761 nt of SD01-
08 genome), p3xFLAG-EU-nsp1β (762 nt to 1376 nt of SD01-08 genome) and p3xFLAG-
NA-nsp1β (731 nt to 1339 nt of SD95-21 genome). Specific mutations in nsp1β were 
constructed by site-directed mutagenesis using QuickChange
TM
 site-directed mutagenesis kit 
(Stratagene) following the manufacturer’s instruction. Table 1 lists each construct and 
corresponding mutations introduced into nsp1β. Four reporter plasmids were used in this 
study. The p125-Luc plasmid expresses the firefly luciferase under the control of the IFN-β 
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promoter (Yoneyama et al., 1996); The pISRE-Luc plasmid expresses the firefly luciferase 
under the control of the interferon-stimulated response element (ISRE) promoter (Stratagene); 
The pRL-SV40 plasmid expresses a Renilla luciferase under the control of a simian virus (SV) 
40 promoter (Promega), and pEGFP-N1 plasmid expresses the enhanced green fluorescence 
protein (EGFP) under the control of CMV promoter (Clone Tech). For expression of nsp1β-2 
in a vaccinia-T7 polymerase system, the nsp1β-2 region was RT-PCR amplified from 
genomic RNA of PRRSV SD01-08 (EU) or SD95-21 (NA). The PCR product of nsp1β-2 was 
cloned into the pL1a plasmid (Snijder et al., 1994), designated as pL-EU-nsp1β-2 (763 nt to 
4559 nt of SD01-08 genome) or pL-NA-nsp1β-2 (731 nt to 4927 nt of SD95-21 genome). 
The K130A and R134A mutations were introduced into the nsp1β region of pL-EU-nsp1β-2 
to construct plasmid pL-EU-nsp1β-2-mt, while K124A and R128A mutations were 
introduced into the nsp1β region of pL-NA-nsp1β-2 to construct plasmid pL-NA-nsp1β-2-mt. 
In addition, C96S mutation was introduced into PCPβ catalytic site of pL-EU-nsp1β-2 to 
construct the plasmid EU-nsp1β-2-C96S. These plasmids containing the nsp1β-2 (or its 
nsp1β mutant) gene are under the control of a T7 RNA polymerase promoter and an 
encephalomyocarditis virus internal ribosomal entry site, followed by a downstream T7 
terminator sequence.  
Cell transfection and luciferase reporter assay. HEK-293T cells were seeded at 0.5×10
5
 
cells/ml in 24-well plates one day prior to the transfection. Cells were transfected with 
p3xFLAG-EU-nsp1β or p3xFLAG-NA-nsp1β (or their mutants) plasmid DNA (0.5 μg) 
mixed with luciferase reporter plasmid p125-Luc, pISRE-Luc (0.4 μg) or pRL-SV40 (0.02 
μg). Transfection was performed using FuGENE HD transfection reagent followed the 
manufacturer's instruction (Roche Molecular Biochemicals). At 24 h post-transfection, cells 
were infected with Sendai virus at 100 HA unit/ml/well for 12–16 h, or treated with IFN-β at 
2000 IU/ml/well for 16 h. Cells were harvested and subjected to reporter gene assay using the 
luciferase reporter system (Promega) according to manufacturer's instruction. Firefly or 
Renilla luciferase activity was measured in a luminometer (Bethold). Cell lysates were also 
subjected to SDS-PAGE and western blot analysis for protein expression. 
Quantitative analysis of mRNA. To measure the IFN-β mRNA expression level, HEK-293T 
cells were transfected with a plasmid expressing nsp1β or its mutant using FuGENE HD 
transfection reagent (Roche Molecular Biochemicals) followed the manufacturer’s instruction. 
The empty plasmid was also used to transfect cells as a control. At 24 h post-transfection, 
cells were infected with 100 HA unit/ml of SeV or mock infected. At 16 h post-infection 
(hpi), total intracellular RNAs were extracted using the TRIzol® RNA Isolation Reagents 
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(Invitrogen, Carlsbad, CA). The contaminating genomic DNA was digested with DNase I 
(Invitrogen, Carlsbad, CA). Total RNA (1ug) was used to synthesize first strand cDNA using 
high capacity RNA- to -cDNA kit (Invitrogen, Carlsbad, CA). Subsequently, real-time PCR 
was performed to quantify the expression of IFN-β mRNA and 18S rRNA (as endogenous 
control) using a TaqMan gene expression master mix reagent kit (Applied Biosystems). A 
total of 40 cycles was performed on an ABI PRISM 7900 real-time thermocycler (Applied 
Biosystems, Foster City, CA). The amount of IFN-β mRNA was normalized to the 
endogenous 18S rRNA. For quantitative analysis of reporter gene mRNA expression, HEK-
293T cells were co-transfected with the plasmid expressing nsp1β (or its mutant) and pRL-
SV40 expressing Renilla luciferase. At 24h post-transfection, total intracellular RNAs were 
extracted, and the expression level of Renilla luciferase mRNA was measured by real-time 
PCR using a TaqMan gene expression master mix reagent kit (Applied Biosystems).   
Western Blot Analysis. Virus-infected or plasmid DNA-transfected cells were harvested and 
lysed in lyses buffer (10 mM Tris, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% 
sodium dodecyl sulfate [SDS], 1 mM EDTA, PH7.4) supplemented with protease inhibitor 
cocktail (Roche). Cell lysates were frozen at -80°C, thawed, and centrifuged to remove the 
insoluble pellet. Protein concentration in the supernatant was determined by a Bradford assay 
(Bio-Rad). Equal amounts of protein samples from different treatments were separated by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated 
proteins were blotted onto a nitrocellulose membrane, and the membrane was blocked with 
5% non-fat dry milk in PBST (0.05% Tween 20 in 1×PBS). The membrane was then 
incubated with primary antibodies for 1 h at room temperature. For detection of the PRRSV 
nsp1β and nsp2 expression, mouse monoclonal antibodies (mAbs) against nsp1β and nsp2 
were used as described previously (Li et al., 2012). For detection of FLAG-tagged proteins, 
the anti-FLAG mAb (sigma) was used. In addition, mAb to EGFP (sigma) or ISG15 (Santa 
Cruz Biotechnology) was used as a primary antibody. The anti-β-tubulin mAb (Lamda 
Biotech) was used as a control. After incubation with the primary antibody, the membrane 
was washed three times with PBST. DyLight 680-labeled goat anti-rabbit antibody or 
DyLight 800-labeled goat anti-mouse antibody (LI-COR Biosciences, Lincoln, NE) was 
added and the membrane was incubated for additional 1 h at room temperature. Image of the 
membrane was obtained by scanning under an appropriate excitation wavelength using a 
digital image system (Odyssey infrared imaging system; LI-COR Biosciences, Lincoln, NE). 
Quantification of protein expression levels was performed by using Adobe Photoshop, 
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following the method described at http://rsbweb.nih.gov/ij/. For each protein lane on the 
Western blot, the target protein level was normalized to that of β-tubulin. 
Recovery recombinant virus from infectious cDNA clones. The PRRSV full-length cDNA 
infectious clones, pCMV-SD01-08 (type 1 PRRSV) and pCMV-SD95-21 (type 2 PRRSV) 
and their nsp1β-mutated plasmids were used to transfect BHK-21 cells. Transfection was 
performed using Lipofectamine® LTX with Plus™ Reagent followed the manufacturer's 
instruction (Life technology). To rescue the virus, cell culture supernatant obtained at 24 - 48 
h post-transfection was passaged on MARC-145 cells. Cells were stained with the mAb 
specific to nsp1β (Li et al., 2012) and FITC-conjugated SDOW17 to nucleocapsid (N) protein 
for monitoring genome replication and subgenomic transcription as we described previously 
(Fang et al., 2006). The passage 3 viruses from the MARC-145 cells were used for further 
analysis. 
Sequencing of nsp1β mutation regions. To determine the stability of each mutation, cell 
lysate from recombinant virus-infected cells was harvested and RNA was extracted using a 
QiaAmp viral RNA kit (Qiagen) following the manufacturer’s instruction. The corresponding 
mutations were amplified by RT-PCR, and PCR products were sequenced at the Iowa State 
University DNA sequencing facility (Ames, IA). 
Virus titration and plaque assay. MARC-145 cells were infected with nsp1β mutants and 
wild-type virus at an MOI of 0.1. Infected cells were harvested at 48 hpi, and virus titers were 
determined by fluorescent focus assay as described previously (Sun et al., 2012). Plaque 
morphology between the nsp1β mutant and wild-type virus was compared by plaque assay 
using the method we described previously (Fang et al., 2006).   
Nsp1β-2 expression in recombinant vaccinia virus/T7 polymerase system. The pL-EU-
nsp1β-2-C96S, pL-EU-nsp1β-2, pL-EU-nsp1β-2-mt, pL-NA-nsp1β-2, or pL-NA-nsp1β-2-mt 
plasmid was transiently expressed in HEK-293T cells using the recombinant vaccinia virus-
T7 polymerase expression system (Fuerst et al., 1986) as described previously (Snijder et al., 
1994). Cells were harvested at 24 h post transfection and subjected to western blot analysis 
using the mAbs specific to nsp1β and nsp2 PLP2 domain (Li et al., 2012; Fang et al., 2012).   
Swine cytokine fluorescence microsphere immunoassay (FMIA). Porcine alveolar 
macrophages were infected with 1 MOI of wild-type or recombinant viruses. At 24 hpi, 
culture supernatant was harvested for analyzing the IFN-α expression using a FMIA as 
described previously (Lawson et al., 2010). The quantity of IFN-α was determined using 
mean fluorescent intensity (MFI) values, and the result was compared with the mean values 
from Mock-infected control cells. 
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 3.3 Results 
Generation of PRRSV nsp1β mutants with reduced ability to suppress type I interferon 
production and signaling 
Since PRRSV nsp1β was determined to be one of the main interferon antagonists, in 
an effort to knock down its interferon antagonist function, a panel of site-specific nsp1β 
mutations was constructed (Table 1). They were designed based on the protein surface 
accessibility prediction (Emini et al., 1985), hydrophilicity analysis (Hopp & Woods, 1981) 
and crystal structure of nsp1β (Xue et al., 2010). The conserved hydrophilic amino acids 
predicted to be exposed on the protein surface were targeted for mutation (Fig. 3.1). Each of 
the nsp1β genes carrying double mutations was cloned into the plasmid, p3xFLAG-CMV-24, 
in which the gene expression is under the control of CMV promoter and expressed as FLAG-
tagged protein. Initially, the panel of nsp1β mutants generated from a type 1 PRRSV strain, 
SD01-08 (Table 1.1) was analyzed in an IFN-β promoter driven-luciferase reporter assay. 
The HEK-293T cells were cotransfected with a plasmid expressing wild-type or mutated 
nsp1β and a reporter plasmid (p125-Luc) that expresses luciferase reporter gene under the 
control of IFN-β promoter. As controls, the PCPβ catalytic site mutant C96S and empty 
plasmid p3xFLAG-CMV-24 were included in the analysis. At 24 hour (h) post transfection, 
cells were mock-infected or infected with Sendai virus (SeV). Cells were harvested to test the 
luciferase activities at 16 h post-infection (hpi). As shown in Fig. 3.2A, SeV infection 
induced high level of luciferase reporter expression in cells transfected with empty plasmid, 
but luciferase expression was about 7 to 50-fold lower in cells expressing wild-type nsp1β 
and C96S, E28A/D31A, E41A/E43A, E68A/E71A mutants. In contrast, about 30-fold higher 
level of reporter signal was detected in cells expressing K130A/R134A mutant in comparison 
to that of wild-type nsp1β. We further determined whether these mutations had effect on 
nsp1β’s ability to suppress IFN-dependent signaling pathway for the ISG expression. The 
panel of nsp1β mutants was analyzed using an ISRE promoter driven-luciferase reporter 
assay. Similar result was generated as that obtained in Fig. 3.2A, about 7 to 14-fold higher 
level of reporter signal was detected in cells expressing K130A/R134A mutant in comparison 
to those expressing wild-type nsp1β and C96S, E28A/D31A, E41A/E43A, E68A/E71A 
mutants (Fig. 3.2B). These results suggest that K130A and R134A mutations impaired IFN 
antagonist function of nsp1β. 
To further confirm these results, we tested whether K130A/R134A mutations had 
effect on endogenous IFN-β mRNA expression. HEK-293T cells were transfected with the 
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empty plasmid, or the plasmid expressing wild-type nsp1β or K130A/R134A mutant, and 
then mock-infected or infected with SeV. At 16 hpi, intracellular RNA was extracted and the 
amount of IFN-β mRNA was measured by real-time RT-PCR. As shown in Fig. 3.3A, 
expression of wild-type nsp1β strongly inhibited the SeV-induced IFN-β mRNA 
accumulation. In contrast, there was about 3-fold increase of IFN-β mRNA expression in 
cells transfected with K130A/R134A mutant. This result indicates that K130A and R134A 
mutations impaired nsp1β’s ability to suppress IFN-β mRNA expression. The K130 and 
R134 residues in nsp1β of type 1 PRRSV correspond to K124 and R128 in nsp1β of type 2 
PRRSV. We repeated our experiment using nsp1β from a type 2 PRRSV strain, SD95-21. 
The result was consistent with that obtained from type 1 virus. The expression of wild-type 
nsp1β strongly suppressed the IFN-β mRNA expression (Fig. 3.3B) as well as IFN-β 
activation and signaling (Fig. 3.4), while increased levels of IFN-β mRNA (Fig. 3.3B) and 
luciferase reporter expression (Fig. 3.4) were observed in cells expressing K124A/R128A 
mutant.  
Mutations on amino acids K130(124) and R134(128) impaired nsp1β’s ability to 
suppress “self-expression” and reporter gene expression in vitro 
Western blot analysis confirmed the expression of nsp1β wild-type and mutants in 
luciferase assays (Fig. 3.2 and 3.4). Interestingly, the data consistently showed that mutations 
in K130(124) and R134(128) caused increased amount of nsp1β expression in comparison to 
that of wild-type nsp1β and other mutants, which suggested that nsp1β may suppress its “self-
expression”. To confirm this notion, we repeated luciferase assays and compared the cellular 
expression level of nsp1β with nsp1α, since nsp1α was also determined to be an interferon 
antagonist in previous studies (Beura et al., 2010; Chen et al., 2010; Song et al., 2010). The 
HEK-293T cells were cotransfected with the reporter plasmid and equal amount of plasmid 
DNA expressing nsp1α or nsp1β. As we expected, the result showed that both nsp1α and 
nsp1β suppressed the expression of IFN-β promoter driven luciferase (Fig. 3.8A), and nsp1β 
had stronger inhibition on the gene expression under the control of ISRE promoter (Fig. 
3.8B). Western blot analysis using anti-FLAG antibody detected higher amount of nsp1α 
protein, but only trace amount of nsp1β protein was detected in both luciferase assays. 
The data made us speculate that nsp1β may have general effect on cellular gene expression, 
including its “self-expression” in vitro. To test this possibility, we examined the effect of 
nsp1β on the reporter gene mRNA expression. The HEK-293T cells were cotransfected with 
a reporter plasmid (pRL-SV40) expressing Renilla luciferase reporter gene under the control 
of SV40 promoter, and the plasmid expressing type 1 wild-type nsp1β or K130A/R134A 
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mutant. The empty plasmid was used as a control. Intracellular RNA was extracted at 24 h 
post transfection, and the amount of mRNA was determined by real-time RT-PCR. In 
comparison to the Renilla luciferase mRNA expression level in cells transfected with empty 
plasmid, the wild-type nsp1β showed strong inhibition effect. However, the luciferase mRNA 
level was about 3-fold higher in cells expressing K130A/R134A mutant comparing to those 
in cells expressing wild-type nsp1β (Fig. 3.5A). In contrast, there was no apparent difference 
on the amounts of 28S and 18S rRNAs among different treatments (Fig. 3.5B). These data 
indicate that nsp1β specifically suppressed reporter gene mRNA expression and 
K130A/R134A mutations impaired this specific activity. Next, we determined the effect of 
nsp1β expression on the reporter protein production. In comparison to those cells expressing 
K130A/R134A mutant or transfected with empty plasmid, there was about 7 to 8-fold 
reduction on the amount of Renilla luciferase protein in cells expressing wild-type nsp1β (Fig. 
3.5C). To further confirm this result, we cotransfected cells with a plasmid expressing 
another reporter gene, the enhanced green fluorescent protein (EGFP), and the plasmid 
expressing wild-type nsp1β or its mutant from both type 1 and type 2 viruses. Expression of 
EGFP was analyzed by fluorescence microscopy. As shown in Fig. 3.5E, in comparison to 
those cells cotransfected with empty plasmid, the expression of EGFP was strongly 
suppressed in cells expressing wild-type nsp1β. In contrast, higher levels of EGFP expression 
were observed in cells expressing K130A/R134A and K124A/R128A mutants. Western blot 
analysis using anti-nsp1β and anti-EGFP antibodies confirmed the expression of nsp1β and 
EGFP proteins (Fig. 3.5D and F). Due to the difference in sensitivity of different antibodies, 
we used anti-FLAG antibody to detect and compare the expression levels of different proteins. 
The result consistently showed that wild-type nsp1β expression resulted in lower levels of 
EGFP production, whereas 2- or 8-fold higher level of EGFP proteins were detected in cells 
cotransfected with the plasmid expressing nsp1β mutant from type 1 or type 2 PRRSV. Again, 
about 2- or 3-fold increased level of nsp1β protein was detected in cells expressing 
K130A/R134A or K124A/R128A mutant in comparison to those cells expressing wild-type 
nsp1β, indicating the important role of K130(124)/R134(128) residues involved in the nsp1β 
activities.  
Amino acids K130(124) and R134(128) locate on a highly conserved motif among 
PRRSV strains from both genotypes 
Based on the crystal structure of nsp1β from a type 2 PRRSV (Xue et al., 2010), the 
K124 and R128 residues are exposed on the protein surface. We further searched the 
potential functional motif in this region and result showed that these two resides are located 
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on a potential B-cell epitope motif, GKYLQRRLQ (Kolaskar & Tongaonkar, 1990). This 
motif has the highest surface accessibility value in comparison to the other regions of nsp1β 
(Fig. 3.1A; Emini et al., 1985). Amino acid sequence alignment of nsp1β sequences from 212 
PRRSV isolates available in GenBank revealed that the GKYLQRRLQ motif is highly 
conserved among all available PRRSV stains, including both type 1 and type 2 viruses (Fig. 
3.1B), which suggests important role of GKYLQRRLQ motif in nsp1β function.    
Characterize recombinant viruses containing mutations in GKYLQRRLQ motif 
We further investigated whether specific mutations introduced into nsp1β region of 
the virus could improve innate immune responses in PRRSV-infected cells. Initially, two 
PRRSV nsp1β mutants were generated using reverse genetics (Fig. 3.6A), including vSD01-
08-K130A/R134A (vSD01-08-mt) that contains K130A and R134A mutations in the nsp1β 
region of type 1 PRRSV SD01-08; and vSD95-21-K124A/R128A (vSD95-21-mt) that 
contains K124A and R128A mutations in the nsp1β region of type 2 PRRSV SD95-21. As a 
comparison, the wild-type viruses, vSD01-08 and vSD95-21 were also recovered from 
reverse genetics. Stability of those mutations introduced into the virus was determined by 
serial passaging each virus 10 times in MARC-145 cells, and sequence analysis showed that 
all targeted mutations were stably maintained in the virus. The growth property of these two 
mutants was compared with their wild-type parental viruses. Both mutants showed crippled 
growth phenotype in MARC-145 cells. The peak viral titer for vSD95-21-mt was 10
5.4
 
FFU/ml, compared to the titer of 10
6.3
 FFU/ml for vSD95-21. The vSD01-08-mt appeared to 
be highly attenuated on its growth in cell culture (Fig. 3.6B). The virus titer remained around 
10
2
 FFU/ml through all passages. Plaque assay result consistently showed that vSD95-21-mt 
developed smaller plaques than that of wild-type virus, while vSD01-08-mt barely produced 
plaques. In order to stimulate a measurable host IFN response, a high virus dose is required 
for the initial infection. Therefore, vSD95-21-mt was used in subsequent experiments for 
comparison of innate immune gene expression between cells infected with nsp1β mutant and 
wild-type virus (see below and data presented in Fig. 3.7).   
The nsp1β encodes PCPβ protease that is responsible for proteolytic cleavage of the 
nsp1β/nsp2 site of pp1a and pp1ab polyproteins, a critical step in viral replication (Fang & 
Snijder, 2010). To investigate whether the crippled growth property of these mutants could be 
due to an effect on the function of PCPβ in replicase maturation, the nsp1β-2 region was 
expressed from both type 1 and type 2 PRRSV, designated as EU-nsp1β-2 and NA-nsp1β-2, 
respectively. Subsequently, K130A/R134A or K124A/R128A mutations were introduced into 
the nsp1β-2 region to generate EU-nsp1β-2-mt or NA-nsp1β-2-mt constructs. For a 
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comparison, PCPβ catalytic site mutant EU-nsp1β-2-C96S was also constructed. These 
constructs were analyzed in a recombinant vaccinia virus/T7 RNA polymerase expression 
system. The result showed that the C96S mutant prevented the cleavage of nsp1β/2 site as the 
nsp1β-2 proteins were detected as an uncleaved precursor form. In contrast, both 
K130A/R134A and K124A/R128A mutants being efficiently cleaved at the nsp1β/2 site, as 
individual nsp1β and nsp2 proteins were detected in the amount quite similar to those 
produced by the wild-type nsp1β-2 control (Fig. 3.9). The data indicate that the proteolytic 
function of PCPβ towards the nsp1β/2 site is not directly affected by mutation of K130(124) 
and R134(128), suggesting that the reduced growth rate (viral titer) of the vSD01-08-mt and 
vSD95-21-mt viruses may not directly caused by a basic defect in replicase polyprotein 
proteolysis, but instead may be due to an impaired ability to counteract cellular innate 
immune responses (see below).   
Expression of innate immune genes in nsp1β mutant-infected cells  
Since mutations introduced in GKYLQRRLQ motif reduced the nsp1β’s ability to 
suppress IFN-β activity, we further determined whether these mutations could alter the effect 
of PRRSV on the innate immune response. Initially, we performed the IFN-β promoter-
luciferase reporter assay using the full-length cDNA infectious clone of SD95-21 and its 
K124A/R128A mutant. HEK-293T cells were cotransfected with p125-Luc reporter plasmid 
and full-length cDNA of SD95-21 or K124A/R128A mutant. At 24 h post-transfection, cells 
were mock-infected or infected with SeV. After 16 h stimulation, cells were assayed for IFN-
β activation. As shown in Fig. 3.7A, in comparison to that in empty plasmid vector-infected 
cells, the replication of wild-type virus significantly inhibited IFN-β promoter-dependent 
luciferase expression. The experiment was repeated three times and the result consistently 
showed that there was about a 2-fold increase of luciferase reporter level in cells transfected 
with full-length cDNA of K124A/R128A mutant comparing to that in cells transfected with 
full-length cDNA of parental virus. To further confirm this result, IFN-α expression was 
examined in vSD95-21-mt and vSD95-21 wild type virus-infected porcine alveolar 
macrophages. At 24 h post infection, culture supernatants were harvested and IFN-α 
expression level was quantified by a swine cytokine fluorescence microsphere immunoassay 
(FMIA). As shown in Fig. 3.7B, there was a 40-fold increase of IFN-α expression level in the 
vSD95-21-mt-infected cells, in comparison to that in the wild type virus-infected cells. 
We further determined the effect of K124A and R128A mutations on the expression of ISG15 
in mutant or wild type virus-infected MARC-145 cells. Initially, cells were mock-infected or 
infected with vSD95-21-mt or vSD95-21 wild type virus. At 18 hpi, cells were treated with 
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IFN-α to activate the expression of ISGs. Western blot analysis showed a 5-fold increase in 
the level of ISG15 protein production in vSD95-21-mt virus-infected cells, in comparison to 
those in wild type virus-infected cells (Fig. 3.7C). The expression level of nsp1β was also 
analyzed in western blot. Interestingly, in contrast to in vitro expression system, similar level 
of nsp1β protein expression was detected in vSD95-21-mt and vSD95-21 wild-type virus-
infected cells.  
 
 3.4 Discussion 
Previous studies from our laboratory and others identified PRRSV nsp1β as an 
interferon antagonist, in which nsp1β inhibited type I IFN activities in expression systems 
employing mainly reporter gene-based assays (Beura et al., 2010; Chen et al., 2010; Kim et 
al., 2010; Patel et al., 2010). It was suggested that the PRRSV nsp1β protein may act on the 
IFN-β production and signaling pathways, in which it could have a direct effect on the 
formation of the transcription enhanceosome on the IFN-β promoter in the nucleus as well as 
effect on the nuclear translocation of STAT1/STAT2 (Beura et al., 2010; Chen et al., 2010; 
Kim et al., 2010; Patel et al., 2010). The data generated from current study consistently 
showed that nsp1β inhibited reporter gene mRNA expression, resulting to a strong inhibition 
in reporter protein synthesis. Expression of nsp1β also suppressed Sendai virus-induced 
endogenous IFN-β mRNA accumulation and inhibited IFN-β protein synthesis. Another 
interesting phenomenon is that the level of nsp1β protein expression in nsp1β-transfected 
cells was lower in comparison to the expression level of another replicase protein, nsp1α, 
which also has ability to antagonize IFN function. Initially, we suspected that the nsp1β may 
have general effect on host gene expression, including its own RNA transcripts in vitro. 
However, it appeared not affect 28S and 18S rRNAs and β-actin expression. A similar 
observation was also reported for SARS-CoV nsp1 (Huang et al., 2011; Kamitani et al., 2009; 
Kamitani et al., 2006; Narayanan et al., 2008). Individual expression of SARS-CoV nsp1 
resulted low expression level, which was due to its ability to promote cellular mRNA 
degradation, including its own RNA transcripts. However, during the infection, virus 
developed mechanism to prevent degradation of its own viral mRNAs, and the nsp1 protein 
only selectively cleaved cellular mRNAs with certain structures. We also noticed the 
difference in PRRSV nsp1β expression levels using different plasmid expression systems. 
When the PRRSV nsp1β expressed using p3xFLAG plasmid, which is under the control of 
CMV promoter, we detected lower level of nsp1β expression. In contrast, when nsp1β gene 
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was expressed under the control of a T7 RNA polymerase promoter and an internal ribosomal 
entry site, the wild-type nsp1β was expressed in a similar level as its mutant (Fig. 3.9), which 
could due to different mRNA structure in comparison to that expressed under the control of 
CMV promoter. Similar to that of SARS-CoV nsp1, in infected cells, PRRSV nsp1β did not 
appear to suppress the expression of its own mRNA (Fig. 3.7C), suggesting the virus evolves 
a mechanism to recognize its own mRNA structure in infected cells. The detailed mechanism 
of this activity is still unknown. PRRSV nsp1β may selectively suppress the expression of 
host cellular genes, including those involve in host innate immune responses. This leaves 
intact viral mRNA and host translational machineries for viral-specific protein synthesis. 
Therefore, besides promoting the cellular resources benefiting for its replication, PRRSV 
may also use nsp1β to block host innate immune responses to establish the infection. 
In order to knock down the IFN antagonist function of nsp1β, we introduced a panel 
of site-specific mutations into the hydrophilic regions of the protein. The effect of 
GKYLQRRLQ motif mutations on nsp1β’s immune suppression function highlights the 
importance of this region in viral pathogenesis. Our results showed that double mutations 
introduced at K130(124) and R134(128) residues of GKYLQRRLQ motif impaired the 
function of nsp1β on the suppression of IFN-β and reporter gene expression, as well as its 
“self-suppression” in vitro. The data suggest the association between the nsp1β’s function on 
the suppression of IFN-β and its “self-suppression”, since higher expression levels of the 
nsp1β-K130A/R134A and nsp1β-K124A/R128A mutant proteins result in reduced ability to 
suppression IFN activities. More importantly, amino acid sequence analysis showed that 
GKYLQRRLQ motif is conserved among all known PRRSV strains, implicating its critical 
role in viral replication and pathogenesis. Crystal structure analysis showed that this motif is 
exposed on the surface of PCPβ domain. However, the PCPβ proteinase cleavage function 
did not seem to be directly affected by K130(124) and R134(128) mutations in our in vitro 
proteinase cleavage assay (Fig. 3.9). We suspect that these mutations may affect the nsp1β’s 
activity on primary targeting host mRNA and interaction with host cellular gene expression 
shut off factors. A detail mechanism of this effect needs to be elucidated in the future.  
In an effort to reduce the innate immune suppression function of PRRSV, viable 
recombinant viruses containing mutations in GKYLQRRLQ motif were generated, but these 
viruses showed certain level of impaired growth ability. The vSD95-21-K124A/R128A 
mutant replication caused a reduced ability to inhibit IFN-α, IFN-β and ISG15 expression in 
comparison to that of wild-type virus. These data further support the notion that PRRSV 
nsp1β is a key factor to suppress host innate immune response in PRRSV-infected cells. In 
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correlation with the result from in vitro PCPβ cleavage assay, the data suggest that impaired 
replication of nsp1β mutant may not be directly caused by an effect on PCPβ cleavage, but 
may rather be due to an impaired ability to suppress host innate immune gene expression. 
However, we cannot exclude the possibility that those mutations in GKYLQRRLQ motif 
may affect other replicative functions of the PCPβ domain, which could have an indirect 
effect on viral replication.   
The identification of viral elements responsible for innate immune evasion is 
fundamental for the development of a modified live PRRSV vaccine. Our mutagenesis study 
showed that modifying the key residues in GKYLQRRLQ motif of nsp1β could attenuate the 
virus growth and improve the host innate immune responses. Since the GKYLQRRLQ motif 
is highly conserved among PRRSV strains, the technology developed in this study would be 
easily adapted to other viral strains. Future studies are needed to test the ability of nsp1β 
mutants for induction of protective immune responses in animals. 
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Figure 3. 1 Surface accessibility prediction and sequence alignment of nsp1β. (A) Emini 
surface accessibility prediction, four peaks highlighted with gray boxes shown the highest 
surface accessiblity values. (B) Amino acid sequence alignment of nsp1β from representative 
type 1 and type 2 PRRSV strains. The secondary-structure elements of PRRSV nsp1β are 
shown on the top of alignment based on the crystal structure of type 2 PRRSV XH-GD strain 
(Xue et al., 2010). The conserved motif, GKYLQRRLQ, is highlighted in black box. Amino 
acid numbers on the top refer to the residue position in nsp1β sequence of XH-GD strain. 
Sequences presented in the figure were from GenBank: GU737264 (07V063), GU067771 
(Amervac PRRS), GU047344 (BJEU06-1), AY366525 (EuroPPRSV), EU076704 (HKEU16), 
FJ349261 (KNU-07), M96262 (LV; Lelystad Virus), GU047345 (NMEU09-1), DQ489311 
(SD01-08), GQ461593 (SHE), EU624117 (XH-GD), EU708726 (JX143), AY424271 
(JA142), DQ988080 (Ingelvac ATP), AF325691 (NVSL), AF494042 (P129), EF536003 
(VR2332), EF488739 (MN184), AF066183.4 (RespPRRS MLV), KC469618 (SD95-21). 
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Figure 3. 2 Effect of mutations on type 1 PRRSV nsp1β expression and its ability to 
inhibit IFN-β activation and signaling. (A) HEK-293T cells were cotransfected with p125-
Luc and a plasmid expressing FLAG-tagged nsp1β of PRRSV SD01-08 (WT) or its mutants. 
The empty plasmid vector (EV) was included as a control. At 20 h post transfection, cells 
were infected with SeV (100 HA units/ml) to stimulate the production of type I IFN. The 
luciferase activity was measured at 12-16 h post stimulation. (B) HEK-293T cells were 
cotransfected with pISRE-Luc and a plasmid expressing FLAG-tagged nsp1β (WT) or its 
mutants or empty vector (EV). Cells were treated with IFN-β (2000 IU/ml) for 16 h. The cells 
were harvested and measured for the firefly luciferase activity. The expression of nsp1β 
protein was analyzed by Western blot. Membranes were stained with anti-FLAG and anti-β 
tubulin monoclonal antibodies. Each experiment was repeated three times and a mean value 
was calculated. Error bars show standard deviations.  
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Figure 3. 3 Effect of amino acids K130(124) and R134(128) mutations on the ability of 
nsp1β to suppress IFN-β mRNA expression. (A) HEK-293T cells were transfected with a 
plasmid expressing type 1 PRRSV nsp1β (EU-nsp1β) or K130A/R134A mutant (EU-nsp1β-
mt). (B) HEK-293T cells were transfected with a plasmid expressing type 2 PRRSV nsp1β 
(NA-nsp1β) or K124A/R128A (NA-nsp1β-mt). The empty plasmid vector (EV) was used as 
a control. Cells were mock-infected or infected with 100 HA units/ml SeV for 16 h. Cells 
were harvested and the level of IFN-β mRNA expression was measured by quantitative RT-
PCR. The relative amount of IFN-β mRNAs was normalized to the expression level of 
endogenous 18S rRNA. Each experiment was repeated three times. 
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Figure 3. 4 Effect of K124A/R128A mutations on type 2 PRRSV nsp1β expression and 
its ability to inhibit IFN-β activation and signaling. (A) HEK-293T cells were 
cotransfected with p125-Luc and a plasmid expressing FLAG-tagged nsp1β of PRRSV 
SD95-21 (NA-nsp1β) or K124A/R128A mutant (NA-nsp1β-mt). The empty plasmid vector 
(EV) was included as a control. At 24 h post transfection, cells were infected with Sendai 
virus (SeV, 100 HA units/ml) to stimulate the type I IFN activation. The luciferase activity 
was measured at 12-16 h post stimulation. (B) HEK-293T cells were cotransfected with 
pISRE-Luc and a plasmid expressing FLAG-tagged nsp1β (NA-nsp1β) or K124A/R128A 
mutant (NA-nsp1β-mt) or empty vector (EV). Cells were treated with IFN-β (2000 IU/ml) for 
16 h. Cells were harvested and measured for firefly luciferase activity. Each experiment was 
repeated three times. Standard deviations are shown as error bars. Western blot analysis was 
performed to evaluate the expression of nsp1β in both experiments using anti-FLAG mAbs. 
Membranes were also stained with anti-β tubulin antibody for loading control. 
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Figure 3. 5 Effect of nsp1β on the expression of reporter genes. (A-D) Effect of nsp1β on 
Renilla luciferase reporter gene expression. HEK-293T cells were cotransfected with the 
reporter plasmid pRL-SV40 and a plasmid expressing FLAG-tagged nsp1β (EU-nsp1β) or 
K130A/R134A mutant (EU-nsp1β-mt) or empty vector (EV). At 24 h post transfection, cells 
were harvested for RNA or protein quantification. (A) The amount of Renilla luciferase 
mRNAs was quantified by real-time PCR, and normalized to the expression level of 
endogenous 18S rRNA. (B) Ethidium Bromide Staining for detection of rRNA expression. (C) 
The Renilla luciferase activity measured by luciferase assay (Promega). Each experiment was 
repeated three times and the data are presented as mean values and standard deviations. (D) 
Western blot analysis for the expression of FLAG-tagged nsp1β and its mutant. (E-F) Effect 
of nsp1β on EGFP reporter gene expression. HEK-293T cells were cotransfected with the 
pEGFP-N1 and a plasmid expressing type 1 PRRSV nsp1β (EU-nsp1β) or K130A/R134A 
mutant (EU-nsp1β-mt), type 2 PRRSV nsp1β (NA-nsp1β) or K124A/R128A mutant (NA-
nsp1β-mt). Empty plasmid vector (EV) was included as a control. (E) EGFP reporter gene 
expression was observed under fluorescence microscopy, and pictures were taken at 24 h post 
transfection. (F) Western blot analysis for detection the expression of EGFP and nsp1β. The 
membrane was stained with anti-FLAG and anti-EGFP mAbs. β-tubulin was detected as a 
loading control in all experiments. 
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Figure 3. 6 Recovery and growth characterization of vSD01-08-K130A/R134A (vSD01-
08-mt) and vSD95-21-K124A/R128A (vSD95-21-mt) recombinant viruses. (A) Recovery 
of recombinant viruses from cells transfected with full-length cDNA of wild-type viruses or 
nsp1β mutants. The fixed cells were first stained with a primary anti-nsp1β mAb at 37oC for 
1 h. The Alexa Fluor 549-labeled goat anti-mouse antibody (Kirkegaard & Perry Laboratories) 
was used as a secondary antibody for detecting the expression of nsp1β. Nucleocapsid protein 
was detected by staining the cells with FITC-conjugated mAb SDOW17. Cell nucleus was 
stained with 4', 6-diamidino-2-phenylindole (DAPI, Molecular Probes). Images were 
obtained by fluorescence and phase-contrast microscopy using a 20X objective. (B) Virus 
titers of the parental and mutant viruses. P0: parental and recombinant viruses originally 
recovered from BHK-21 cells transfected with the full-length cDNA; P3: viruses passaged 
three times on MARC-145 cells.  
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Figure 3. 7 Effect of nsp1β K124/R128A mutations on the ability of PRRSV to inhibit 
IFN-β activation and signaling. (A) HEK-293T cells were cotransfected with p125-Luc () 
and pCMV-SD95-21(SD95-21), p125-Luc and pCMV-SD95-21-K124/R128A (SD95-21-mt), 
or p125-Luc and empty plasmid vector (EV). At 24 h after transfection, cells were mock-
infected or infected with 100 HA units/ml SeV to stimulate the production of type I IFN. 
Cells were harvested and luciferase activity was measured at 16 hpi. Western blot analysis 
was performed to detect nsp1β expression using anti-nsp1β mAb. (B) Swine macrophages 
were infected with 1 MOI of parental virus (vSD95-21), nsp1β K124A/R128A mutated virus 
(vSD95-21-mt), or mock-infected. At 24 hpi, culture supernatant was harvested for analyzing 
the IFN-α expression. Each experiment was repeated three times and the data are presented as 
mean values with standard deviations. (C) MARC-145 cells were infected with 0.1 MOI of 
vSD95-21, vSD95-21-mt, or mock-infected. At 18 hpi, cells were mock-treated or treated 
with 10000 IU/ml of IFN-α for 12 h. Cells were harvested and subjected to Western blot 
analysis. Membrane was probed with anti-ISG15 and anti-nsp1β mAbs for detecting the 
expression of ISG15 and nsp1β, and the β-tubulin expression was detected as a loading 
control. 
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Figure 3. 8 PRRSV nsp1α and nsp1β inhibit IFN-β expression and signaling. HEK-293T 
cells were cotransfected with a plasmid expressing FLAG-tagged nsp1α (EU-nsp1α) or nsp1β 
(EU-nsp1β), and p125-Luc (A) or pISRE-Luc (B). The empty plasmid vector (EV) was used 
as a control. (A) Cells were mock-infected or infected with 100 HA units /ml SeV for 16 h; 
(B) Cells were mock-treated or treated with 2000 IU/ml IFN-β for 16 h. Cells were harvested 
and measured for firefly luciferase activity. Each experiment was repeated three times and a 
mean value was calculated. Error bars show the standard deviation of a mean value. Western 
blot analysis was performed to evaluate the expression of nsp1α, nsp1β and β-tubulin. 
Membranes were stained with anti-FLAG and anti-β tubulin mAbs.  
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Figure 3. 9 Effect of amino acids K130(124) and R134(128) mutations on the proteolytic 
cleavage activity of PCPβ. HEK-293T cells were infected with the recombinant vaccinia 
virus at 10 MOI. After 1 hpi, cells were transfected with pL-EU-nsp1β-2-C96S, pL-EU-
nsp1β-2, pL-EU-nsp1β-2-mt, pL-NA-nsp1β-2, or pL-NA-nsp1β-2-mt. The cells were 
harvested at 24 h post transfection and subjected to western blot analysis using mAbs specific 
to nsp1β and nsp2. The β-tubulin was detected as a loading control. 
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Table 3. 1 List of constructs used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Construct Mutation WT codon Mutant codon Virus strain 
E28A/D31A E-28→A GAA GCA Type 1 
D-31→A GAC GCC 
E41A/E43A E-41→A GAG GCG Type 1 
E-43→A GAA GCA 
E68A/E71A E-68→A GAG GCG Type 1 
E-71→A GAG GCG 
K130A/R134A K-130→A AAG GCG Type 1 
R-134→A CGC GCC 
K124A/R128A  K-124→A AAG GCG Type 2 
R-128→A CGG GCG 
C96S C-96→A TGC AGC Type 1 
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Chapter 4 - Transactivation of programmed ribosomal 
frameshifting by a viral protein  
Abstract: Programmed –1 ribosomal frameshifting (–1 PRF) is a widely used translational 
mechanism facilitating the expression of two polypeptides from a single mRNA. Commonly, 
the ribosome interacts with an mRNA secondary structure that promotes –1 frameshifting on 
a homopolymeric slippery sequence. Recently, Fang et al. (2012) described an unusual –2 
frameshifting (–2 PRF) signal directing efficient expression of a transframe protein (nsp2TF) 
of porcine reproductive and respiratory syndrome virus (PRRSV) from an alternative reading 
frame overlapping the viral replicase gene. Unusually, this arterivirus PRF signal lacks an 
obvious stimulatory RNA secondary structure, but as confirmed here, can also direct the 
occurrence of –1 PRF, yielding a third, truncated nsp2 variant named nsp2N. Remarkably, we 
now show that both –2 and –1 PRF are transactivated by a protein factor, specifically a 
PRRSV replicase subunit (nsp1β). Embedded in nsp1β’s papain-like autoproteinase domain, 
we identified a highly conserved, putative RNA-binding motif that is critical for PRF 
transactivation. The minimal RNA sequence required for PRF was mapped within a 
34-nucleotide region that includes the slippery sequence and a downstream conserved 
CCCANCUCC motif. Interaction of nsp1β with the PRF signal was demonstrated in pull-
down assays. These studies demonstrate for the first time that a protein can function as a 
transactivator of ribosomal frameshifting. The newly-identified frameshifting determinants 
provide potential anti-viral targets for arterivirus disease control and prevention. Moreover, 
protein-induced transactivation of frameshifting may be a widely employed mechanism, 
potentially including previously undiscovered viral strategies to regulate viral gene 
expression and/or modulate host cell translation upon infection.  
 
4.1 Introduction 
Among the repertoire of mechanisms that viruses use to control or regulate their gene 
expression, non-canonical translation plays an important role, in particular for positive-strand 
RNA viruses whose genomic RNA serves a dual function as mRNA and genome [reviewed 
in (Firth & Brierley, 2012)]. A commonly used strategy is –1 programmed ribosomal 
frameshifting (–1 PRF), in which mRNA signals induce a significant proportion of translating 
ribosomes to change reading frame, with ribosomes slipping back (in the 5' direction) by one 
nucleotide (nt) into an overlapping open reading frame (ORF) before continuing translation, 
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generating a fusion protein composed of the products of both upstream and downstream 
ORFs [reviewed in (Atkins & Bjork, 2009; Brierley et al., 2010; Firth & Brierley, 2012; 
Giedroc & Cornish, 2009)]. PRF was first described as the mechanism by which the Gag-Pol 
polyprotein of the retrovirus Rous sarcoma virus (RSV) is expressed from overlapping gag 
and pol ORFs (Jacks et al., 1988a; Jacks & Varmus, 1985) and related signals have since 
been documented in many other viruses of medical, veterinary, and agricultural importance 
(Firth & Atkins, 2009; Jacks et al., 1988b; Mador et al., 1989; Nam et al., 1993; Thiel et al., 
2003). PRF has also been increasingly recognized in cellular genes of both prokaryotes and 
eukaryotes as well as in other replicating elements, such as insertion sequences and 
transposons (Atkins & Gesteland, 2010). 
Recently, we identified an unusual –2 programmed ribosomal frameshifting (–2 PRF) 
event that operates during the translation of the genome of porcine reproductive and 
respiratory syndrome virus (PRRSV), a member of the arterivirus family in the order 
Nidovirales (Fang et al., 2012). PRRSV can be divided into distinct European (EU, type 1) 
and North American (NA, type 2) genotypes. The viral genome comprises a positive-sense 
RNA molecule, ~15 kb in length (Snijder et al., 2013). As in other nidoviruses, its 5' 
proximal region contains two large replicase open reading frames [ORF1a and ORF1b; (Fang 
& Snijder, 2010)], with the ORF1b product being expressed as a fusion with the ORF1a 
product following –1 PRF in the short ORF1a/ORF1b overlap region (see Fig. 4.1). Four 
ORF1a-encoded proteinases (residing in nsp1α, nsp1β, nsp2, and nsp4) subsequently cleave 
the pp1a and pp1ab polyproteins into (at least) 14 different non-structural proteins (nsps; Fig. 
4.1A). The recently identified –2 PRF signal is located several kilobases upstream of the 
ORF1a/ORF1b –1 PRF signal, and maps to the part of ORF1a that encodes nsp2. This large, 
multifunctional replicase subunit is involved in diverse steps of the arterivirus replicative 
cycle, including replicase polyprotein processing (Wassenaar et al., 1997), the formation of 
replication structures (Knoops et al., 2012; Snijder et al., 2001), and innate immune evasion 
(Frias-Staheli et al., 2007; Sun et al., 2010; Sun et al., 2012; van Kasteren et al., 2013). At 
the PRRSV –2 PRF signal, a proportion of ribosomes back up two nucleotides, to generate a 
transframe fusion protein (nsp2TF) comprising the N-terminal two-thirds of nsp2 and the 
product encoded by a conserved alternative ORF (transframe; TF) in the   –2 reading frame. 
Compared to full-length nsp2, the nsp2TF product is truncated, equipped with an alternative 
C-terminal transmembrane domain (Fig. 4.1A), and targeted to a different subcellular 
compartment (Fang et al., 2012). Mutations preventing nsp2TF expression reduce PRRSV 
replication efficiency in cell culture 50- to 100-fold, highlighting the biological importance of 
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the frameshifting event and nsp2TF expression. The –2 PRF takes place at a highly conserved 
RG_GUU_UUU slippery sequence (R = G or A), and frameshifting is remarkably efficient 
[around 20% in virus-infected cells and up to 50% in expression systems; (Fang et al., 2012)].  
As depicted in Fig. 4.1B-C, the elements that promote PRF in PRRSV are quite 
distinct. The –1 PRF signal at the ORF1a/1b junction comprises a “slippery” sequence 
(generally U_UUA_AAC) where the ribosome changes frame, and a stimulatory RNA 
pseudoknot structure immediately downstream, an organization that is conserved throughout 
the Nidovirales order (Brierley et al., 1989; den Boon et al., 1991) and widely used in other 
viral –1 PRF  mechanisms. It is thought that interaction of the translating ribosome with the 
pseudoknot confounds its RNA-unwinding activity (Qu et al., 2011; Takyar et al., 2005) and 
may induce tension in the mRNA that assists in the uncoupling of codon:anticodon 
interactions at the shift site (Lin et al., 2012; Namy et al., 2006; Plant & Dinman, 2005). In 
contrast, only a few cases of –2 PRF in mammalian cells have been documented thus far 
(Fang et al., 2012; Lin et al., 2012) and the elements involved are poorly understood. Our 
previous computer-based RNA folding analysis suggested that the RNA downstream of the 
slippery sequence (RG_GUU_UUU) used for –2 PRF in PRRSV is rather unstructured and 
does not fold into a structure compatible with canonical RNA-structure-stimulated PRF 
However, mutations within a conserved CCCANCUCC motif located 11 nt downstream of 
the shift site can reduce or inhibit frameshifting, consistent with the presence of a 3' 
stimulatory element of some form (Fang et al., 2012). Remarkably, our previous study also 
provided indications for the occurrence of efficient –1 frameshifting at (or near) the same 
slippery sequence. Due to the presence of a translation termination codon in the –1 reading 
frame immediately following the slippery sequence, this would yield a truncated form of nsp2, 
termed nsp2N (Fig. 4.1A). 
In this report, we identify PRRSV replicase subunit nsp1β as a transactivator of 
efficient –2 and –1 PRF at the same slippery sequence and provide evidence that its 
frameshift-stimulatory activity requires interaction with the viral mRNA. In support of this, a 
highly conserved putative RNA-binding motif (GKYLQRRLQ), integrated into the structure 
of nsp1β’s papain-like autoproteinase domain, was found to be critical for the stimulation of 
frameshifting and for interacting with the RNA sequence of the PRRSV PRF signal. The 
minimal RNA sequence required to direct efficient PRF was mapped within a 34-nt region of 
the PRRSV nsp2-coding sequence that includes the shift site and the conserved 
CCCANCUCC motif. Our findings reveal an unusual non-canonical translation mechanism 
in which a viral protein functions as a transactivator of efficient –2 and –1 PRF. This study 
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advances our understanding of non-canonical translation, suggests that viruses may employ 
additional strategies to modulate viral and potentially host cell translation during infection, 
and has practical implications in biotechnology and the design of antiviral strategies. 
 
4.2 Materials and methods 
Cells and viruses. HEK-293T, RK-13, BHK-21, and MARC-145 cells were cultured as 
described previously (Fang et al., 2006; Snijder et al., 1994). The US type 1 PRRSV isolate 
SD01-08 (GenBank accession #DQ489311) and type 2 PRRSV isolate SD95–21 (GenBank 
accession #KC469618) were used in all experiments.  
Antibodies. Antibodies recognizing PRRSV proteins (see also Fig. 4.9B for the 
nomenclature used in this paper), including mAb 22–28 (α-EU-nsp1β), mAb 123-128 (α-NA-
nsp1β), mAb 36-19 (α-EU-PLP2), mAb 58-46 (α-EU-nsp2), mAb140-68 (α-NA-PLP2), mAb 
148-43 (α-NA-nsp2), and a rabbit antiserum recognizing the C-terminal part of nsp2TF (α-
EU-TF) were produced as described previously (Fang et al., 2012). A rabbit antiserum (α-
NA-TF) recognizing the C-terminal epitope (CFLKVGVKSAGDLV) of nsp2TF of type 2 
PRRSV was generated by GenScript (Piscataway, NJ). For detection of FLAG-tagged 
proteins, an anti-FLAG mAb was obtained from Sigma® Life Science. Anti-β-tubulin and 
anti-dsRNA (J2-0601) mAbs were obtained from Lamda Biotech and English & Scientific 
Consulting, respectively. 
DNA constructs. Except for the KO2 (Fig. 4.9) and pLnsp1βcc–2 (Fig. 4.11) mutants, for 
which synthetic DNA was used, all other constructs were made by using the Quick-Change 
site-directed mutagenesis kit (Stratagene) following the manufacturer’s instruction and 
recombinant DNA techniques. Plasmids for expression of full-length or partial PRRSV 
ORF1a were constructed by RT-PCR amplification of corresponding regions from genomic 
RNA (nt 191-7702 nt of the SD95–21 genome; nt 222-7361 of the SD01-08 genome). The 
PCR product was digested with NcoI and NotI restriction enzymes and ligated into a pL1a 
backbone digested with the same enzymes. The design of pL1a was described previously 
(Fang et al., 2012).  
Plasmid pLnsp1βcc–2 was constructed by extensively mutating the SD01-08 PRRSV 
nsp1β-coding region with synonymous replacements (Fig. 4.11), while keeping the encoded 
amino acid sequence intact and avoiding rare codons. The modified sequence (nsp1βcc) was 
produced as a synthetic gene and fused back with the nsp2-coding region to generate the 
nsp1βcc–2 construct. To construct plasmids for the dual-luciferase assay, a 79-nt 
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oligonucleotide (3506 to 3584 nt of SD01-08 genome) containing the WT sequence or 
mutations (Fig. 4.11, IFC and KO2) at the PRF region was synthesized and cloned into the 
dual luciferase vector pDluc as described previously (Fixsen & Howard, 2010; Grentzmann 
et al., 1998).  
The plasmid expressing FLAG-tagged nsp1β (pFLAG-nsp1β) was generated by PCR 
amplification of the nsp1β-coding region (nt 762-1376 of the SD01-08 genome) and cloned 
into the plasmid vector p3xFLAG-CMV–24 (Sigma). Plasmids expressing EGFP-tagged PRF 
sequence (pR79WT-EGFP, pR79KO2-EGFP, and pR79CC2-EGFP) were generated by 
cloning the PRF region (nt 3506 to 3584 of SD01-08) into the plasmid vector pEGFP-N1 
(Clontech). 
Reverse genetics. Procedures for the construction of plasmids are provided in SI Materials 
and Methods. Methods for in vitro transcription, virus rescue from full-length cDNA clones, 
and virus titration were described previously (Fang et al., 2006; Li et al., 2013), (Fang et al., 
2012). 
Mass spectrometry. Nsp2N was immunoprecipitated from SD95-21-M1–infected MARC-
145 cell lysate using mAb α-NA-PLP2 and samples were separated on a 6% SDS-PAGE gel, 
which was fixed and stained with Coomassie Brilliant Blue G-250 (Bio-Rad). The band 
expected to contain nsp2N* (based on predicted protein size) was excised. Trypsin digestion 
and LC-MS/MS analysis were performed as described previously (van den Akker et al., 
2011). MS spectra were searched against a custom-made protein database containing the 
nsp2N* sequence. As positive control, a synthetic version of the identified frameshift peptide 
was made and analyzed by LC-MS/MS.  
Immunoassays. To define the minimal sequence required for PRF, different regions of 
PRRSV ORF1a were transiently expressed in RK-13 cells or HEK-293T cells using 
truncated derivatives of expression plasmid pL1a and the recombinant vaccinia virus/T7 
polymerase expression system (Snijder et al., 1994). The expression of nsp1β and nsp2-
related products was detected by immunoprecipitation and Western blot, as described 
previously (Fang et al., 2012). To detect the expression of nsp1β and nsp2-related products in 
cells infected with SD95-21 WT and mutants, proteins were radioimmunoprecipitated with 
mAb α-NA-PLP2 or analyzed by Western blot using mAb α-NA-nsp1β, as described 
previously (Li et al., 2013). Wild-type and mutant SD01-08 viruses were launched by 
transfecting in vitro transcribed full-length RNA into BHK-21 cells, and 
radioimmunoprecipitation was conducted to detect the expression of nsp1β and nsp2-related 
products. 
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Dual luciferase assay. Using FuGENE HD transfection reagent (Roche Molecular 
Biochemicals), HEK-293T cells were co-transfected with 0.2 μg of dual luciferase plasmid 
containing the PRRSV PRF sequence and 50 ng of pFLAG-nsp1β.  At 24h post-transfection, 
cells were harvested and luciferase expression was measured using the Dual Luciferase Stop 
& Glo® Reporter Assay System (Promega) and a luminometer (Bethold). Frameshifting 
efficiencies were calculated from the ratio of firefly to Renilla luciferase activities, using the 
IFC control construct as the standard. 
Analysis of protein sequences and structure. Sequence alignment of the PLP1β domain of 
PRRSV, LDV, and SHFV nsp1β and EAV nsp1 was performed using the MUSCLE 
algorithm in Geneious 6 (Biomatters Ltd, Auckland, NZ). Potential RNA-binding residues in 
nsp1β were identified using the program BindN (Wang & Brown, 2006).  Images of the 
crystal structure of the PRRSV nsp1β dimer (PDB: 3MTV) (Xue et al., 2010) were created 
using PyMOL (DeLano, 2002). 
Assays for detecting interactions between nsp1β and viral RNA. Immunoprecipitation 
assays to detect RNA-binding proteins were performed using the Magna RIP™ kit (Millipore) 
and Ribo Trap kit (Medical & Biological Laboratories) following the manufacturer’s 
instructions. The amount of target mRNA bound to nsp1β was determined by quantitative 
RT-PCR, and the presence of nsp1β in RNA-protein complexes was verified by Western blot.  
In vitro transcription and radioimmunoprecipitation analysis of SD01-08 WT and 
mutants. Full length SD01-08-WT, KO2, or 1βKO RNA was transcribed from 1 ug of 
linearized plasmid DNA using the mMESSAGE mMACHINE T7 kit (Ambion) following the 
manufacturer’s instructions. BHK-21 cells (4x106) were electroporated with 8 ug of in vitro 
transcribed RNA using program T-020 of the Amaxa Nucleofector and kit T (Lonza). Newly 
synthesized proteins were labeled from 16.5 to 18.5 hours post transfection in cysteine- and 
methionine-free medium containing 200 µCi/ml [
35
]S-methionine and [
35
]S-cysteine (Perkin-
Elmer). Cell lysis and immunoprecipitation analysis were performed as described previously 
(Snijder et al., 1994). The mAbs α-EU-nsp1β and α-EU-nsp2 were used to 
immunoprecipitate nsp1β and nsp2/nsp2TF/nsp2N, and precipitated proteins were separated 
on a 12% SDS-PAGE gel. Protein bands were visualized using phosphorimaging and a 
Typhoon Variable Mode Imager (GE Healthcare). Image analysis was performed with the 
ImageQuant TL software (GE Healthcare). 
Pulse-chase analysis of nsp1β expression by SD01-08 WT and mutants KO2 and 1βKO.  
Following electroporation with in vitro transcribed SD01-08 WT, KO2, or 1βKO RNA, 
0.3x10
6
 BHK-21 cells were labeled at 16.5h post transfection for 15’ in cysteine- and 
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methionine-free medium containing 500 µCi/ml [
35
]S-methionine and [
35
]S-cysteine (Perkin-
Elmer). After removal of the label medium, cells were either lysed immediately or chased for 
1h in the presence of an excess of unlabeled methionine and cysteine. Immunoprecipitation 
was performed as described previously (Snijder et al., 1994) with mAb α-EU-nsp1β. 
Precipitated proteins were separated on a 12% SDS-PAGE gel and phosphorimaging was 
performed as described above. 
Immunofluorescence microscopy of transfected BHK-21 cells. Following electroporation 
with in vitro transcribed SD01-08 WT, KO2, or 1βKO RNA, 0.15x106 BHK-21 cells were 
seeded on glass coverslips. At 18 h post transfection, cells were fixed in 3% para-
formaldehyde in PBS. Cells were double-labeled with a mAb recognizing dsRNA and 
Hoechst 33342 to stain nuclear DNA.  
RNA isolation, denaturing formaldehyde gel electrophoreses and in gel hybridization. 
BHK cells (0.75x106) were electroporated with in vitro transcribed RNA of SD01-08 WT, 
KO2, and 1βKO. At 18 h post transfection, cells were lysed in 20 mM Tris-HCl (pH 7.4), 100 
mM LiCl, 2 mM EDTA, 5 mM DTT, 5% (w/v) lithium dodecyl sulfate, and 100 μg/ml 
proteinase K. Total RNA was extracted and separated on a denaturing formaldehyde gel. 
Positive-stranded viral RNA was visualized by gel drying and hybridization with a 32P-
labeled oligonucleotide probe (PRRSV-hyb1 5’-TCGCCCTAATTGAATAGGTG-3’) that is 
complementary to the 3’ end of the viral genome and therefore recognizes all viral mRNAs. 
18S ribosomal RNA was used as a loading control and was detected with probe 5'-
ATGCCCCCGGCCGTCCCTCT-3'. Hybridized gels were analyzed by phosphorimaging as 
described above. Correction for loading variations was performed using the amount of 18S 
RNA in the same lane. The sum of the signal for all viral mRNAs in each lane was used to 
calculate the relative abundance of each individual mRNA. 
RNA-binding protein immunoprecipitation and RNA pull-down assay. RNA-binding 
protein immunoprecipitation was performed using a Magna RIP™ kit (Millipore) according 
to the manufacturer’s instruction. Briefly, HEK 293T cells seeded in 10-cm petri dishes were 
co-transfected with plasmids expressing the RNA bait (R79WT-EGFP, R79KO2-EGFP, 
R79CC2-EGFP, or pEGFP; 8ug) and the nsp1β bait (nsp1β-WT, nsp1β-KO, or pFLAG; 2 
μg). At 24 h post transfection, cell lysates were prepared for co-immunoprecipitation. FLAG-
tagged nsp1β was immunoprecipitated using an α-FLAG mAb, and co-precipitating target 
RNA was quantified by qRT-PCR using TaqMan® Gene Expression Assay kit (Life 
technologies) targeting the EGFP RNA sequence. The expression of nsp1β in all co-
transfected samples was determined by Western blot analysis using an nsp1β-specific mAb. 
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Ribo Trap kit (MBL International Corporation) was used to further confirm the interaction 
between nsp1β and the 79-nt RNA sequence from the PRRSV PRF region. The R79WT, 
R79KO2, or R79CC2 RNA was labeled with 5-bromo-U and in vitro synthesized using the 
MEGAscript® T7 Kit (Life technologies). The 5-bromo-U-labeled RNA transcripts were 
bound to magnetic beads conjugated with anti-BrU mAb. Subsequently, these magnetic beads 
were incubated with lysates of HEK 293T cell expressing FLAG-tagged 1βKO or WT of 
nsp1β. The amount of nsp1β pulled-down with the RNA bait was determined by western blot 
analysis using an nsp1β-specific mAb. 
 
4.3 Results 
Alternative –2 and –1 PRF at the same PRRSV slippery sequence.  
Previously (Fang et al., 2012), we demonstrated expression of the PRRSV TF ORF 
(Fig. 4.1A) using a rabbit antiserum raised against the epitope on the C-terminus of the 
polypeptide it encodes. Subsequently, the frameshift product was immunopurified from 
infected cells and mass spectrometry (MS) was employed to identify both the site 
(RG_GUU_UUU) and direction (–2, rather than +1) of ribosomal frameshifting. In both 
PRRSV-infected cells and an ORF1a expression system, and using distantly related type 1 
and type 2 PRRSV isolates, the same studies revealed an additional nsp2-related product 
(nsp2N) with a size consistent with –1 PRF occurring at the same site [estimated efficiency 
~7%; (Fang et al., 2012)]. However, a stop codon is present in the –1 frame immediately 
downstream of the  RG_GUU_UUU slippery sequence (Fig. 4.1A) and consequently, if 
nsp2N were derived from –1 frameshifting, it would lack a unique C-terminal sequence that 
could be used to discriminate it from a product derived through the internal proteolytic 
cleavage of full-length nsp2. In an attempt to confirm the occurrence of –1 PRF by IP-MS, 
we sought to extend the potential –1 frameshift product with a unique C-terminal signature. 
In a full-length cDNA clone of the previously used PRRSV isolate SD01-08 [a type 1 virus; 
(Fang et al., 2006)], the –1 frame stop codon (UGA) was replaced by a tryptophan codon 
(UGG), extending the –1 frame by an additional 87 codons (Fig. 4.9, SD01-08-M1). However, 
this point mutation unavoidably also introduced amino acid substitutions in the overlapping 0 
and –2 frames encoding nsp2 and nsp2TF (Glu→Gly and Lys→Glu, respectively), and 
perhaps as a consequence, the resulting recombinant virus was severely crippled (titer 
reduced to 10
3
 FFU/ml), preventing us from immunopurifying sufficient nsp2N for reliable 
MS analysis. We, therefore, reverted to a type 2 PRRSV isolate [SD95-21; (Li et al., 2013)] 
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and introduced the same A to G mutation, which in this case extended the –1 ORF by 23 
additional codons to generate mutant SD95-21-M1 (Fig. 4.9). Fortunately, despite carrying 
Asp→Gly and Thr→Ala mutations in the nsp2 and nsp2TF products respectively, this 
recombinant virus replicated to much higher titers (10
6.2
 FFU/ml) and the C-terminally 
extended nsp2N product (nsp2N*) could be immunopurified from infected MARC-145 cells. 
A gel slice containing the nsp2N* band was analyzed by LC/MS/MS and a QVFWPR tryptic 
peptide that spanned the frameshift site and is compatible with −1 PRF at the 
RG_GUU_UUU sequence was identified (Fig. 4.10). To verify correct identification of this 
peptide, a synthetic version was subjected to the same LC/MS/MS analysis. The tandem mass 
spectrum of this synthetic peptide was found to be identical to that of the peptide derived 
from the nsp2N*-containing gel slice (Fig. 4.10D), confirming that nsp2N is indeed 
translated via −1 PRF at the RG_GUU_UUU slippery sequence, which is, therefore, able to 
direct both −1 and −2 PRF. 
PRRSV nsp1β is required for efficient −1 and −2 frameshifting in the nsp2-coding 
region. 
Previously we demonstrated that translation of the complete PRRSV ORF1a sequence 
is sufficient to allow efficient –2 PRF (Fang et al., 2012). To define the minimal sequence 
requirements for –2/–1 PRF in PRRSV isolate SD01-08, we focused our attention on the N-
terminal half of ORF1a (the nsp1α-nsp3 region) and generated a panel of truncated ORF1a 
constructs (Fig. 4.2A) for expression in the recombinant vaccinia virus/T7 RNA polymerase 
system (Fuerst et al., 1986). Following radiolabeling of proteins synthesized in transfected 
cells, expression of nsp2, nsp2TF, and nsp2N was analyzed by immunoprecipitation using 
monoclonal antibody (mAb) α-EU-nsp2 and rabbit antiserum α-EU-TF, recognizing all three 
nsp2-related products and the unique C-terminal epitope of nsp2TF, respectively (see Fig. 
4.9B for a summary of antibody nomenclature and epitopes recognized). As shown in Fig. 
4.2B, constructs lacking the nsp1α- and/or nsp3-coding region still efficiently expressed 
nsp2TF and nsp2N. In contrast, constructs lacking the nsp1β-coding region expressed nsp2 
but only trace amounts of nsp2TF or nsp2N were detected. This indicates that nsp1β, or the 
RNA sequence encoding nsp1β, is required for efficient –2/–1 PRF at the RG_GUU_UUU 
slippery sequence in the nsp2-coding region, located some 2.5 kb downstream of the nsp1β-
coding region.  
Extending this further, separate plasmids expressing nsp2 (pLnsp2) and a FLAG 
epitope-tagged nsp1β (pFLAG-nsp1β) were co-transfected into HEK 293T cells. In this 
system, nsp2TF and nsp2N were again produced (Fig. 4.2C), indicating that nsp1β can 
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stimulate –2/–1 PRF in trans (i.e. outside the setting of the regular replicase polyprotein). To 
test whether this effect was mediated by the nsp1β protein rather than the nsp1β-coding RNA 
sequence, a drastically altered version of the nsp1β-nsp2 expression vector (pLnsp1β-2) was 
produced in which almost every codon of the nsp1β-coding sequence was mutated 
synonymously, while avoiding rare codons (mutant pLnsp1βcc-2; Fig. 4.11). This 
pLnsp1βcc-2 construct expresses an unaltered nsp1β protein, but the nucleotide sequence 
encoding it is changed to such an extent that we would expect to have disrupted any primary 
sequence or RNA secondary structure elements that might be involved in –2 PRF (for 
example, an element having a long-range interaction with the PRF region in the nsp2-coding 
sequence). Immunoprecipitation and Western blot analysis revealed that nsp2TF and nsp2N 
were expressed with equal efficiency in cells transfected with pLnsp1βcc-2 and wild-type 
pLnsp1β-2 (Fig. 4.2D), indicating that PRF stimulation involves the nsp1β protein itself 
rather than an RNA signal in the nsp1β-coding sequence. 
Minimal RNA sequence requirements for –2/–1 PRF.  
We next set out to define the minimal RNA sequences in the nsp2-coding region that 
are required for efficient –2/–1 PRF. To this end, we prepared a reporter gene construct in 
which PRRSV RNA sequences from the PRF-inducing region were placed between two 
luciferase genes [pDluc (Fixsen & Howard, 2010; Grentzmann et al., 1998); Fig. 4.3A]. 
Whereas the ORF1a frame of the PRRSV insert was placed in-frame with the upstream 
(Renilla) luciferase gene, the downstream (firefly) luciferase was in the –2 frame and thus its 
expression depended on the occurrence of –2 frameshifting. Also –1 PRF could be monitored, 
since the native stop codon in the –1 frame was retained and –1 PRF would, therefore, yield a 
polypeptide slightly shorter than the product resulting from translation termination in the zero 
reading frame. As controls, an in-frame control (IFC) construct was also prepared in which 
the two luciferase genes were aligned in the same frame by inserting two nucleotides (CU) 
immediately downstream of the slippery sequence. A previously described PRF knockout 
construct [KO2; Fig. 4.9; (Fang et al., 2012)] containing point mutations within the slippery 
sequence and downstream C-rich region was also included in the analysis.  
Initially, a 79-nt region spanning 5 nt upstream of the slippery sequence to 66-nt 
downstream (including the conserved CCCANCUCC motif) was cloned between the two 
luciferase genes (construct pDluc-WT). Frameshifting efficiencies were determined by 
comparing the ratio of enzymatic activities of firefly and Renilla luciferase in parallel 
HEK293T cell cultures transfected with individual pDluc constructs with or without co-
transfection of the plasmid expressing nsp1β. As shown in Fig. 4.3B, in comparison to the 
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IFC control, the wild-type PRRSV –2 PRF efficiency was ~38%, and this high-level of –2 
PRF was only observed in cells co-transfected with the nsp1β-expressing plasmid; in the 
absence of the transactivator, only low levels of –2 PRF (<5%) were observed. As expected, 
frameshifting was not observed in cells transfected with pDluc-KO2. Western blot analysis of 
transfected cell lysates revealed that both efficient –2 PRF and efficient –1 PRF could be 
observed with pDluc-WT provided that an nsp1β expression plasmid was co-transfected (Fig. 
4.3C). These data indicated that the 79-nt PRRSV sequence included in pDluc-WT contains 
all cis-acting sequences required for efficient –2/–1 PRF, and that, as documented above, 
both types of frameshift depend on the presence of nsp1β. In the absence of this 
transactivator, only low levels of PRF were observed.  
To further investigate the key RNA sequences required for PRF, in-frame deletions 
were introduced into pDluc-WT, starting from the 3' end of the PRRSV insert. As shown in 
Fig. 4.3C, an initial deletion that reduced the PRRSV sequence downstream of the shift site to 
45 nt (pDluc-45) led to a small reduction in –2 PRF (about 2-fold), albeit with a concurrent 
increase in –1 PRF. Subsequent deletions had no further effect until part of the conserved 
CCCANCUCC motif was removed (Fig. 4.3C; compare pDluc-21 and pDluc-15). In pDluc-
15, which lacked the second half (CUCC) of the conserved motif, the capacity for 
transactivation of PRF by nsp1β was lost. These data provided further support for a role of 
the C-rich motif in PRF, and allowed us to define the functional PRRSV –2/–1 PRF cassette 
as a 34-nt region containing the slippery sequence and the 3' C-rich motif. 
Identification of a conserved nsp1β motif that is critical for PRF transactivation.  
The nsp1α-nsp1β region has previously been implicated in a variety of processes in 
the arterivirus replicative cycle, including replicase polyprotein processing (den Boon et al., 
1995), transcriptional control (Nedialkova et al., 2010; Tijms et al., 2001), and innate 
immune evasion (Chen et al., 2010; Li et al., 2013). An analysis of nsp1β sequence 
conservation (Fig. 4.4A), together with the published crystal structure of nsp1β from a type 2 
PRRSV isolate [(Xue et al., 2010); Fig. 4.4B-C], pointed towards a previously identified 
conserved sequence motif as a potential RNA interaction domain. This sequence, 
GKYLQRRLQ in both type 1 and type 2 PRRSV, forms one of three alpha-helices [labeled 
α4 in (Xue et al., 2010)] in the region between the active site Cys and His residues of the 
papain-like proteinase domain (PLP1β) that constitutes the C-terminal two-thirds of nsp1β. 
Interestingly, compared to the active site of the PLP1β proteinase, helix α4 maps to the other 
side of the molecule and, in the available crystal structure, the three conserved basic residues 
of the GKYLQRRLQ motif are exposed on the nsp1β surface. Moreover, in the nsp1β 
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homodimer that was the basis for structural studies, the α4 helices of both monomers map to 
the same side of the dimer and may form a continuous surface across the protein that binds 
nucleic acid (Fig. 4.4C; see Discussion).  
In a recent study (Li et al., 2013), the GKYLQRRLQ motif was targeted by site-
directed mutagenesis and the Lys and the first Arg of the motif were replaced with Ala 
(mutant 1βKO, Fig. 4.9). For both PRRSV genotypes, the replication of the 1βKO mutant in 
MARC-145 cells was found to be seriously crippled. The fact that we had observed similar 
defects in mutants in which the –2/–1 PRF signal had been inactivated, or in which the 
expression of a functional nsp2TF was prevented (Fang et al., 2012), prompted us to 
investigate whether this KR→AA double mutation affected nsp2TF/nsp2N expression. 
Strikingly, upon expression of nsp1β-nsp2 from either PRRSV genotype carrying these nsp1β 
mutations, nsp2TF could not be detected; only trace amount of nsp2N was detected in type 2 
PRRSV mutant (Fig. 4.5). These data indicate that the GKYLQRRLQ motif plays a key role 
in PRF activation. 
To investigate nsp1β transactivation of PRF in the context of PRRSV infection, we 
analyzed nsp2 expression using the 1βKO mutant of both PRRSV genotypes. As controls, we 
included the corresponding KO2 mutants, which carry mutations within the slippery sequence 
and C-rich region that eliminate frameshifting [Fig. 4.9 (Fang et al., 2012)]. Using reverse 
genetics, KO2 and 1βKO mutant viruses were recovered from full-length infectious clones of 
the two PRRSV genotypes. Both mutants replicated poorly in MARC-145 cells, but for the 
type 2 PRRSV isolate (SD95-21), they produced titers (10
5.1
 and 10
5.3
 FFU/ml for KO2 and 
1βKO, respectively) that sufficed for the subsequent experiments of infection, metabolic 
labeling and radioimmunoprecipitation analysis. As expected (Fig. 4.6A), the expression of 
nsp2, nsp2TF, and nsp2N was detected in SD95-21-WT-infected cells, whereas only nsp2 
was recovered from cells infected with either SD95-21-KO2 or SD95-21-1βKO, while their 
nsp1β was expressed at a level similar to that observed with the wild-type (WT) virus.  
Unfortunately, the 1βKO mutant of the PRRSV type 1 isolate (SD01-08) yielded very 
low titers in MARC-145 cells (10
2
 FFU/ml). Considering the number of viral functions and 
properties potentially affected by nsp1β mutations (see Discussion), we therefore performed a 
so-called ‘first-cycle analysis’ of the phenotypes of SD01-08 WT, KO2, and 1βKO. The three 
viruses were launched by transfecting in vitro transcribed full-length RNA into BHK-21 cells, 
which support replication of transfected PRRSV RNA but cannot be infected by the progeny 
virus released from the transfected cells, due to the lack of the appropriate receptor(s) on their 
surface (Meulenberg et al., 1998). Moreover, BHK-21 cells have a defect in interferon 
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production (Clarke & Spier, 1983), thus minimizing the (potential) impact of host innate 
responses on the comparison of viral replication phenotypes. Following metabolic labeling of 
protein synthesis in transfected cells, a radioimmunoprecipitation analysis revealed that 
SD01-08-1βKO produced large amounts of nsp2, whereas the production of nsp2TF was 
greatly reduced and nsp2N was not detected (Fig. 4.6B). As previously established, SD01-08-
KO2 produced only nsp2, while SD01-08-WT produced all three nsp2 variants. Equal 
expression of nsp1β in WT-, KO2-, and 1βKO-transfected cells was confirmed by 
immunoprecipitation with an nsp1β-specific mAb. We also investigated whether the 
mutations in 1βKO affected the activity of the PLP1β protease or the (potential) involvement 
of nsp1β in the control of viral subgenomic mRNA synthesis. While the total amount of 
nsp1β and viral RNA was somewhat reduced in 1βKO-transfected cells, cleavage of the site 
between nsp1β and nsp2 and subgenomic mRNA production (Fig. 4.12B-C), were not 
affected by the mutations in the GKYLQRRLQ motif, nor did they affect nsp1β stability (Fig. 
4.12D). Finally, we included a double-transfection of BHK-21 cells with KO2 and 1βKO 
full-length RNA (Fig. 4.6B) and demonstrated complementation between the two PRF-
negative mutants leading to reactivation of nsp2TF/nsp2N expression. As expected, the wild-
type nsp1β expressed by mutant KO2 was able to transactivate -2/-1 PRF on the wild-type 
ORF signal in the 1βKO genome, again confirming that the GKYLQRRLQ motif plays a 
critical role in the PRF stimulatory activity of nsp1β in PRRSV-infected cells. 
PRRSV nsp1β interacts with the RNA signals that direct –2/–1 PRF.  
To test the hypothesis that nsp1β, and specifically its GKYLQRRLQ motif, interacts 
with the PRRSV RNA sequences that direct –2/–1 PRF, we developed an RNA-binding 
protein immunoprecipitation assay. To produce an RNA target, we engineered plasmid 
pR79WT-EGFP yielding an RNA in which a 79-nt PRRSV SD01-08 RNA sequence (Fig. 
4.3A) containing the shift site and conserved CCCAUCUCC motif was fused to the enhanced 
green fluorescent protein (EGFP) open reading frame (Fig. 4.7A). The latter served as a 
target for quantitative RT-PCR (qRT-PCR) amplification of target RNA bound to nsp1β. As 
controls, we included plasmids pR79KO2-EGFP and pR79CC2-EGFP, containing 
combinations of point mutations in the shift site and/or CCCAUCUCC motif that were 
previously demonstrated to completely inactivate PRF [Fig. 4.9; (Fang et al., 2012)]. To 
express the nsp1β bait, we used constructs pFLAG-nsp1β-WT and pFLAG-nsp1β-KO, 
producing wild-type and mutant (K130A/R134A) nsp1β, respectively, each fused to an N-
terminal triple FLAG tag. The empty vectors pFLAG and pEGFP were included as negative 
controls. 
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Following co-transfection of vectors expressing RNA target and nsp1β into 293T cells, 
cell lysates were prepared. Western blot and qRT-PCR analysis (Fig. 4.7B) were first used to 
determine the expression levels of nsp1β bait and target RNA, respectively, and confirmed 
the presence of similar amounts of both molecules in all co-transfection samples. 
Subsequently, we immunoprecipitated FLAG-nsp1β using an anti-FLAG mAb and analyzed 
these samples for co-immunoprecipitation of target RNA using the same qRT-PCR method, 
while verifying successful immunoprecipitation of nsp1β with a specific mAb (Fig. 4.7C). A 
strong and specific RNA co-immunoprecipitation signal was detected only in samples from 
cells co-transfected with pFLAG-nsp1β-WT and pR79WT-EGFP. In contrast, when mutant 
1βKO carrying the K130A/R134A double mutation in the GKYLQRRLQ motif was used, 
only very low levels of target RNA were pulled down, suggesting that the K130A/R134A 
mutations impaired the interaction of nsp1β with PRRSV RNA. Only background signal was 
detected when using a negative control mouse IgG for immunoprecipitation, or when 
expressing the pFLAG empty vector control, demonstrating specificity for nsp1β. When the 
PRRSV PRF-specific sequences in the RNA target were mutated (R79KO2-EGFP or 
R79CC2-EGFP) or the pEGFP empty vector control was used, only trace amounts of RNA 
(6% or less of the R79WT-EGFP signal) could be captured, thus demonstrating that co-
immunoprecipitation of the target RNA strongly depends on the presence of the 
CCCAUCUCC motif. 
To further corroborate the interaction between nsp1β and the 79-nt RNA sequence 
from the PRF region, we employed a complementary assay [RiboTrap system; (Beach & 
Keene, 2008)] in which RNA transcripts were labeled with 5-bromo-uridine, facilitating their 
immunopurification using a 5-bromo-U-specific mAb, and subsequent analysis of 
immunoprecipitates for the presence of proteins binding to the RNA bait. Using PCR 
amplicons containing T7 promoter and 79-nt PRRSV RNA sequence (R79WT, R79KO2, or 
R79CC2) as template, 5-bromo-U-labeled RNA transcripts were produced in vitro and 
incubated with lysates of 293T cells transfected with the plasmid expressing 1βKO or wild-
type nsp1β. Following immunoprecipitation with the 5-bromo-U-specific mAb, samples were 
analyzed for the presence of nsp1β using SDS-PAGE and Western blot analysis (Fig. 4.8). A 
strong and specific nsp1β signal was detected only when the R79WT bait was incubated with 
cell lysates containing nsp1β-WT. When using lysates containing 1βKO of nsp1β, only a very 
small fraction of the available protein was bound to the RNA. Likewise, only trace amounts 
of wild-type nsp1β were pulled down when 5-bromo-U-labeled R79KO2 or R79CC2 RNA 
was used as bait. These data are consistent with those obtained in the RNA-binding protein 
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immunoprecipitation assay presented in Fig. 4.7 and further support a key role for the 
GKYLQRRLQ motif in the specific transactivation of the PRRSV –2/–1 PRF by nsp1β. 
 
4.4 Discussion 
In this paper, we report the remarkable discovery that efficient ribosomal 
frameshifting in the expression of the PRRSV nsp2TF and nsp2N proteins requires the viral 
nsp1β protein as a transactivator. Protein-stimulated PRF is unprecedented. It has been 
reported that cellular annexin A2 may interact with the –1 PRF signal of the coronavirus 
infectious bronchitis virus, but its role appears to be to down-regulate frameshifting through 
destabilization of the stimulatory pseudoknot (Kwak et al., 2011), and no specific frameshift-
stimulatory protein factors have been identified to date. While down-regulation of eukaryotic 
translation release factor levels can lead to a low-level stimulation of –1 PRF (Kobayashi et 
al., 2010; Park et al., 2009), this is a poorly-characterized phenomenon, likely to be a rather 
non-specific effect brought about by changes in translation rates (Gendron et al., 2008). It is 
known that –1 PRF at the human immunodeficiency virus type 1 slippery sequence can be 
promoted by replacing the natural stimulatory RNA with a combination of the iron-
responsive element (IRE) RNA and its cognate binding partner (the IRE-binding protein), but 
this is a highly artificial experimental system and the stimulation of –1 PRF is very weak 
(Kollmus et al., 1996). 
Exactly how nsp1β stimulates frameshifting remains to be determined. Based on the 
RNA binding experiments, we propose that the region 3' of the PRRSV PRF slippery 
sequence acts to recruit nsp1β, or an nsp1β-containing protein complex, which modulates 
ribosome function to promote frameshifting. Our evidence to date supports the view that 
nsp1β binds directly to the C-rich region, since point mutations within this region strongly 
reduce RNA binding (Fig. 4.7). However, we cannot rule out the involvement of other factors, 
for example, poly C-binding proteins [PCBPs; (Makeyev et al., 2005)], which are known to 
interact with C-rich regions. Moreover, certain PCBPs have been reported to bind to PRRSV 
nsp1β in pull-down assays (Beura et al., 2011). As the C-rich region is located only 11 nt 
downstream of the slippery sequence, this would likely place bound nsp1β, or an nsp1β-
containing complex, in close proximity to a ribosome decoding the slippery sequence, 
permitting interactions that may lead to frameshifting. While this model is speculative, there 
is growing evidence that proteins can modulate the elongation step of protein synthesis. The 
fragile X mental retardation protein reversibly stalls ribosomes on its target mRNAs (Darnell 
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et al., 2011) and the HIF-1α mRNA-associated cytoplasmic polyadenylation element binding 
protein 2 binds eEF2 and slows elongation (Chen & Huang, 2012). Conceivable routes 
through which bound proteins could modulate ribosomal function include induction of 
ribosomal pausing by acting as a roadblock, recruitment of, or localized depletion of 
translation factors, and direct interaction with a ribosomal component(s). It may be 
significant that nsp1β was reported to interact with rpS14 (Beura et al., 2011), a protein 
immediately adjacent to rpS3 of the ribosomal helicase (Ben-Shem et al., 2011), and PCBP1, 
which is known to interact with RACK1, a ribosome-associated protein located close to the 
mRNA entry channel (Nahar-Gohad et al., 2013). These features are consistent with a role 
for nsp1β in modulating the ribosomal helicase, the suspected target for the stimulatory RNA 
sequences of canonical –1 PRF signals.  
An interesting aspect of this PRRSV PRF signal is that both –2 and –1 frameshifting 
events are promoted. Tandem slippage of ribosome-bound tRNAs on RG_GUU_UUU would 
allow complete A-site re-pairing in both –1 and –2 frames (tRNA anticodon:mRNA codon 
pairing in 0-frame is 3'-AAG-5' : 5'-UUU-3'; single tRNA
Phe
 isoacceptor AAG), but 
especially for –2 PRF, P-site re-pairing appears to be compromised [at least at the 2nd and 
3rd positions (lower case), 3'-Cai-5' : 5'-Ggg-3'; i is inosine]. Some tolerance for P-site mis-
pairing has been noted at certain viral –1 PRF signals, but usually, these are associated with 
single mis-matches in the anticodon:codon interaction (Brierley et al., 1992; Firth & Brierley, 
2012). It may be that in the particular context of a –2 PRF, stable P-site re-pairing is not 
required, reminiscent of the unusual “single-tRNA” slippage events seen in prokaryotic 
systems with slippery sequences ending in AAG, where P-site re-pairing does not appear to 
be present (Mejlhede et al., 1999; Napthine et al., 2003). In a recent study on RNA secondary 
structure-stimulated –1 and –2 PRF on a GU_UUU_UUA slippery sequence (Lin et al., 
2012), it was noted that the length of the spacer between slippery sequence and secondary 
structure affected the relative utilisation of –1 or –2 PRF modes, perhaps a reflection of 
differences in mRNA tension arising as the ribosomal helicase unwinds the secondary 
structure, with increased tension forcing the ribosome into the –2 rather than the –1 frame. 
Interestingly, the relative levels of the PRRSV –2 and –1 PRF products were seen to change 
as the length of the PRRSV region 3' of the slippery sequence was shortened from 67 to 45 nt 
(Fig. 4.3C), although the sum total of PRF was similar. This may hint at the involvement of 
additional factors, or some subtle effect on the positioning of a bound protein (or complex), 
that can influence frameshift magnitude, although it remains to be determined whether this is 
linked to mRNA tension.  
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Analysis of the published structure of nsp1β from a type 2 PRRSV isolate provides 
insights into the mechanism of how the protein may interact with viral RNA. The PLP1β 
domain of nsp1β adopts a papain-like fold consisting of three -helices that pack against a -
sheet of 4 antiparallel strands (Xue et al., 2010) (Fig. 4.4B). One of the helices (helix α4 in 
the overall nsp1β structure) contains a conserved GKYLQRRLQ motif that we now show 
plays a critical role in the transactivation of frameshifting. The crystal structure of nsp1β 
suggests that the protein exists as a homodimer (Xue et al., 2010) and, interestingly, helix α4 
of both nsp1β monomers resides on the same side of the dimer, which may generate a 
continuous, positively charged surface that could bind a long single- or double-stranded RNA 
molecule (Fig. 4.4C). The involvement of an -helix in RNA binding is consistent with the 
observation that nucleoproteins of many RNA viruses encapsidate the viral genome using 
domains of -helical structure (Albertini et al., 2006; Ruigrok et al., 2011). Thus, it is 
plausible that the GKYLQRRLQ motif of helix α4 directly binds viral RNA, although we 
cannot exclude the possibility that this helix may be a binding site for a cellular protein that 
in turn could bind to the PRF signal in the viral RNA. 
Except for equine arteritis virus (EAV), the –2 PRF mechanism seems to be 
conserved in all currently known arteriviruses as judged by the presence of a TF ORF 
overlapping ORF1a and a conserved slippery sequence and downstream C-rich region (Fang 
et al., 2012). In PRRSV and lactate dehydrogenase elevating virus (LDV) –1 PRF can occur, 
but in contrast the RG_GUC_UCU shift site in some of the recently identified simian 
haemorraghic fever virus (SHFV)-like viruses (Lauck et al., 2013) would preclude –1 PRF 
while still allowing –2 PRF. It is expected that such PRF events in LDV and SHFV would 
also be controlled by nsp1β, and indeed the transactivating motif in nsp1β was found to be 
largely conserved in these viruses (Fig. 4.4A). Possibly, the nsp1β component of the 
frameshift mechanism, which is encoded several kilobases upstream of the PRF site, evolved 
secondarily, for example to enhance the efficiency of nsp2TF/nsp2N expression, since in the 
absence of nsp1β low levels of PRF could still be observed (Fig. 4.2A). Amino acid sequence 
comparisons reveal that the GKYLQRRLQ motif-containing helix is highly conserved in the 
PLP1β domains of PRRSV, SHFV, and LDV, but the motif is lacking in EAV. For the latter 
virus, the three helices of the PLP1β domain are predicted to be present, but with an insertion 
of three amino acids in the EAV equivalent of the α4 helix compared to the other 
arteriviruses. The nsp2-encoding region of EAV lacks an equivalent of the (overlapping) TF 
ORF and produces a substantially smaller nsp2. Assuming the TF ORF was lost at some point 
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during the evolution of the EAV lineage, changes in this helix may have been tolerated when 
it was no longer required to stimulate PRF in trans. Although an alternative evolutionary 
scenario (i.e. a common ancestor of PRRSV, SHFV, and LDV independently acquiring a TF 
ORF) cannot be excluded, loss of the requirement to transactivate PRF may also explain a 
second remarkable difference between the nsp1 region of EAV and other arteriviruses: the 
inactivation of the proteolytic activity of the PLP1α proteinase, resulting in the synthesis of a 
single nsp1 protein rather than nsp1α and nsp1β (den Boon et al., 1995; Snijder et al., 1992). 
In particular, the N-terminal zinc finger of nsp1 (EAV) or nsp1α (PRRSV) has been 
implicated in the control of viral subgenomic mRNA synthesis (Kroese et al., 2008; 
Nedialkova et al., 2010; Sun et al., 2009; Tijms et al., 2007), a function that may not be 
compatible with a role in PRF transactivation, thus requiring the internal cleavage of nsp1 by 
PLP1α in arteriviruses that employ nsp1β-mediated transactivation of TF ORF expression. 
The capacity of nsp1β to stimulate both –1 and –2 PRF suggests that protein 
transactivation could be employed more widely in the induction of programmed 
frameshifting events in diverse systems. With regards to arteriviruses, it is possible that nsp1β 
might also modulate translation of host cell mRNAs containing appropriate signals. A 
cursory search of porcine mRNAs revealed hundreds of –1 and/or –2 frameshift-compatible 
shift sites followed by C-rich motifs at an appropriate spacing, though no site that is exactly 
identical to the PRRSV minimal PRF cassette (8-nt shift site plus the downstream 21 nt). 
Whether and to what extent frameshifting occurs at such sites remains to be investigated. 
While the occurrence of nsp1β-responsive frameshift signals in host mRNAs would 
presumably be spurious, the overall effect may perturb cellular gene expression, thus adding 
an extra dimension to virus-host interactions. 
When screening PRRSV nonstructural proteins for their capacity to suppress type I 
IFN expression, both nsp1β and nsp2 were found to possess such activities (Beura et al., 
2011; Chen et al., 2010; Li et al., 2013; Sun et al., 2010; van Kasteren et al., 2013). In 
reporter gene-based assays, nsp1β had the strongest potential to inhibit IFN-β promoter 
activity and could also inhibit downstream IFN-induced signaling pathways for expression of 
IFN-stimulated genes (ISGs), including ISG15 (Beura et al., 2011; Chen et al., 2010; Kim et 
al., 2010; Li et al., 2013; Patel et al., 2010). On the other hand, the PLP2 activity of nsp2 is 
able to disrupt innate immune signalling by removing ubiquitin (Ub) and Ub-like modifiers 
from host cell substrates, exhibiting a general deubiquitinating (DUB) activity towards 
cellular ubiquitin conjugates and also cleaving the ubiquitin homolog ISG15 (Frias-Staheli et 
al., 2007; Sun et al., 2010; Sun et al., 2012; van Kasteren et al., 2013). As documented here, 
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nsp1β transactivates both nsp2TF and nsp2N expression, resulting in the synthesis of three 
nsp2-related proteins (nsp2, nsp2TF, and nsp2N) that have the N-terminal PLP2-DUB 
domain in common. Thus, it remains to be established to which extent nsp1β directly 
modulates the innate immune response or does so by stimulating the expression of nsp2TF 
and nsp2N. Furthermore, nsp1β may affect the immune response through modulation of host 
cell mRNA translation. The identification of viral/host elements responsible for innate 
immune evasion is fundamental for the development of modified live virus vaccines. As 
illustrated by our reverse genetics studies, mutagenesis of key residues in nsp1β and the PRF 
site could attenuate virus growth and improve host innate immune responses (Fang et al., 
2012; Li et al., 2013). Since the GKYLQRRLQ motif and PRF site are highly conserved, 
technologies developed in this study may have broad application in the field. 
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Figure 4. 1 PRRSV genome organization and location of ribosomal frameshifting signals. 
 (A) Overview of the ~15-kb PRRSV genome. The long 5′ ORFs 1a and 1b encode 
nonstructural polyproteins, and at least eight shorter 3′ ORFs (2a-7) encode structural 
proteins. The 3′ ORFs are translated from a nested set of subgenomic mRNAs, two of which 
are bicistronic. ORF1a and ORF1b are translated from the genomic RNA, with translation of 
ORF1b depending on −1 PRF at the end of ORF1a. The TF ORF overlaps the central ORF1a 
region in the −2 reading frame and is accessed via −2 PRF (13). A –1 frameshift at the same 
site generates the nsp2N product (see text). The vertical red line indicates the location of the 
RG_GUU_UUU shift site (R = A or G, in different arteriviruses). Domains in nsp2/nsp2TF: 
PLP2, papain-like proteinase; HVR, hypervariable region; TM/TM′, (putative) 
transmembrane domains; C, Cys-rich domain. (B) Sequence of the SD01-08 RNA in the 
region of the −2/−1 PRF signal, with the slippery sequence (red) and C-rich motif (blue) 
highlighted. The −1 reading frame stop codon is underlined and codons for each of the 
reading frames are indicated. (C) Features of the canonical −1 PRF signal present in the 
PRRSV ORF1a/ORF1b overlap region. The stimulatory RNA pseudoknot is composed of 
two stems connected by single-stranded loops. 
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Figure 4. 2 PRRSV nsp1β transactivates –2/–1 PRF.  (A) Schematic representation of 
expression vectors encoding different combinations of replicase subunits from the nsp1α-
nsp3 region of type 1 PRRSV (isolate SD01-08), which were expressed as single nsps or self-
cleaving multi-nsp polyproteins. PRRSV pp1a and its processing scheme are shown at the top 
and the proteins expressed from different constructs are shown in grey, whereas the 
polypeptide encoded by the TF ORF is indicated in black. The nsp2-3-IFC control (13) is an 
in-frame construct that expresses nsp2TF only. (B) Expression of different protein 
combinations (A) using the recombinant vaccinia virus/T7 RNA polymerase expression 
system and RK-13 cells, revealing that nsp1β expression is required for efficient –2/–1 PRF. 
After metabolic labeling, expression products were immunoprecipitated with the antibodies 
indicated below each panel; mAb α-EU-nsp2 recognizes the common N-terminal domain of 
nsp2, nsp2TF, and nsp2N, while α-EU-TF recognizes the C-terminal domain of nsp2TF. 
Immunoprecipitated (IP) proteins were separated by SDS-PAGE and visualized by 
autoradiography. (C) Analysis of −2/−1 PRF transactivation by nsp1β using the recombinant 
vaccinia virus–T7 RNA polymerase expression system as described for B. RK-13 cells were 
transfected with plasmid DNAs expressing nsp2, nsp1β-2, nsp2+nsp1β (from separate 
plasmids), or nsp1βcc-2, with the latter containing an nsp1β-coding sequence in which the 
large majority of codons had been synonymously mutated (Fig. 4.11). Expression products 
were immunoprecipitated using specific antibodies indicated at the bottom of each panel and 
visualized by SDS/PAGE and autoradiography. 
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Figure 4. 3 Delineation of RNA elements required for PRRSV –2/–1 PRF. (A) Schematic 
representation of the pDluc dual luciferase construct. The GG_GUU_UUU shift site, 5 
upstream nucleotides and 66 downstream nucleotides (79 nt in total) were inserted between 
the Renilla and firefly luciferases genes such that –2 PRF is required for firefly luciferase 
expression. (B) Dual luciferase reporter assay showing that efficient –2 PRF depends on co-
expression of nsp1β.  For type1 PRRSV (isolate SD01-08), nsp1β was co-expressed with dual 
luciferase constructs containing a WT or –2 PRF knock out (KO2) frameshift signal. Mutant 
KO2 [Fig. 4.9; (Fang et al., 2012)] contains point mutations within both slippery sequence 
and downstream C-rich motif. The –2 PRF efficiencies were calculated by comparing the 
ratio of firefly and Renilla luciferase activities, using the in-frame control mutant (IFC, Fig. 
4.9A) as a reference. Error bars represent the standard deviation of three independent 
experiments, in which each construct was transfected in duplicate. The bottom panel shows a 
Western blot analysis confirming equal expression of nsp1β and equal loading (β tubulin). (C) 
Delineation of the minimal RNA sequence requirements for efficient –2/–1 PRF. Starting 
from a construct containing the 66 nt downstream of the slippery sequence, a series of 3’ 
truncations was engineered in pDluc. Upon co-expression with nsp1β, cell lysates were 
analyzed by Western blot, using an antibody recognizing the common Renilla luciferase part 
of all pDluc translation products (see panel A). The number below each lane represents the 
remaining PRRSV-specific RNA sequence downstream of the slippery sequence, of which 21 
nt were sufficient for efficient –2/–1 PRF in this assay.  
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Figure 4. 4 PRRSV nsp1β sequence and structure. (A) Amino acid sequence alignment of 
the PLP1 domains from selected arterivirus nsp1β proteins. Secondary structure elements 
[based on the published crystal structure from type 2 PRRSV isolate XH-GD; (Xue et al., 
2010)] are shown above the alignment and are color-matched to the nsp1β structure in panel 
B. Conserved basic residues in PLP1 helix 4 are boxed in orange; #, residues mutated in 
mutant 1βKO (see text for details); *, PLP1 active site residues. PRRSV sequences are 
numbered (black) from the nsp1α/nsp1β cleavage site, whereas all other sequences are 
numbered (grey) starting from the N-terminus of the pp1a polyprotein. EAV, equine arteritis 
virus; LDV, lactate dehydrogenase elevating virus; SHFV, simian hemorrhagic fever virus; 
names of specific isolates used are indicated. Genbank accession numbers of sequences used: 
EU624117 (PRRSV XH-GD), DQ489311 (PRRSV SD01-08), KC469618 (PRRSV SD95-
21), NC_001639 (LDV P), NC_003092 (SHFV LVR), HQ845737 (SHFV krc1), HQ845738 
(SHFV krc2), JX473847 (SHFV krtg1), NC_002532 (EAV Bucyrus). (B) Cartoon 
representation of the crystal structure of the nsp1 dimer from a type 2 PRRSV isolate 
[PRRSV XH-GD; PDB entry 3MTV; (Xue et al., 2010)]. For both monomers, the N-terminal 
domain is colored purple, whereas the PLP1 domain and the C-terminal extension (leading 
up to the nsp1/nsp2 site cleaved by PLP1) are colored green and red, respectively. Helix 
4 of PLP1, containing the conserved GKYLQRRLQ motif, is colored orange with basic 
residues represented as sticks. (C) Electrostatic surface representation of the nsp1 dimer 
showing the positively charged (blue) patches on helix 4 of PLP1 (boxed in orange) 
created by the basic residues of the GKYLQRRLQ motif. Both patches reside on the same 
side of the structure, potentially allowing for RNA to bind across the entire dimer surface.  
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Figure 4. 5 A conserved motif in PRRSV PLP1β is critical for transactivation of –2/–1 
PRF in an expression system. The recombinant vaccinia virus/T7 RNA polymerase 
expression system and HEK 293T cells were used to express WT and 1βKO mutant nsp1β-
nsp2 polyproteins from (A) type 1 and (B) type 2 PRRSV. The 1βKO mutant carried a double 
Ala substitution of basic residues in the highly conserved GKYLQRRLQ motif of nsp1β (see 
also Fig. 4.4 and 4.9). Expression products were immunoprecipitated with mAbs recognizing 
the common N-terminal domain of the nsp2-related products. Following SDS-PAGE, they 
were identified in Western blot analysis using antibodies recognizing the common nsp2 
domain, the C-terminus of nsp2TF, or nsp1β. A tubulin antiserum was used for a loading 
control.  
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Figure 4. 6 A conserved motif in PRRSV PLP1β is critical for transactivation of –2/–1 
PRF in infected cells. (A) Analysis of nsp2-related products in MARC-145 cells infected 
with WT type 2 PRRSV (isolate SD95-21) or mutants KO2 and 1βKO. Mutant KO2 (Fig. 4.9) 
contained PRF-inactivating point mutations in both slippery sequence and downstream C-rich 
motif, whereas 1βKO carried a double Ala substitution of basic residues in the highly 
conserved GKYLQRRLQ motif of nsp1β. Following metabolic labeling, proteins were 
immunoprecipitated using mAb α-NA-nsp2 and visualized by SDS-PAGE and 
autoradiography. The expression of nsp1β was monitored by Western blot analysis. (B) BHK-
21 cells were transfected with in vitro transcribed full-length RNA of WT, KO2 or 1βKO 
PRRSV SD01-08 (type 1) or were double-transfected with equal amounts of KO2 and 1βKO 
RNA to demonstrate complementation between these two virus mutants. Following metabolic 
labeling, viral proteins were immunoprecipitated using specific mAbs that recognize a 
common nsp2 domain (α-EU-nsp2 panel), the polypeptide encoded by the TF ORF (α-EU-TF 
panel), or nsp1β (α-EU-nsp1β panel). Protein products were visualized using SDS-PAGE and 
autoradiography. 
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Figure 4. 7 An RNA carrying the PRRSV –2/–1 PRF signal co-immunoprecipitates with 
nsp1β. A protein-RNA interaction assay was designed based on co-immunoprecipitation of 
nsp1β and RNA transcripts containing 79-nt of type1 PRRSV sequence, including the –2/–1 
PRF signal. (A) Schematic representation of the target RNA in which a WT 79-nt PRF signal 
(R79WT-EGFP), or its mutant KO2 or CC2 derivatives (see Fig. 4.9A), was fused to the 
EGFP sequence. The latter served as a target for qRT-PCR amplification (primer set and 
TaqMan probe indicated), which was used to quantify the amount of RNA target bound to 
nsp1β. (B-C) HEK-293T cells were co-transfected with a plasmid expressing WT or 1βKO 
FLAG-tagged nsp1β and a plasmid expressing a WT or mutant target RNA. Empty vectors 
(pFLAG and pEGFP) were included as negative controls. (B) Detection of input levels of 
nsp1β bait and RNA target in cell lysates prior to the co-immunoprecipitation assay. 
Quantitative qRT-PCR was used to determine the levels of WT or mutant R79-EGFP mRNA 
in transfected cells (top panel). Western blot analysis was used to monitor the input of 1βKO 
or WT nsp1β bait (middle panel) and to verify the use of equal amounts of cell lysate (β-
tubulin control; bottom panel). Lane numbers are explained in panel B. (C) Following FLAG-
nsp1β immunoprecipitation, the amount of co-precipitating target RNA was determined by 
qRT-PCR (see panel A). Western blot analysis using a mAb α-EU-nsp1β was used to monitor 
the amount of immunoprecipitated nsp1β. A legend explaining the co-transfected plasmids 
for each lane number is given on the right side of the panel.   
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Figure 4. 8 PRRSV nsp1β can be pulled-down using an RNA carrying the –2/–1 PRF 
signal. Cell lysates from 1βKO or WT nsp1β-expressing HEK-293T cells were incubated 
with in vitro produced BrU-labeled RNA transcripts containing WT or mutant (KO2 or CC2, 
Fig. 4.9) versions of a 79-nt sequence from the –2/–1 PRF region of type 1 PRRSV (isolate 
SD01-08). RNA-protein complexes were immunoprecipitated with an anti-BrU antibody and 
subjected to Western blot analysis using an nsp1β-specific mAb. The amount of β-tubulin in 
the initial samples was monitored to verify equal loading. 
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Figure 4. 9 Overview of mutants and antibodies used in this study. (A) List of WT and 
mutant sequences of the PRRSV PRF region (GGUUUUU shift site and conserved 
CCCANCUCC motif indicated with orange and magenta boxes, respectively). Mutated 
nucleotides are highlighted in cyan. Coordinates of starting nucleotides refer to PRRSV 
sequences DQ489311 (type 1 PRRSV) and KC469618 (type 2 PRRSV). IFC, in-frame 
control; CC2, disrupted CCCANCUCC motif; M1, mutated  –1 frame termination codon to 
C-terminally extend nsp2N; KO2, knockout mutant 2 (premature –2 frame termination codon 
and disrupted frameshift cassette); 1βKO, knockout mutant 3 (double mutation introduced 
into the nsp1β GKYLQRRLQ motif). (B) Sizes of nsp2-related polypeptides described in this 
study and location of epitopes recognized by the PRRSV-specific antibodies in the nsp1β-2 
region. Nsp2N* refers to the C-terminally extended version of nsp2N that is produced by 
mutant M1, due to removal of the stop codon (see panel A). Origin and original name of each 
antibody are provided in the Materials and Methods section. Sizes (in aa) for nsp2-related 
products are shown for GenBank sequences DQ489311 (SD01-08, PRRSV type 1) and 
KC469618 (SD95-21, PRRSV type 2).  
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Figure 4. 10 Mass spectrometric analysis of nsp2N* (a C-terminally extended version of 
nsp2N) purified from cells infected with mutant SD95-21-M1. (A) PRRSV-infected or 
mock-infected MARC-145 cell lysates were immunoprecipitated with nsp2-specific α-NA-
PLP2. Immunoprecipitated proteins were separated by SDS-PAGE and stained with 
Coomassie Blue. The positions of nsp2, nsp2TF, and nsp2N are indicated. (B) Fragmentation 
spectrum of the –1 frameshift-specific peptide QVFWPR. (C) Complete amino acid sequence 
of nsp2N* comprising nsp2N and a 23-amino-acid C-terminal extension (highlighted in gray). 
Peptides identified by mass spectrometry are depicted in red. The peptide spanning the –1 
frameshift site is underlined in green. (D) Peptide sequence of the nsp2N* –1 frameshift-
specific peptide. The fragment ions that were identified in the LC-MS/MS analysis of the gel 
slice are indicated. (E) Nucleotide sequence and -1 PRF-directed translation of nsp2N* at the 
frameshift site. 
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Figure 4. 11 Nucleotide sequences of the WT and synonymously mutated nsp1β-coding 
region. For each block, the top, middle, and bottom line gives the wild type nsp1β-coding 
sequence (black), the synonymously mutated sequence (mutations present in pLnsp1βcc-nsp2 
given in red), and the (unchanged) translation into amino acids (blue).  
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Figure 4. 12 First-cycle analysis of RNA synthesis and nsp1β stability of WT and 
mutant (KO2/1βKO) SD01-08 virus in BHK-21 cells. (A) IF microscopy analysis of 
transfection rate in BHK-21 cells electroporated with in vitro transcribed full-length PRRSV 
RNA. Transfected cells were double labeled with a mAb specific for viral dsRNA (green) 
and Hoechst 33342 (blue) for staining of DNA in cell nuclei. (B, C) Gel hybridization 
analysis and quantification of PRRSV-specific mRNA accumulation in cells transfected with 
mutants KO2 and 1βKO or a WT control. (B) Total intracellular RNA was isolated at 18 h 
post-transfection and resolved by denaturing formaldehyde agarose gel electrophoresis. 
PRRSV-specific mRNAs were detected by hybridization of the dried gel with a 
32
P-labelled 
probe complementary to the 3’-end of the viral genome and subsequent phosphorimaging. 
The positions of the PRRSV genome (RNA1) and the six sg mRNAs (RNA2 to RNA7) are 
indicated. (C) The volume of the bands corresponding to each of the viral mRNAs was 
quantified by phosphorimaging and adjusted for the control 18S ribosomal RNA band in the 
same lane. The sum of the signals for all viral mRNA bands in each lane was used to 
calculate the relative abundance of each individual mRNA. (D) Pulse-chase analysis of nsp1β 
expression. BHK-21 cells were transfected with RNA transcribed from WT or mutants of 
PRRSV full-length cDNA clones. At 16.5 h post transfection, protein synthesis was labeled 
for 15 min and chased for 1h. Cells were lysed and, following immunoprecipitation with 
mAb α-EU-nsp1β, the production and turn-over of nsp1β were analyzed using SDS-PAGE 
and autoradiography. 
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Chapter 5 - Attenuation of porcine reproductive and respiratory 
syndrome virus by inactivating expression of ribosomal 
frameshifting products: implication for the rational design of 
vaccines 
Abstract: The ribosomal frameshift products of PRRSV, nsp2TF and nsp2N, are novel 
proteins recently identified. In this study, they were determined to have ability to interfere 
with cellular protein ubiquitination (Ub) and ISGylation activities that associated with innate 
immune suppression function of the virus. Three recombinant viruses (KO1, KO2 and 1βKO), 
generated by partially or completely inactivation of nsp2TF/nsp2N expression, displayed 
impaired de-Ub and de-ISGylation ability and induced higher levels of IFN-α and ISG15 
expression in infected cells. When tested in our nursery pig model, these mutants showed 
reduced level of viremia compared to wild-type (WT) virus. After challenge, mutant virus-
immunized pigs demonstrated improved protection with reduced lung lesion and viral load in 
lung and tonsil tissues, in comparison to pigs immunized with WT virus. Taken together, the 
results suggest that nsp2TF and nsp2N may have important functions in modulation of host 
immune response, and nsp2TF-deficient viruses are attenuated in vivo.  
 
 5.1 Introduction 
The innate immune response provides the first line of defense against pathogen 
intruders. It is essential for the initial control of infection and allows time for the 
establishment of an adaptive immune response. The type I interferon (IFN) system is a key 
component of the innate immune response (reviewed by (Haller & Weber, 2007; Randall & 
Goodbourn, 2008; Samuel, 2001)). Initially, the pathogen-associated molecular pattern in 
double stranded RNA (dsRNA) is recognized by host cell receptors to activate protein 
signaling cascades, which results in the activation of type I IFN production and signaling. In 
the signaling pathways, critical signaling proteins are dynamically modulated by protein 
posttranslational modifications. Among various posttranslational modifiers, ubiquitin (Ub) 
and Ub-like proteins, such as ISG15, are key molecules for orchestrating the appropriate 
innate immune responses. Both Ub conjugation (ubiquitination) and ISG15 conjugation 
(ISGylation) to substrate proteins follow a similar process, and together with other 
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posttranslational modifications (phosphorylation, acetylation, SUMOylation), they fine-tune 
the strength and duration of the innate immune responses. 
As a counteraction to cellular antiviral effects, some viruses express proteins to 
suppress innate immune responses (reviewed in (Randall & Goodbourn, 2008; Versteeg & 
Garcia-Sastre, 2010)). Previous studies showed that porcine reproductive and respiratory 
syndrome virus (PRRSV) encodes multiple proteins to suppress type 1 IFN response 
(reviewed in (Fang & Snijder, 2010)). PRRSV is an enveloped, positive-stranded RNA virus, 
which belongs to the order Nidovirales, family Arteriviridae, a family which also includes 
equine arteritis virus (EAV), mouse lactate dehydrogenase-elevating virus (LDV), and simian 
hemorrhagic fever virus (SHFV) (reviewed in (Snijder et al., 2013)). Its genome is about 
15kb in length and contains at least eleven open reading frames. The replicase-associated 
genes, ORF1a and ORF1b, are situated at the 5’ end and represent nearly 75% of the viral 
genome. ORF1a and ORF1b encode two long nonstructural polyproteins, pp1a and pp1ab, 
with expression of the latter depending on a -1 programmed ribosomal frameshift in the 
ORF1a/ORF1b overlap region. Following their synthesis from the genomic mRNA template, 
the pp1a and pp1ab replicase polyproteins are processed into at least 14 functional 
nonstructural proteins (nsps) by a complex proteolytic cascade that is directed by four 
proteinase domains encoded in ORF1a - two papain-like cysteine proteases (PLPα and PLPβ) 
located in nsp1α and nsp1β, a cysteine protease (PLP2) domain located in the N-terminal 
region of nsp2, and a serine protease (SP) located in nsp4. PLPα autocleaves between 
nsp1α/1β, PLPβ autocleaves between nsp1β/2, and PLP2 cleaves between nsp2/3, thus 
mediating rapid release of nsp1α, nsp1β and nsp2 from the polyprotein (Fang & Snijder, 
2010). In previous studies, nsp1α, nsp1β and nsp2 (PLP2) were identified to be innate 
immune antagonists (Beura et al., 2010; Chen et al., 2010; Kim et al., 2010; Li et al., 2013; 
Sun et al., 2010; Sun et al., 2012).  
Recently, a new ORF (TF) was discovered overlapping a central region of ORF1a in 
the –2/+1 reading frame (Fang et al., 2012). TF is translated via a novel –2 programmed 
ribosomal frameshifting (PRF) mechanism to produce a novel transframe fusion protein 
comprising the N-terminal approximately two thirds of nsp2 followed by a unique C-terminal 
domain that is specified by the novel TF ORF (Fang et al., 2012). The same frameshift site 
also induces efficient -1 PRF to yield a third, truncated nsp2 variant named nsp2N. 
Remarkably, our recent study showed that both –2 and –1 PRF are transactivated by a 
PRRSV replicase subunit, nsp1β. Embedded in PLP1β, a highly conserved, putative RNA-
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binding motif was identified to be critical for PRF transactivation at the TF frameshift site (Li 
et al., 2014). 
The newly identified nsp2TF and nsp2N proteins add to the complexity of potential 
functions encoded in the nsp2 region of the viral genome, and this region has been previously 
explored for genetically modified live virus (MLV) vaccine development (reviewed in (Fang 
& Snijder, 2010)). More importantly, nsp2, nsp2TF and nsp2N share the N-terminal PLP2 
domain. In previous studies, PLP2 was determined to be able to disrupt innate immune 
signaling by removing Ub and Ub-like modifiers from host cellular proteins. PLP2 was found 
to exhibit general de-Ub activity towards cellular Ub conjugates and also showed 
deISGylation activity to remove the IFN-induced Ub homologue ISG15 (Frias-Staheli et al., 
2007; Sun et al., 2010; Sun et al., 2012). The biological significance of these activities was 
supported by the ability of PLP2 to inhibit type I IFN activation and antagonize the antiviral 
effect of ISG15 (Sun et al., 2012; van Kasteren et al., 2012). In this study, we analyzed the 
de-Ub and deISGylation function of nsp2TF and nsp2N. A panel of nsp2TF/nsp2N deficient 
recombinant viruses was constructed by mutating the key RNA and protein sites required for 
-1/-2 PRF. Their potential application as candidate MLV vaccines was assessed in a PRRSV 
challenge piglet model.  
 
5.2 Materials and Methods 
Virus and Cells: The US type 2 PRRSV isolate SD95-21 (GenBank accession no. 
KC469618) and its nsp2TF-deficient mutants were used in all experiments. BHK-21 cells 
were used for initial transfection and recovery of recombinant virus. MARC-145 cells were 
used for recombinant virus rescue and subsequent experiments. These cells were maintained 
in Eagle’s minimum essential medium (Invitrogen) supplemented with 10% heat-inactivated 
fetal bovine serum and antibiotics at 37
0
C with 5% CO2. Porcine alveolar macrophages were 
obtained by lung lavage of 6-week-old PRRSV-naıve piglets using a method described 
previously (Zeman et al., 1993). The Sendai virus (SeV) Cantell strain was grown in 
embryonated chicken eggs. Virus titer was determined by hemagglutination assay using 
chicken red blood cells as described previously (Yonemitsu and Kaneda, 1999). 
Luciferase reporter assay: HEK-293T cells were transfected with 0.5 µg plasmid DNA of 
p125-luc (a luciferase reporter plasmid containing IFN-β promoter) or pISRE-luc (a 
luciferase reporter plasmid containing ISRE promoter), 20 ng plasmid DNA of pRL-SV40, 
and 0.5µg of plasmid DNA expressing nsp2, nsp2TF, nsp2N, PLP2 or empty vector (EV). 
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Transfection was conducted using FuGENE HD reagent (Promega) following the 
manufacturer’s instructions. At 24 h post transfection, cells were stimulated by SeV at 100 
HA unit per ml for 16 hours. Cells were harvested and subjected to a reporter gene assay 
using a dual luciferase reporter system (Promega) according to the manufacturer’s 
instructions. Firefly or Renilla luciferase activity was measured in FLUOstar Omega (BMG 
Labtech). Cell lysates were also subjected to SDS-PAGE and Western blot analysis using 
mAb 140-68 specific to PLP2 domain of nsp2-related proteins. 
Ubiquitination assay: HEK-293T cells were transfected with plasmid DNAs of pcDNA3.1-
HA-Ub (0.5 µg) expressing HA-tagged ubiquitin and pCMV-SD95-21 (2 µg) containing the 
full-length cDNA clone of type 2 PRRSV SD95-21 or nsp2TF-deficient mutant KO1, KO2, 
or 1βKO. Transfection was conducted using FuGENE HD reagent (Promega) following the 
manufacturer’s instruction. At 48 h post-transfection, cells were harvested for Western blot 
analysis. The mAb HA.11 clone 16B12 (Covance, Inc.) was used to detect the expression of 
HA-tagged proteins. The expression of PRRSV nsp1β was detected by mAb 123-128 as 
described previously (Li et al., 2012), and mAb anti-β tubulin (Applied Biological Materials, 
Inc.) was used to detect β-tubulin expression. 
ISG15 conjugation (ISGylation) assay: MARC-145 cells were infected with PRRSV SD95-
21 WT or nsp2TF-deficient mutants, KO1, KO2, or 1βKO. At 18 h post-infection, cells were 
stimulated with IFN-α at 1000 IU/ml. The cell monolayer was lysed in Laemmli sample 
buffer for Western blot analysis at 16 h post-stimulation. For the detection of ISG15 
expression, the nitrocellulose membrane was probed with mAb F-9 or rabbit polyclonal 
antibody H-150 (both from Santa Cruz Biotechnology, Santa Cruz, CA). The expression of 
PRRSV nsp1β was detected by mAb 123-128 as described previously (Li et al., 2012), and 
mAb anti-β tubulin (Applied Biological Materials, Inc.) was used to detect β-tubulin 
expression. 
Radioimmunoprecipitation analysis: MARC-145 cells were infected with 0.01 MOI of 
viruses. Newly synthesized proteins were labeled from 24 to 26 hours post transfection in 
cysteine- and methionine-free medium containing 500 µCi/ml [
35
]S-methionine and [
35
]S-
cysteine (Perkin-Elmer). Cell lysis and immunoprecipitation analysis were performed as 
described previously (Li et al., 2014). The mAb 140-68 (anti-PLP2) was used to 
immunoprecipitate nsp2/nsp2TF/nsp2N, and precipitated proteins were separated on a 6% 
SDS-PAGE gel. Protein bands were visualized using phosphorimaging and a Typhoon 
Variable Mode Imager (GE Healthcare).  
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In vitro growth characterization of recombinant viruses in cell culture: Growth kinetics 
of the recombinant and parental viruses were examined by infecting MARC-145 cells with 
viruses at a multiplicity of infection (MOI) of 0.01. Infected cells were collected at 0, 12, 24, 
36, 48, 60 and 72 hours post infection (hpi), and viral titers were determined by 
immunofluorescent assay (IFA) on MARC-145 cells and quantified as fluorescent focus units 
(FFU)/ml.  
Animals and challenge groups: A total of forty-five 4-week-old, PRRSV-naıve pigs 
obtained from a certified PRRSV-negative herd were divided randomly into 6 groups and 
housed separately in the animal isolation facility. Nsp2TF-deficient mutants or WT viruses (2 
ml, 1x10
5
 TCID50/ml) were used to immunize pigs. After a four-day acclimation period, pigs 
from group3-6 (n = 8) were inoculated intramuscularly with parental virus (group 3) and 
mutant virus of KO1 (group 4), KO2 (group 5), 1βKO (group 6). Group 1 (n=5) and group 2 
(n=8) pigs were mock-infected with cell culture medium. At 10 days post-infection (dpi), 
three pigs from group 2-6 were euthanized for assessment of gross pathology following acute 
infection. At 28 dpi, the rest of pigs (n=5) in group 2-6 were challenged intranasally with the 
WT virus, SD95-21 (2 ml, 1x10
6
 TCID50/ml). The group 1 pigs were kept as mock-infected 
negative control. Pigs were euthanized at 13 days post challenge (dpc).  
Blood and tissue sampling and lung pathology: Blood samples were obtained from all pigs 
on days 0, 3, 7, 14, 21, 28, 31, 35, 41 days post-infection. Gross lung lesions were evaluated 
using a previously developed system (Halbur et al., 1995) based on the approximate volume 
that each lobe contributes to the entire lung: the left and right apical lobes, the left and right 
cardiac lobes, and the intermediate lobe each contribute 10% of the total lung volume, and 
the left and right caudal lobes each contribute 25%. These scores were then used to calculate 
the total lung lesion score based on the relative percentage contributions of each lobe. Blood 
and lung tissue samples were collected at the time of euthanasia. For tissue sampling, a 
representative tissue was collected from each lobe of the lung.    
Full-length genome sequencing: At 21 dpi, WT and mutant viruses were isolated by 2-fold 
titration of serum samples on Marc-145 cells. After 3-4 days incubation, the culture 
supernatant was harvested, and cells were fixed for detection of virus using IFA. Viral RNA 
was extracted from the harvested culture supernatant using a QIAamp viral RNA kit (Qiagen) 
following the manufacturer’s instruction. To remove DNA contamination, viral RNAs were 
further processed with DNA-free RNA kit
TM (Zymo Research) following the manufacturer’s 
instruction. Next generation sequencing was performed to determine viral full-length genome 
at Genomic core facility of Purdue University. 
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Quantification of viral load:  For the detection of viral RNA and quantification of viral load, 
serum and tissue samples were examined using a Tetracore VetAlert PRRS quantitative RT-
PCR kit (Tetracore, MD) following the manufacturer’s instruction. 
Fluorescence microsphere immunoassay (FMIA) detection of IFN-α expression: Porcine 
alveolar macrophages were infected with 1 MOI of WT virus or nsp2TF-deficient mutants. 
At 48 hpi, culture supernatant was harvested for analyzing the IFN-α expression using a 
cytokine FMIA as described previously ((Lawson et al., 2010). The quantity of IFN-α was 
determined using mean fluorescent intensity (MFI) values, and the result was compared with 
the mean values from mock-infected control cells. 
Statistical analysis: Statistical analysis was performed using GraphPad InStat version 5.0 
(GraphPad Software). Comparison was performed by unpaired t test to determine the 
statistical significance. Differences between groups of pigs at different times post-inoculation 
were considered statistically significant at P<0.05 for all analyses. 
 
5.3 Results 
Nsp2TF and nsp2N expression affect cellular protein ubiquitination and ISGylation 
Initially, we examined the innate immune suppression ability of nsp2TF and nsp2N 
using an IFN-β promoter-luciferase reporter assay. Each of these protein-encoding regions 
(Fig. 5.1A) was cloned into a eukaryotic expression vector, p3xFLAG. As controls, the empty 
plasmid vector (EV) and a plasmid expressing the PLP2 domain region were included in the 
analysis. Protein expression from these plasmids was confirmed by Western blot analysis 
(Fig. 5.1B). As expected, PLP2 strongly suppressed expression of the luciferase reporter gene 
driven by the IFN-β promoter. Compared to full-length nsp2 and nsp2TF, nsp2N showed 
greater inhibition of luciferase reporter gene expression (Fig. 5.1C). We further evaluated the 
effect of these proteins on the expression of downstream type I IFN signaling pathway. 
Luciferase reporter assay was performed using the pISRE-luc reporter plasmid that expresses 
firefly luciferase under the control of the interferon-stimulated response element (ISRE) 
promoter. Again, PLP2 strongly suppressed expression of the luciferase reporter gene driven 
by the ISRE promoter. Compared to full-length nsp2, nsp2TF and nsp2N had a stronger 
suppressive effect on luciferase reporter gene expression (Fig. 5.1D). Next, we compared the 
effect of full-length nsp2, nsp2TF and nsp2N expression on host cellular protein 
ubiquitination. HEK-293T cells were transfected with a plasmid expressing HA-tagged 
ubiquitin and the plasmid expressing full-length nsp2, nsp2N or nsp2TF. Again, the plasmid 
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expressing nsp2-PLP2 and the empty p3xFLAG plasmid were used as controls. As shown in 
Fig. 5.2A, expression of all four PLP2-containing products resulted in a decreased level of 
ubiquitin-conjugated proteins. In comparison to nsp2, both nsp2TF and nsp2N had the greater 
effect on ubiquitin conjugation. Subsequently, we analyzed the effect of nsp2N and nsp2TF 
expression on host cellular protein ISGylation. ISG15 conjugates were generated by 
transfecting HEK-293T cells with plasmids that express ISG15 and E1, E2, and E3 enzymes. 
Cells were co-transfected with plasmids expressing each of the individual nsp2-related 
products. Co-expression of either nsp2TF or nsp2N resulted in a clear decrease in the level of 
ISGylated proteins (Fig. 5.2B). Taken together, these data confirmed that individually 
expressed nsp2TF or nsp2N has the ability to interfere with cellular protein ubiquitination 
and ISGylation processes.  
Effect of inactivating nsp2TF expression on the ability of PRRSV to suppress host 
cellular innate immune responses 
To determine whether the de-Ub and de-ISGylation effect induced by nsp2TF and 
nsp2N in the in vitro expression system is consistent with that in the context of viral infection, 
we further analyzed nsp2TF-deficient mutants. Previously, a panel of recombinant viruses 
that partially or completely knocked out nsp2TF/nsp2N expression was constructed (Fang et 
al., 2012; Li et al., 2014; Li et al., 2013). In this study, three type 2 PRRSV mutants were 
analyzed (Fig. 5.3A), including vSD95-21-KO1 (KO1), vSD95-21-KO2 (KO2) and vSD95-
21-nsp1βKO (1βKO). KO1 makes a truncated nsp2TF protein that lacks the C-terminal 
region encoded by the 3' end of the TF ORF (indicated by red arrow in Fig.3B), but the 
expression of nsp2 and nsp2N is not affected. KO2 contains mutations that disrupt the 
frameshift site and the downstream frameshift-stimulatory CCCANCUCC motif. These 
mutations were intended to knock out the frameshift signal completely so that only nsp2 is 
expressed. The 1βKO mutant contains mutations in nsp1β, in which the Lys and the first Arg 
of a GKYLQRRLQ motif in nsp1β were replaced with Ala. This mutant was designed to 
inactivate the PRF-transactivation function of nsp1β to inhibit frameshifting, so that again 
only nsp2 would be expressed (Li et al., 2014). None of the mutations in KO1 and KO2 affect 
the nsp2 amino acid sequence. As shown in Fig. 5.3B, the expression of nsp2 appears not to 
be affected by the mutations in each individual recombinant virus. Growth kinetics analysis 
(Fig. 5.3C) showed that all three mutants grew to a similar viral titer in MARC-145 cells. 
They reached peak viral titer (10
5.06
-10
5.27 
FFU/ml) 12-24 h later than wild-type (WT) virus, 
with peak titers about 20 to 40-fold lower than the peak viral titer of WT virus (10
6.6
FFU/ml), 
indicating that these nsp2TF-deficient mutants had reduced growth ability in cell culture.  
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To determine whether knock out of nsp2TF/nsp2N expression could alter the virus 
ability to interfere with cellular ubiquitination and ISGylation process, we performed de-Ub 
and de-ISGylation assays. HEK-293T cells were co-transfected with a plasmid expressing 
HA-tagged ubiquitin and a plasmid containing full-length cDNA of WT PRRSV or its 
mutants. The empty plasmid vector was used as a control. As shown in Fig. 5.4A, 
transfection with WT PRRSV resulted in decreased expression levels of ubiquitin-conjugated 
proteins, while the nsp2TF-deficient mutants displayed an impaired ability to interfere with 
cellular protein ubiquitination. Next, we tested the de-ISGylation ability of these nsp2TF-
deficient mutants. The result of the ISGylation assay is shown in Fig. 5.4B. A clear decrease 
in the level of ISGylated proteins was observed in cells infected with WT virus, 
demonstrating the ability of WT virus to counteract the ISGylation of cellular proteins. In 
contrast, all three mutants, KO1, KO2 and 1βKO, had almost lost their ability to interfere 
with ISGylation (Fig. 5.4B), even though the knockout of nsp2TF/nsp2N expression did not 
appear to affect the expression level of nsp2 (Fig. 5.3B). 
As indicated previously, the biological significance of de-Ub and deISGylation 
activities is to disrupt innate immune signaling and suppress IFN activation (reviewed in 
(Fang & Snijder, 2010; Snijder et al., 2013)). Thus, IFN-α expression was examined in 
porcine alveolar macrophages infected with nsp2TF-deficient mutant or WT viruses. Cells 
were infected with equal MOI of KO1, KO2, 1βKO, and WT viruses. At 48 h post-infection, 
culture supernatants were harvested and IFN-α expression level was quantified by a swine 
cytokine fluorescence microsphere immunoassay (FMIA). Compared to WT virus, each of 
the three mutants showed an increased level of IFN-α induction (Fig. 5.5A). KO2 and 1βKO 
had significantly impaired ability to inhibit IFN-α activation, with 1.7 and 2.1-fold increased 
IFN-α expression, respectively, while KO1 induced a slightly higher level of IFN-α 
production. Subsequently, we analyzed the effect of nsp2TF knockout on the expression of 
ISG product. When virus-infected Marc-145 cells were stimulated by IFN-α, the type 1 IFN 
signaling pathway was activated. Compare to WT virus-infected cells, we observed a 0.9-fold 
increase of ISG15 expression in KO1-infected cells, and 2.3-fold and 1.3-fold higher ISG15 
expression in KO2 and 1βKO-infected cells, respectively (Fig. 5.5B). 
Nsp2TF-deficient mutants are attenuated in vivo  
To assess the potential application of nsp2TF-deficient mutants in vaccine 
development, we performed in vivo characterization of these mutants in a nursery pig model. 
WT virus was included as a control. Six groups of pigs were used. Group 3-6 pigs were 
infected with 2x10
5
 FFU of WT virus (group 3), KO1 (group 4), KO2 (group 5) or 1βKO 
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(group 6). Group 1 and 2 pigs kept uninfected. To determine whether these nsp2TF-deficient 
mutants replicated in vivo, serum samples collected at 7–28 days post-infection (dpi) were 
used for virus isolation on MARC-145 cells. Viruses were recovered from the serum samples 
of pigs from groups 3–6 collected at 7, 14 and 21 dpi, indicating active replication of the 
mutant viruses in pigs. To confirm the stability of the mutations, full-length genome 
sequencing was performed using viruses isolated from serum samples collected at 21 dpi. The 
results confirmed that the viruses recovered from pigs infected with the KO1, KO2 or 1βKO 
mutants retained the corresponding mutations in the ORF1a region. 
The duration and peak amount of viremia was quantified by real-time qRT-PCR (Fig. 
5.6). At 3 and 7 dpi, pigs infected with any of the three nsp2TF-deficient mutant viruses had 
significantly lower viral load than those pigs infected with WT virus (Fig. 5.6A and 6B). At 
14, 21 and 28 dpi, the viral loads in all three groups of mutant-infected pigs were lower than 
in WT-infected pigs, although at these time-points the differences were not statistically 
significant. The 1βKO group of pigs consistently showed a lower mean viral load than the 
other groups of pigs during the 0-28 dpi time course (Fig. 5.6A). Clinical symptoms were 
monitoring during the first 10 dpi. None of the infected animals developed fever, cough or 
other clinical signs. At 10 dpi, lung pathology during the acute infection was assessed with 
three pigs from each of the group 2-6 pigs. Gross lung lesions were absent in mutant virus-
infected pigs, and mild lesions (5-6%) were observed in two of the WT virus-infected pigs 
(data not shown). These results indicate that the mutant viruses were attenuated in vivo and 
they were safe for administration to piglets. 
Nsp2TF-deficient mutants induced protection in pigs against homologous virus 
challenge  
To investigate whether these nsp2TF-deficient mutants are capable of inducing 
protection against PRRSV challenge, group 2-6 pigs were challenged with 2x10
6
 FFU of WT 
virus at 28 dpi. In comparison to group 2 pigs (negative control/challenged: NC group in Fig. 
5.6 & 7), viral load in serum was significantly lower in all immunized pigs at 3 and 7 days 
post challenge (dpc; Fig. 5.6C). At necropsy (13 dpc), the mean scores of lung lesions in 
immunized pigs (WT, KO1, KO2, and 1βKO) were lower than those in the group 2 pigs (Fig. 
5.7A). Significant differences were observed for the KO1 and KO2 groups of pigs in 
comparison to the group 2 pigs. The protection (based on lung pathology) appeared to be 
more effective in the pigs immunized with the nsp2TF-deficient mutants. In comparison to 
the mean lung lesion score of 25.6 for the WT group of pigs, the lesion score was 53% 
reduced in the KO1 group of pigs, 70 % reduced in the KO2 group of pigs and 38% reduced 
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in the 1βKO group of pigs. Results from real time RT-PCR confirmed that there was a 0.4-
1.4 log reduced mean viral load in lung tissues from pigs immunized with the nsp2TF-
deficient mutants in comparison to that from pigs infected with WT virus (Fig. 5.7B). Since 
tonsil is another main tissue site harboring PRRSV, we further measured the viral load in 
tonsils and the result was consistent with that from lung tissues. In comparison to WT group 
pigs, the mean viral load in tonsils showed a 1.3-1.5 log reduction in KO1 and KO2 group 
pigs, while mean viral load in tonsils from 1βKO pigs showed a 0.8 log reduction (Fig. 5.7C). 
 
5.4 Discussion 
Since its emergence, PRRSV has caused tremendous economic loss and it has been 
estimated to cost at least $600 million annually in the US swine industry alone (Miller, 2011). 
The difficulties encountered in the development of a broadly effective PRRS vaccine 
emphasize our incomplete understanding of the viral biology and PRRS immunology. 
PRRSV infection appears to elicit poor innate immune responses. This initial suppression of 
the innate immune response, leading to the delayed induction of protective cellular and 
humoral immunity, provides a window of time allowing PRRSV to replicate, shed and 
transmit to other contact naïve animals. Therefore, one of the key steps in new PRRS vaccine 
construction is to identify and alter the viral proteins/genetic elements involved in 
antagonizing host innate immune response.  
Previous studies determined the PRRSV PLP2 domain as a major innate immune 
antagonist (Frias-Staheli et al., 2007; Sun et al., 2010; Sun et al., 2012; van Kasteren et al., 
2012). The recently identified nsp2TF and nsp2N proteins share the PLP2 domain with nsp2, 
which raised the question on which of the three proteins actually function as innate immune 
antagonist(s). In this study, we compared the ability of the full-length nsp2, nsp2TF and 
nsp2N proteins to suppress the host innate immune response. They were first analyzed in an 
in vitro expression system and the result showed that nsp2TF and nsp2N both have the 
capacity to de-conjugate ubiquitin and ISG15 from host cellular proteins at a level apparently 
higher than that of nsp2. To exclude the possibility that the observed effects may be (partially) 
due to more general consequences of cytotoxicity caused by protein over-expression, we 
further analyzed recombinant viruses in which nsp2TF/nsp2N expression was partially or 
completely knocked out. The results were consistent with those obtained from the in vitro 
expression system, in which all three mutants showed impaired de-Ub and deISGylation 
ability. To determine whether impaired de-Ub and deISGylation ability could subsequently 
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alter the ability of the virus to antagonize Ub- and ISG15-dependent innate immune 
responses, we analyzed IFN-α and ISG15 expression in porcine alveolar macrophages and 
Marc-145 cells infected with mutant viruses. The mutant viruses had a reduced ability to 
inhibit IFN-α and ISG15 expression in comparison to WT virus, which further indicated that 
nsp2TF/nsp2N are involved in the modulation of the innate immune response. The 1βKO 
mutant had the highest reduction in its ability to inhibit IFN-α and ISG15 expression. This 
result is expected, since mutations in 1βKO were introduced in nsp1β, which is also an innate 
antagonist. In previous studies, we have demonstrated that the K124A/R128A mutations in 
nsp1β not only knocked out the expression of nsp2TF and nsp2N (Li et al., 2014), but also 
affected the innate immune suppression function of nsp1β (Li et al., 2013). It remains to be 
established to what extent nsp1β directly modulates the innate immune response or does so 
by stimulating the expression of nsp2TF and nsp2N. The mutations introduced in KO1 
appeared to have less effect on the ability of the virus to suppress cellular IFN-α and ISG15 
expression. This could be explained that the KO1 mutations only C-terminally truncated the 
nsp2TF protein but do not inhibit frameshifting or the expression of nsp2N and the truncated 
nsp2TF, both still containing the PLP2 domain. In PRRSV-infected cells, nsp2TF was found 
to be targeted to a different location from full-length nsp2, i.e. the exocytic pathway rather 
than the modified ER membranes where nsp2 is located and associated with viral RNA 
synthesis (Fang et al., 2012). Our results showed that all three mutants had reduced de-Ub 
and de-ISGylation ability, even though knock out of the expression of nsp2TF (and nsp2N in 
KO2 and nsp1βKO) still permitted the expression of similar levels of nsp2 as that of WT 
virus (Fig. 5.2B). These data made us speculate that nsp2TF and/or nsp2N, rather than nsp2, 
might be the protein(s) mainly involved in the suppression of the host innate immune 
response. It could be possible that nsp2TF/nsp2N localizes to the specific cellular 
compartment(s) (locations) to antagonize the host innate immune response, whereas nsp2 
localizes to the ER as a membrane-anchored protein for the formation of the replication 
complex. It also worth noting that, while the TF region of nsp2TF contains predicted TM 
domains (Fang et al., 2012), nsp2N lacks both nsp2TF and nsp2 C-terminal TM domains, and 
could be a secretory protein possessing unique function(s). The mechanistic aspects of the 
role of PRRSV nsp2TF and nsp2N in counteracting host innate immune response need to be 
further studied. 
The identification of viral elements responsible for immune evasion is fundamental 
for the development of modified live virus (MLV) vaccines. Previous studies demonstrated 
that recombinant viruses generated with targeted mutations (deletions) in genes encoding for 
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immune antagonists are excellent candidates for MLV vaccines (Kochs et al., 2007; Richt et 
al., 2006; Steel et al., 2009; Valarcher et al., 2003). For example, the influenza virus NS1 
protein is a strong innate immune antagonist. Recombinant viruses with truncated NS1 
proteins are attenuated in animals and provide protection against wild-type virus challenge 
(reviewed in (Richt & Garcia-Sastre, 2009)). In our study, we successfully knocked out the 
expression of two potential innate immune antagonists, nsp2TF and nsp2N, and viable 
recombinant viruses were generated. We further used a nursery pig model to assess the 
feasibility of applying these TF-deficient mutants in vaccine development. The result 
demonstrated that all three mutants were attenuated in pigs. No clinical symptoms and 
adverse side effects were observed in these mutant virus-infected pigs. Viable mutant viruses 
could be isolated from serum of infected pigs at 21 dpi, indicating active viral replication in 
the host. Further genomic sequencing results confirmed the stability of the mutations 
introduced in the nsp1β or nsp2 regions. In comparison to the WT virus, all three mutants 
showed a lower level of viral load in serum (3-28 dpi) and no apparent lung lesions were 
observed in mutant virus-infected pigs following the acute phase of infection (10 dpi). The 
1βKO-infected pigs had the lowest viral load in serum (3-28 dpi). This correlates well with 
the result from the in vitro cellular immune analysis. As discussed above, the 1βKO 
mutations not only knocked out the expression of nsp2TF and nsp2N, but also affected the 
innate immune suppression function of nsp1β. After challenge, vaccinated pigs showed a 
significant level of protection from a WT virus challenge, as evidenced by the significant 
reduction of gross lung lesions and a 1-3 log reduction of the viral load in serum at 3 and 7 
dpc. Although the viral load in serum had similar levels in all vaccinated pigs, lower levels of 
mean viral load in lung and tonsil tissues were observed in pigs vaccinated with mutant 
viruses, which is correlated with the lower lung lesion scores, demonstrating the improved 
level of protection generated by these TF-deficient mutants. 
The KO2 mutant appears to induce the best protection in animals. It was expected that 
KO2 would generate better protection than KO1. As discussed above, in comparison to KO1, 
the KO2 mutant had a stronger effect on the ability of the virus to interfere with cellular 
protein ubiquitination and ISGylation, and subsequently induced higher IFN-α and ISG15 
expression in cultured cells. Initially, we suspected that 1βKO mutant would induce the best 
protection, but the data from the animal challenge study seemed to contradict our results in 
cultured cells. To explain this discrepancy, one should take into account that the KO2 mutant 
replicated much better than the 1βKO mutant in animals. During 0-21 dpi, KO2 reached a 
serum viral RNA load of 10
5.0
-10
6.0
 copies / ml in infected pigs, whereas 1βKO constantly 
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showed the lowest viral RNA load of 10
4.0
-10
4.5
 copies / ml in serum. Thus, even if KO2 
viruses have a lower intrinsic IFN inducing potential than 1βKO viruses, the higher 
replication capacity of the former viruses in animals could eventually result in a comparably 
stronger stimulation of the IFN system in vivo. This phenomenon provides an insight into 
future study of the role of viral proteins in host immunity and has implications for vaccine 
development. So far, most of the studies in this area have drawn conclusions using data 
generated from in vitro expression systems and cultured cells. However, these require 
extensive follow-up experiments to test in animals to confirm whether specific mutations and 
deletions in certain viral genomic regions alter the IFN and cytokine responses in vivo and 
provide protection in challenged animals. 
In conclusion, we determined that nsp2TF and nsp2N are potential innate immune 
antagonists. Recombinant viruses in which expression of these frameshift products was 
inhibited were attenuated and provided improved protection in vivo. Since the nsp1β motif 
involved in frameshift stimulation, and the ribosomal frameshift site are highly conserved, 
technologies developed in this study could have a broad application in the field. 
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Figure 5. 1 Effect of full-length nsp2, nsp2TF and nsp2N expression on IFN-β synthesis 
and signaling, host cellular protein ubiquitination and ISGylation. (A) A schematic 
diagram of the viral genomic regions cloned for the expression of nsp2-related proteins. 
Numbers refer to amino acid number of ORF1a in PRRSV strain SD95-21 (GenBank 
accession no. KC469618).   (B) Western blot analysis of the expression of nsp2-related 
proteins in HEK-293T cells. The membrane was stained with anti-PLP2 mAb. β-tubulin was 
used as a loading control. (C) IFN-β promoter luciferase reporter assay to determine the 
effect of nsp2-related proteins on IFN-β induction. HEK-293T cells were transfected with a 
plasmid that expresses a nsp2-related protein, or p3xFLAG empty vector (EV), along with 
the reporter plasmid p125-Luc and Renilla luciferase expression plasmid pRL-SV40. (D) 
ISRE promoter luciferase reporter assay to evaluate the effect of nsp2-related proteins on the 
type 1 IFN signaling pathway. In experiments for both (B) and (D), cells were stimulated 
with Sendai virus at 24 h post-transfection. Luciferase activity was measured at 16 h post-
stimulation. Relative luciferase activity is defined as the ratio of firefly luciferase reporter 
activity to Renilla luciferase activity. Each data point represents a mean value from three 
experiments. Error bars show standard deviations of the normalized data.  
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Figure 5. 2 Effect of full-length nsp2, nsp2TF and nsp2N expression on host cellular 
protein ubiquitination and ISGylation. (A) HEK-293T cells were cotransfected with a 
plasmid expressing HA-tagged ubiquitin and a plasmid expressing nsp2, nsp2TF, nsp2N, 
PLP2 or the p3xFLAG empty vector (EV). Cells were lysed at 48 h post-transfection and 
analyzed by Western blotting using anti-HA mAb. (B) Plasmids expressing conjugation 
enzymes E1/E2/E3 and ISG15 were cotransfected with a plasmid expressing nsp2, nsp2TF, 
nsp2N, PLP2 or the p3xFLAG empty vector (EV) control in HEK-293T cells. At 48 h post-
transfection, cells were harvested for Western blot analysis. Free or conjugated form of 
ISG15 was detected by mouse anti-FLAG monoclonal antibody. 
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Figure 5. 3 In vitro characterization of nsp2TF-deficient recombinant viruses. (A) List of 
WT and mutant sequences of recombinant viruses. The GGUUUUU frameshift site and the 
conserved downstream CCCANCUCC frameshift stimulatory motif are indicated with orange 
and cyan boxes, respectively. Mutated nucleotides are colored in red. Numbers of starting 
nucleotides refer to the PRRSV SD95-21 sequence (GenBank accession no. KC469618); 
KO1, knockout mutant 1 (premature termination codons in the TF ORF); KO2, knockout 
mutant 2 (disrupted frameshift cassette); 1βKO, nsp1β knockout mutant (double mutation 
introduced into the nsp1β GKYLQRRLQ motif). (B) Analysis of nsp2-related products in 
cells infected with WT or nsp2TF-deficient mutants. MARC-145 cells were infected with 
WT or nsp2TF-deficient mutants, or were mock-infected. Following metabolic labeling with 
35
S-Met/Cys, proteins were immunoprecipitated with anti-PLP2 mAb and precipitated 
products were analyzed by SDS-PAGE and autoradiography. Size markers and nsp2-related 
products are indicated at the side of each panel. The red arrow points to the C-terminally 
truncated nsp2TF produced by the KO1 mutant. (C) Growth kinetics of WT virus or nsp2TF-
deficient mutants. MARC-145 cells were infected in parallel at an MOI of 0.01 with parental 
or recombinant viruses. At 12, 24, 36, 48, 60 and 72 h post-infection, cells were harvested 
and virus titers were determined by an immunofluorescence assay with MARC-145 cells. The 
results are mean values from three replications of the experiment, and viral titers are 
expressed as numbers of fluorescence focus units per milliliter (FFU/ml). 
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Figure 5. 4 Effect of inactivating nsp2TF expression on the de-ubiquitination and de-
ISGylation ability of PRRSV.  (A) Comparison of de-ubiquitination ability of WT virus and 
nsp2TF-deficient mutants in transfected cells. HEK-293T cells were transfected with a 
plasmid expressing HA-tagged ubiquitin and the plasmid pCMV-SD95-21 containing the 
full-length cDNA clone of PRRSV SD95-21 or nsp2TF-deficient mutants, KO1, KO2, or 
1βKO. The expression of ubiquitin-conjugated proteins was analyzed by Western blot using 
mAb that recognizes HA-tagged ubiquitin. (B) Comparison of de-ISGylation ability of WT 
virus and nsp2TF-deficient mutants in infected cells. MARC-145 cells were infected with 
PRRSV SD95-21 WT or nsp2TF-deficient mutants, KO1, KO2, or 1βKO. At 18 h post-
infection, cells were stimulated with IFN-α at 1000 IU/ml. The expression of free ISG15 or 
ISG15-conjugated cellular proteins was detected by Western blot using anti-ISG15 rabbit 
polyclonal antibody. The expression of PRRSV nsp1β was detected by a specific mAb, and 
β-tubulin expression was detected as a loading control. 
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Figure 5. 5 Effect of inactivating nsp2TF expression on the ability of PRRSV to inhibit 
IFN-β activation and signaling. (A) Swine macrophages were infected with WT virus or 
nsp2TF-deficient mutants, or were mock infected. At 24 h post infection, cell-culture 
supernatant was harvested for the quantification of IFN-α expression. Each experiment was 
repeated three times, and results are shown as mean value ± standard deviation. (B) MARC-
145 cells were infected with WT virus or nsp2TF-deficient mutants, or were mock infected. 
At 18 h post infection, cells were mock-treated or treated with 10,000 IU IFN-α/ml for 12 h. 
Cells were harvested and subjected to Western blot analysis using anti-ISG15 and anti-nsp1β 
mAbs to detect the expression of ISG15 and nsp1β. The expression of β-tubulin was detected 
as a loading control. Numbers shown on the bottom of the upper panel indicate the fold 
changes in the ISG15 expression level compared with that in cells infected with WT virus. 
154 
 
 
 
Figure 5. 6 Viral-RNA load in serum samples from pigs infected with WT virus or 
nsp2TF-deficient mutants.Viral-RNA load was quantified by real-time RT-PCR, and the 
result was interpreted as RNA copy numbers per ml. (A) Mean viral-RNA load in serum from 
each group of pigs through the time course of study. Dotted line indicates the time point (28 
dpi) for challenge. (B) Comparison of viral load in serum among different treatment groups 
of pigs at 3 and 7 days post infection; and (C) Comparison of viral load in serum among 
different treatment groups of pigs at 3 and 7 days post challenge. Significant differences of 
mean viral-RNA loads are indicated with asterisks (*, p < 0.05, ***, p < 0.001); ns: no 
significant difference; KO1, group of pigs infected with KO1 mutant; KO2, group of pigs 
infected with KO2 mutant; 1βKO, group of pigs infected with 1βKO mutant; WT, group of 
pigs infected with WT virus; NC, uninfected pigs but challenged with WT virus; NEG, 
negative control group of pigs. 
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Figure 5. 7 Comparison of gross lung lesion and viral RNA load in lung and tonsil 
tissues among different groups of pigs after challenged with wild type virus. (A) The 
lung lesion score is assigned based on the evaluation of percent pneumonia in each lobe and 
then added up for the entire lung. Data points are presented as the mean values of gross lung 
lesion scores. Significant differences of mean gross lung lesion are indicated with asterisks (*, 
p < 0.05); ns: no significant difference. (B &C) Viral RNA load in lung and tonsil tissues was 
quantified by real-time RT-PCR, and the result was interpreted as RNA copy numbers per 
gram of tissue sample. (B) Mean viral RNA load in lungs from each group of pigs at 13 days 
post challenge. (C) Mean viral RNA load in tonsils from each group of pigs at 13 days post 
challenge. KO1, group of pigs infected with KO1 mutant; KO2, group of pigs infected with 
KO2 mutant; 1βKO, group of pigs infected with 1βKO mutant; WT, group of pigs infected 
with WT virus; NC, uninfected pigs but challenged with WT virus; NEG, negative control 
group of pigs. 
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Chapter 6 – Conclusion and future prospects 
Since its emergence in the mid 1980’s, PRRSV became the most devastating and 
economically important pathogen to challenge the global swine industry. During the past two 
decades, a great amount of information has been obtained on PRRSV structural proteins. 
However, the structure and function of PRRSV nsps is largely undetermined. In this 
dissertation, we mainly focus on the studies designed to identify ORF1a-encoded nsps in 
PRRSV-infected cells, dissect the function of nsp1β and nsp2 related proteins, and explore 
their potential application in the development of improved vaccine candidates.  
Based on comparative sequence analysis, PRRSV ORF1a-encoded replicase 
polyproteins is predicted to produce at least ten nsps, named as nsp1-8, with nsp1 and nsp7 
being cleaved internally yielding nsp1α/β and nsp7α/β. In chapter 2, we developed a panel of 
monoclonal antibodies and polyclonal antibodies against PRRSV ORF1a-encoded nsps to 
verify previous predictions. Using these antibodies, we detected individual cleavage products 
in PRRSV-infected Marc-145 cells, including nsp1α, nsp1β, nsp2, nsp4, nsp7α, nsp7β and 
nsp8 by multiple immunoassays. As early as 6 h post-infection, most nsps could be detected 
by immunofluorescence microscopy, suggesting this antibody panel could be useful for early 
detection of PRRSV infection. At the early stages of infection, all of the detected nsps co-
localized in the perinuclear region of the cell, where the de novo-synthesized viral RNA was 
recognized by in situ labelling. In addition, consistent with previous studies of replicase 
polyprotein processing in EAV, several long-lived processing intermediates (nsp3–4, nsp5–7, 
nsp5–8 and nsp3–8) were identified by western blot and immunoprecipitation. Thus, this 
PRRSV antibody panel developed in this project will be an important toolbox for further 
structure-function studies of PRRSV nsps.  
Previous studies on the virus-host interaction have demonstrated that PRRSV nsp1β is 
an IFN antagonist with a strong inhibitory effect on type I IFN induction and signaling 
pathways. In chapter 3, we were trying to remove the IFN antagonism function of PRRSV 
nsp1β. Unexpectedly, the data from this study showed that overexpression of nsp1β exhibited 
strong inhibition effect on reporter gene expression at both transcriptional and translational 
level. More interestingly, the self-expression level of nsp1β was inhibited, but β-action 
expression level appeared to be unaffected. A similar observation has been reported for 
SARS-CoV nsp1, and the mechanism is that SARS-CoV nsp1 promotes cellular mRNA 
degradation. Based on the data generated in this study, we speculate that PRRSV nsp1β may 
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inhibit the expression of selected host cellular genes, like genes involved in host innate 
immune response. Future studies are needed to elucidate the basic mechanism of nsp1β 
involves in modulation of cellular gene expression. By mutagenesis analysis, double 
mutations at the K130(124) and R134(128) residues within a highly conserve motif 
(GKYLQRRLQ) was identified to impair nsp1β’s function on the suppression of IFN-β and 
reporter gene expression, as well as its self-suppression effect. Using reverse genetics, the 
recombinant viruses containing the double mutations were generated. In addition to 
attenuated growth behavior in Marc-145 cells, the vSD95-21-K124A/R128A mutant (1βKO) 
showed reduced ability to inhibit IFN-α, IFN-β and ISG15 expression in vitro, in comparison 
with that of the wild type virus. These results suggest the 1βKO mutant could be used as a 
modified live PRRSV vaccine. The in vivo growth phenotype and immunogenicity of this 
mutant virus was further evaluated in the nursery pig disease model in chapter 4.  
Previously, we discovered an unusual -2/-1 PRF signal in PRRSV nsp2 coding-region, 
which is utilized to translate additional viral proteins, nsp2TF and nsp2N. However, the 
detailed mechanism of this -2/-1 PRF is still unknown. In chapter 4, we found that nsp1β-
coding region is required for efficiently expression of nsp2TF and nsp2N by mapping the 
minimal viral protein sequence requirements of -2/-1 PRF. Our data indicate that expression 
of nsp1β in trans can stimulate -2/-1 PRF in the nsp2-coding region. That transactivator 
function of nsp1β protein is supported by that the altered version of nsp1β with coding 
sequence mutated synonymously maintained the transactivating activity. At the same time, 
the minimal RNA sequences in the nsp2-coding region were determined, in which  a 34-nt 
region containing the slippery sequence and the conserved 3’ C-rich motif was defined as 
minimal RNA sequence required for the functional PRRSV −2/−1 PRF. In addition, it is 
noteworthy that the conserved nsp1β motif identified in chapter 3 is also critical for PRF 
transactivation, which further supports that nsp1β functions as a transactivator. The 
interaction between nsp1β protein and -2/-1 PRF signal was further confirmed with RNA 
binding assays, however, the underlying mechanism is largely unknown. Clearly, more 
studies are needed to extensively address the in depth mechanisms of -2/-1 PRF in 
arteriviruses.  
Previous studies identified the PRRSV PLP2 domain as an innate immune antagonist. 
The newly identified PRRSV nsp2TF and nsp2N proteins share the PLP2 domain with nsp2, 
which raised the question on which of the three proteins actually function as innate immune 
antagonist(s). In chapter 5, the study was focused on characterizing the ability of these three 
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proteins to inhibit the host innate immune response. Our data indicates that nsp2TF and 
nsp2N both have ability to suppress type I IFN induction and signaling. In comparison with 
full-length nsp2, nsp2TF and nsp2N proteins show stronger ability to de-conjugate ubiquitin 
and ISG15 from host cellular proteins. By introducing mutations at the -2/-1 PRF signal 
region, we further rescued the recombinant viruses (KO1 and KO2) with partially or 
completely knocked out of nsp2TF/nsp2N expression. We further performed in vitro and in 
vivo characterization of three recombinant viruses, KO1, KO2 and 1βKO (1βKO was 
constructed in chapter 3, in which expression of nsp2TF and nsp2N was completely knocked 
out). Consistent with the data generated from in vitro expression system, all recombinant 
viruses showed impaired de-Ub and de-ISGylation ability. All three mutant viruses have a 
reduced capacity to inhibit IFNα and ISG15 expression in virus-infected porcine alveolar 
macrophages and Marc-145 cells. The nursery pig disease model was used to determine the 
attenuation phenotype and immunogenicity of the mutant viruses. In comparison with the 
wild type virus, all three mutants showed a lower level of viral load in serum (3-28 dpi) and 
no apparent lung lesions were observed in mutant virus-infected pigs following the acute 
phase of infection (10 dpi). Additionally, the KO2 mutant appears to induce the best 
protection in animals. All the data presented here suggest that nsp2TF and nsp2N are 
potential innate immune antagonists, and knock-out (down) the expression of these proteins 
could be a new strategy for the development of improved vaccine candidates. 
Given the importance of nsps in viral replication and virus-host interaction, the 
replicase genes have attracted increasing attention during the past decade. However, current 
information of PRRSV nsps encoded by ORF1a and ORF1ab may be just the tip of the 
iceberg. Clearly, there are more questions raised in this dissertation, including: What are the 
authentic proteolytic cleavage sites in PRRSV polyproteins (pp1a and pp1ab)? Does PRRSV 
utilize two alternative processing pathways (major and minor pathways) for pp1a processing 
like EAV? What is the function of the processing intermediates identified in virus-infected 
cells? Does PRRSV nsp1β suppress the expression a group of cellular genes? What are the 
genes? What the mechanism of nsp1β’s suppression effect on gene expression?  How does 
nsp1β transactivate the unusual -2/-1 PRF? Could nsp1β cause ribosomal frameshifting event 
in the cellular gene containing similar -2 PRF signal? What is the detailed functional 
difference of three nsp2-related proteins? Answering these questions will be future research 
directions. 
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